NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|731385391|ref|XP_010648487|]
View 

leucine-rich repeat receptor-like serine/threonine-protein kinase SKM1 [Vitis vinifera]

Protein Classification

leucine-rich repeat domain-containing protein; leucine-rich repeat protein kinase family protein( domain architecture ID 11476383)

leucine-rich repeat (LRR) domain-containing protein may participate in protein-protein interactions; protein kinase family protein containing leucine-rich repeat(s), may catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine and/or tyrosine residues on protein substrates; similar to plant LRR receptor-like kinases

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
PLN00113 PLN00113
leucine-rich repeat receptor-like protein kinase; Provisional
1-967 0e+00

leucine-rich repeat receptor-like protein kinase; Provisional


:

Pssm-ID: 215061 [Multi-domain]  Cd Length: 968  Bit Score: 1703.12  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391   1 MAKRGAQTCGLFIISMFFFFFSFGMSAREEIELLLSFKASINDPLGFLSNWNSSVDFCNWYGILCTNSSHVSSIDLSGKN 80
Cdd:PLN00113   1 MAKKGPQHCPYLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKN 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391  81 ISGEISPVFFGLPYIETVNLSNNALSGGIPGNIS-LCYSLRYLNLSNNNLTGSMPRGSASGLEALDLSNNVISGEIPADM 159
Cdd:PLN00113  81 ISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFtTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDI 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 160 GLFSRLKVLDLGGNFLVGKIPNSIANITSLEFLTLASNQLVGEIPRELGRMKSLKWIYLGYNNLSGGIPKEIGELTSLNH 239
Cdd:PLN00113 161 GSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH 240
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 240 LDLVYNNLTGEIPSSLGNLSDLHFLFLYQNKLSGSIPPSIFDLKKLISLDLSDNSLSGEIPELVIQLQNLEILHLFANDF 319
Cdd:PLN00113 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNF 320
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 320 TGKIPRALASLPRLQILQLWSNKLSGEIPKNLGKQNNLTVLDLSTNNLSGEIPESLCNSGRLFKLILFSNSLEGEVPKSL 399
Cdd:PLN00113 321 TGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSL 400
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 400 SDCRSLRRVRLQSNHFSGELSSEFMKLPLVYFLDISDNNLTGKISDRRWDMPSLQMLSLARNRFFGNLPQSFGASKLENL 479
Cdd:PLN00113 401 GACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENL 480
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 480 DLSENQFSGAVPSSFGNLSELMQLKLSENMLSGDIPEELSSCKKLVSLNLSHNQLSGHIPASFSDMPVLGQLDLSQNQLS 559
Cdd:PLN00113 481 DLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLS 560
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 560 GKIPPNLGRVESLVQVNLSNNHLHGSLPSTGAFLAINSSSVSGNN-LCGGDTTSGLPPCKRL-KTPVWWFFVTCLLVVLV 637
Cdd:PLN00113 561 GEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIdLCGGDTTSGLPPCKRVrKTPSWWFYITCTLGAFL 640
                        650       660       670       680       690       700       710       720
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 638 VLALAAFAVVFIRRRDGSELKRVEHEDGMWEMQFFDSKASKSITIKGILSSTTENNVISRGRKGISYKGKTKNGEMQFVV 717
Cdd:PLN00113 641 VLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVV 720
                        730       740       750       760       770       780       790       800
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 718 KEINDSNSIPSSFwteFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVLRSLSWERRQKIAIGISKALRFLH 797
Cdd:PLN00113 721 KEINDVNSIPSSE---IADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLH 797
                        810       820       830       840       850       860       870       880
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 798 CNCSPSMVVGNMSPQKIIIDGKDEPHLRLSPPLMVCTDFKCIISSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSP 877
Cdd:PLN00113 798 CRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877
                        890       900       910       920       930       940       950       960
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 878 TDAEFGVHGSIVEWGRYCYSDCHLDMWIDPIIRAQVSSNQNQMVEIMNLALHCTATDPTARPCASDVLKTLESVLR-SSS 956
Cdd:PLN00113 878 ADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRsSSS 957
                        970
                 ....*....|.
gi 731385391 957 CVSGLKFSSPI 967
Cdd:PLN00113 958 CVTGLKFSSLF 968
 
Name Accession Description Interval E-value
PLN00113 PLN00113
leucine-rich repeat receptor-like protein kinase; Provisional
1-967 0e+00

leucine-rich repeat receptor-like protein kinase; Provisional


Pssm-ID: 215061 [Multi-domain]  Cd Length: 968  Bit Score: 1703.12  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391   1 MAKRGAQTCGLFIISMFFFFFSFGMSAREEIELLLSFKASINDPLGFLSNWNSSVDFCNWYGILCTNSSHVSSIDLSGKN 80
Cdd:PLN00113   1 MAKKGPQHCPYLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKN 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391  81 ISGEISPVFFGLPYIETVNLSNNALSGGIPGNIS-LCYSLRYLNLSNNNLTGSMPRGSASGLEALDLSNNVISGEIPADM 159
Cdd:PLN00113  81 ISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFtTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDI 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 160 GLFSRLKVLDLGGNFLVGKIPNSIANITSLEFLTLASNQLVGEIPRELGRMKSLKWIYLGYNNLSGGIPKEIGELTSLNH 239
Cdd:PLN00113 161 GSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH 240
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 240 LDLVYNNLTGEIPSSLGNLSDLHFLFLYQNKLSGSIPPSIFDLKKLISLDLSDNSLSGEIPELVIQLQNLEILHLFANDF 319
Cdd:PLN00113 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNF 320
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 320 TGKIPRALASLPRLQILQLWSNKLSGEIPKNLGKQNNLTVLDLSTNNLSGEIPESLCNSGRLFKLILFSNSLEGEVPKSL 399
Cdd:PLN00113 321 TGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSL 400
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 400 SDCRSLRRVRLQSNHFSGELSSEFMKLPLVYFLDISDNNLTGKISDRRWDMPSLQMLSLARNRFFGNLPQSFGASKLENL 479
Cdd:PLN00113 401 GACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENL 480
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 480 DLSENQFSGAVPSSFGNLSELMQLKLSENMLSGDIPEELSSCKKLVSLNLSHNQLSGHIPASFSDMPVLGQLDLSQNQLS 559
Cdd:PLN00113 481 DLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLS 560
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 560 GKIPPNLGRVESLVQVNLSNNHLHGSLPSTGAFLAINSSSVSGNN-LCGGDTTSGLPPCKRL-KTPVWWFFVTCLLVVLV 637
Cdd:PLN00113 561 GEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIdLCGGDTTSGLPPCKRVrKTPSWWFYITCTLGAFL 640
                        650       660       670       680       690       700       710       720
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 638 VLALAAFAVVFIRRRDGSELKRVEHEDGMWEMQFFDSKASKSITIKGILSSTTENNVISRGRKGISYKGKTKNGEMQFVV 717
Cdd:PLN00113 641 VLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVV 720
                        730       740       750       760       770       780       790       800
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 718 KEINDSNSIPSSFwteFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVLRSLSWERRQKIAIGISKALRFLH 797
Cdd:PLN00113 721 KEINDVNSIPSSE---IADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLH 797
                        810       820       830       840       850       860       870       880
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 798 CNCSPSMVVGNMSPQKIIIDGKDEPHLRLSPPLMVCTDFKCIISSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSP 877
Cdd:PLN00113 798 CRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877
                        890       900       910       920       930       940       950       960
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 878 TDAEFGVHGSIVEWGRYCYSDCHLDMWIDPIIRAQVSSNQNQMVEIMNLALHCTATDPTARPCASDVLKTLESVLR-SSS 956
Cdd:PLN00113 878 ADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRsSSS 957
                        970
                 ....*....|.
gi 731385391 957 CVSGLKFSSPI 967
Cdd:PLN00113 958 CVTGLKFSSLF 968
STKc_IRAK cd14066
Catalytic domain of the Serine/Threonine kinases, Interleukin-1 Receptor Associated Kinases ...
695-949 6.07e-48

Catalytic domain of the Serine/Threonine kinases, Interleukin-1 Receptor Associated Kinases and related STKs; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. IRAKs are involved in Toll-like receptor (TLR) and interleukin-1 (IL-1) signalling pathways, and are thus critical in regulating innate immune responses and inflammation. Some IRAKs may also play roles in T- and B-cell signaling, and adaptive immunity. Vertebrates contain four IRAKs (IRAK-1, -2, -3 (or -M), and -4) that display distinct functions and patterns of expression and subcellular distribution, and can differentially mediate TLR signaling. IRAK-1, -2, and -4 are ubiquitously expressed and are active kinases, while IRAK-M is only induced in monocytes and macrophages and is an inactive kinase. Variations in IRAK genes are linked to diverse diseases including infection, sepsis, cancer, and autoimmune diseases. IRAKs contain an N-terminal Death domain (DD), a proST region (rich in serines, prolines, and threonines), a central kinase domain (a pseudokinase domain in the case of IRAK3), and a C-terminal domain; IRAK-4 lacks the C-terminal domain. This subfamily includes plant receptor-like kinases (RLKs) including Arabidopsis thaliana BAK1 and CLAVATA1 (CLV1). BAK1 functions in BR (brassinosteroid)-regulated plant development and in pathways involved in plant resistance to pathogen infection and herbivore attack. CLV1, directly binds small signaling peptides, CLAVATA3 (CLV3) and CLAVATA3/EMBRYO SURROUNDING REGI0N (CLE), to restrict stem cell proliferation: the CLV3-CLV1-WUS (WUSCHEL) module influences stem cell maintenance in the shoot apical meristem, and the CLE40 (CLAVATA3/EMBRYO SURROUNDING REGION40) -ACR4 (CRINKLY4) -CLV1- WOX5 (WUSCHEL-RELATED HOMEOBOX5) module at the root apical meristem. The IRAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270968 [Multi-domain]  Cd Length: 272  Bit Score: 172.07  E-value: 6.07e-48
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTKNGeMQFVVKEINDSN--SIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSE 772
Cdd:cd14066    1 IGSGGFGTVYKGVLENG-TVVAVKRLNEMNcaASKKEFLTELEMLGRLRHPNLVRLLGYCLESDEKLLVYEYMPNGSLED 79
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 773 VLRS------LSWERRQKIAIGISKALRFLHCNCSPSMVVGNMSPQKIIIDGKDEPHL------RLSPP-------LMVC 833
Cdd:cd14066   80 RLHChkgsppLPWPQRLKIAKGIARGLEYLHEECPPPIIHGDIKSSNILLDEDFEPKLtdfglaRLIPPsesvsktSAVK 159
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 834 TdfkciiSSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSPTD---AEFGVhGSIVEWGRYCYSDCHLDMwIDPIIR 910
Cdd:cd14066  160 G------TIGYLAPEYIRTGRVSTKSDVYSFGVVLLELLTGKPAVDenrENASR-KDLVEWVESKGKEELEDI-LDKRLV 231
                        250       260       270
                 ....*....|....*....|....*....|....*....
gi 731385391 911 AQVSSNQNQMVEIMNLALHCTATDPTARPCASDVLKTLE 949
Cdd:cd14066  232 DDDGVEEEEVEALLRLALLCTRSDPSLRPSMKEVVQMLE 270
LRR COG4886
Leucine-rich repeat (LRR) protein [Transcription];
30-378 1.48e-36

Leucine-rich repeat (LRR) protein [Transcription];


Pssm-ID: 443914 [Multi-domain]  Cd Length: 414  Bit Score: 143.15  E-value: 1.48e-36
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391  30 EIELLLSFKASINDPLGFLSNWNSSVDFCNWYGILCTNSSHVSSIDLSGKNISGEISPVFFGLPYIETVNLSNNALSGGI 109
Cdd:COG4886    3 LLLLSLTLKLLLLLLLELLTTLILLLLLLLLLLALLLLSLLSLLLLLTLLLSLLLRDLLLSSLLLLLSLLLLLLLSLLLL 82
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 110 PGNISLCYSLRYL-NLSNNNLTGSMPRGSASGLEALDLSNNVISgEIPADMGLFSRLKVLDLGGNFLvGKIPNSIANITS 188
Cdd:COG4886   83 SLLLLGLTDLGDLtNLTELDLSGNEELSNLTNLESLDLSGNQLT-DLPEELANLTNLKELDLSNNQL-TDLPEPLGNLTN 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 189 LEFLTLASNQLvGEIPRELGRMKSLKWIYLGYNNLSGgIPKEIGELTSLNHLDLVYNNLTgEIPSSLGNLSDLHFLFLYQ 268
Cdd:COG4886  161 LKSLDLSNNQL-TDLPEELGNLTNLKELDLSNNQITD-LPEPLGNLTNLEELDLSGNQLT-DLPEPLANLTNLETLDLSN 237
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 269 NKLSgSIpPSIFDLKKLISLDLSDNSLSgEIPELvIQLQNLEILHLFANDFTGKIPRALASLPRLQILQLWSNKLSGEIP 348
Cdd:COG4886  238 NQLT-DL-PELGNLTNLEELDLSNNQLT-DLPPL-ANLTNLKTLDLSNNQLTDLKLKELELLLGLNSLLLLLLLLNLLEL 313
                        330       340       350
                 ....*....|....*....|....*....|
gi 731385391 349 KNLGKQNNLTVLDLSTNNLSGEIPESLCNS 378
Cdd:COG4886  314 LILLLLLTTLLLLLLLLKGLLVTLTTLALS 343
S_TKc smart00220
Serine/Threonine protein kinases, catalytic domain; Phosphotransferases. Serine or ...
693-946 6.09e-18

Serine/Threonine protein kinases, catalytic domain; Phosphotransferases. Serine or threonine-specific kinase subfamily.


Pssm-ID: 214567 [Multi-domain]  Cd Length: 254  Bit Score: 84.50  E-value: 6.09e-18
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391   693 NVISRGRKGISYKGKTKNGEMQFVVKEIN--DSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNL 770
Cdd:smart00220   5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKkkKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDL 84
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391   771 SEVLRS---LSWERRQKIAIGISKALRFLHCNCspsmVV-GNMSPQKIIIDgkDEPHLRLspplmvcTDF---------- 836
Cdd:smart00220  85 FDLLKKrgrLSEDEARFYLRQILSALEYLHSKG----IVhRDLKPENILLD--EDGHVKL-------ADFglarqldpge 151
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391   837 ---KCIISSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSPtdaeFgvhgsivewgrycYSDCHLDMWIDPIIRAQV 913
Cdd:smart00220 152 kltTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP----F-------------PGDDQLLELFKKIGKPKP 214
                          250       260       270
                   ....*....|....*....|....*....|....*.
gi 731385391   914 SSNQNQMV---EIMNLALHCTATDPTARPCASDVLK 946
Cdd:smart00220 215 PFPPPEWDispEAKDLIRKLLVKDPEKRLTAEEALQ 250
PK_Tyr_Ser-Thr pfam07714
Protein tyrosine and serine/threonine kinase; Protein phosphorylation, which plays a key role ...
699-948 6.30e-15

Protein tyrosine and serine/threonine kinase; Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyze the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyze the reverse process. Protein kinases fall into three broad classes, characterized with respect to substrate specificity; Serine/threonine-protein kinases, tyrosine-protein kinases, and dual specificity protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins). This entry represents the catalytic domain found in a number of serine/threonine- and tyrosine-protein kinases. It does not include the catalytic domain of dual specificity kinases.


Pssm-ID: 462242 [Multi-domain]  Cd Length: 258  Bit Score: 75.61  E-value: 6.30e-15
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391  699 RKGIsYKGKTKNGEMQFVVKEINDSNSIPS--SFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVLR- 775
Cdd:pfam07714  16 YKGT-LKGEGENTKIKVAVKTLKEGADEEEreDFLEEASIMKKLDHPNIVKLLGVCTQGEPLYIVTEYMPGGDLLDFLRk 94
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391  776 ---SLSWERRQKIAIGISKALRFLH---C--------NC--SPSMVVgnmspqKI-------IIDGKDEPHLRLSPPLMV 832
Cdd:pfam07714  95 hkrKLTLKDLLSMALQIAKGMEYLEsknFvhrdlaarNClvSENLVV------KIsdfglsrDIYDDDYYRKRGGGKLPI 168
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391  833 CtdfkciissaYFAPETRETKDTTEKSDIYGFGLILIELMT-GKSP----TDAEfgVHGSIVEWGR-YCYSDCHldmwid 906
Cdd:pfam07714 169 K----------WMAPESLKDGKFTSKSDVWSFGVLLWEIFTlGEQPypgmSNEE--VLEFLEDGYRlPQPENCP------ 230
                         250       260       270       280
                  ....*....|....*....|....*....|....*....|..
gi 731385391  907 piiraqvssnqnqmVEIMNLALHCTATDPTARPCASDVLKTL 948
Cdd:pfam07714 231 --------------DELYDLMKQCWAYDPEDRPTFSELVEDL 258
PknB_PASTA_kin NF033483
Stk1 family PASTA domain-containing Ser/Thr kinase;
739-953 4.39e-09

Stk1 family PASTA domain-containing Ser/Thr kinase;


Pssm-ID: 468045 [Multi-domain]  Cd Length: 563  Bit Score: 60.19  E-value: 4.39e-09
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 739 KLRHSNVVKL--IGlcRSQKCGYLISEYIEGKNLSEVLRS---LSWERRQKIAIGISKALRFLHCNcspSMVVGNMSPQK 813
Cdd:NF033483  63 SLSHPNIVSVydVG--EDGGIPYIVMEYVDGRTLKDYIREhgpLSPEEAVEIMIQILSALEHAHRN---GIVHRDIKPQN 137
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 814 III--DGKdephlrlsppLMVcTDF--------------KCIISSA-YFAPETRETKDTTEKSDIYGFGLILIELMTGKS 876
Cdd:NF033483 138 ILItkDGR----------VKV-TDFgiaralssttmtqtNSVLGTVhYLSPEQARGGTVDARSDIYSLGIVLYEMLTGRP 206
                        170       180       190       200       210       220       230
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 731385391 877 PTDAEFGVhgSIVewgrycYSdcHLDmwiDPIIRA-QVSSNQNQMVEimNLALHCTATDPTARP-CASDVLKTLESVLR 953
Cdd:NF033483 207 PFDGDSPV--SVA------YK--HVQ---EDPPPPsELNPGIPQSLD--AVVLKATAKDPDDRYqSAAEMRADLETALS 270
 
Name Accession Description Interval E-value
PLN00113 PLN00113
leucine-rich repeat receptor-like protein kinase; Provisional
1-967 0e+00

leucine-rich repeat receptor-like protein kinase; Provisional


Pssm-ID: 215061 [Multi-domain]  Cd Length: 968  Bit Score: 1703.12  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391   1 MAKRGAQTCGLFIISMFFFFFSFGMSAREEIELLLSFKASINDPLGFLSNWNSSVDFCNWYGILCTNSSHVSSIDLSGKN 80
Cdd:PLN00113   1 MAKKGPQHCPYLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKN 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391  81 ISGEISPVFFGLPYIETVNLSNNALSGGIPGNIS-LCYSLRYLNLSNNNLTGSMPRGSASGLEALDLSNNVISGEIPADM 159
Cdd:PLN00113  81 ISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFtTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDI 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 160 GLFSRLKVLDLGGNFLVGKIPNSIANITSLEFLTLASNQLVGEIPRELGRMKSLKWIYLGYNNLSGGIPKEIGELTSLNH 239
Cdd:PLN00113 161 GSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH 240
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 240 LDLVYNNLTGEIPSSLGNLSDLHFLFLYQNKLSGSIPPSIFDLKKLISLDLSDNSLSGEIPELVIQLQNLEILHLFANDF 319
Cdd:PLN00113 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNF 320
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 320 TGKIPRALASLPRLQILQLWSNKLSGEIPKNLGKQNNLTVLDLSTNNLSGEIPESLCNSGRLFKLILFSNSLEGEVPKSL 399
Cdd:PLN00113 321 TGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSL 400
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 400 SDCRSLRRVRLQSNHFSGELSSEFMKLPLVYFLDISDNNLTGKISDRRWDMPSLQMLSLARNRFFGNLPQSFGASKLENL 479
Cdd:PLN00113 401 GACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENL 480
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 480 DLSENQFSGAVPSSFGNLSELMQLKLSENMLSGDIPEELSSCKKLVSLNLSHNQLSGHIPASFSDMPVLGQLDLSQNQLS 559
Cdd:PLN00113 481 DLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLS 560
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 560 GKIPPNLGRVESLVQVNLSNNHLHGSLPSTGAFLAINSSSVSGNN-LCGGDTTSGLPPCKRL-KTPVWWFFVTCLLVVLV 637
Cdd:PLN00113 561 GEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIdLCGGDTTSGLPPCKRVrKTPSWWFYITCTLGAFL 640
                        650       660       670       680       690       700       710       720
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 638 VLALAAFAVVFIRRRDGSELKRVEHEDGMWEMQFFDSKASKSITIKGILSSTTENNVISRGRKGISYKGKTKNGEMQFVV 717
Cdd:PLN00113 641 VLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVV 720
                        730       740       750       760       770       780       790       800
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 718 KEINDSNSIPSSFwteFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVLRSLSWERRQKIAIGISKALRFLH 797
Cdd:PLN00113 721 KEINDVNSIPSSE---IADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLH 797
                        810       820       830       840       850       860       870       880
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 798 CNCSPSMVVGNMSPQKIIIDGKDEPHLRLSPPLMVCTDFKCIISSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSP 877
Cdd:PLN00113 798 CRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877
                        890       900       910       920       930       940       950       960
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 878 TDAEFGVHGSIVEWGRYCYSDCHLDMWIDPIIRAQVSSNQNQMVEIMNLALHCTATDPTARPCASDVLKTLESVLR-SSS 956
Cdd:PLN00113 878 ADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRsSSS 957
                        970
                 ....*....|.
gi 731385391 957 CVSGLKFSSPI 967
Cdd:PLN00113 958 CVTGLKFSSLF 968
STKc_IRAK cd14066
Catalytic domain of the Serine/Threonine kinases, Interleukin-1 Receptor Associated Kinases ...
695-949 6.07e-48

Catalytic domain of the Serine/Threonine kinases, Interleukin-1 Receptor Associated Kinases and related STKs; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. IRAKs are involved in Toll-like receptor (TLR) and interleukin-1 (IL-1) signalling pathways, and are thus critical in regulating innate immune responses and inflammation. Some IRAKs may also play roles in T- and B-cell signaling, and adaptive immunity. Vertebrates contain four IRAKs (IRAK-1, -2, -3 (or -M), and -4) that display distinct functions and patterns of expression and subcellular distribution, and can differentially mediate TLR signaling. IRAK-1, -2, and -4 are ubiquitously expressed and are active kinases, while IRAK-M is only induced in monocytes and macrophages and is an inactive kinase. Variations in IRAK genes are linked to diverse diseases including infection, sepsis, cancer, and autoimmune diseases. IRAKs contain an N-terminal Death domain (DD), a proST region (rich in serines, prolines, and threonines), a central kinase domain (a pseudokinase domain in the case of IRAK3), and a C-terminal domain; IRAK-4 lacks the C-terminal domain. This subfamily includes plant receptor-like kinases (RLKs) including Arabidopsis thaliana BAK1 and CLAVATA1 (CLV1). BAK1 functions in BR (brassinosteroid)-regulated plant development and in pathways involved in plant resistance to pathogen infection and herbivore attack. CLV1, directly binds small signaling peptides, CLAVATA3 (CLV3) and CLAVATA3/EMBRYO SURROUNDING REGI0N (CLE), to restrict stem cell proliferation: the CLV3-CLV1-WUS (WUSCHEL) module influences stem cell maintenance in the shoot apical meristem, and the CLE40 (CLAVATA3/EMBRYO SURROUNDING REGION40) -ACR4 (CRINKLY4) -CLV1- WOX5 (WUSCHEL-RELATED HOMEOBOX5) module at the root apical meristem. The IRAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270968 [Multi-domain]  Cd Length: 272  Bit Score: 172.07  E-value: 6.07e-48
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTKNGeMQFVVKEINDSN--SIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSE 772
Cdd:cd14066    1 IGSGGFGTVYKGVLENG-TVVAVKRLNEMNcaASKKEFLTELEMLGRLRHPNLVRLLGYCLESDEKLLVYEYMPNGSLED 79
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 773 VLRS------LSWERRQKIAIGISKALRFLHCNCSPSMVVGNMSPQKIIIDGKDEPHL------RLSPP-------LMVC 833
Cdd:cd14066   80 RLHChkgsppLPWPQRLKIAKGIARGLEYLHEECPPPIIHGDIKSSNILLDEDFEPKLtdfglaRLIPPsesvsktSAVK 159
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 834 TdfkciiSSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSPTD---AEFGVhGSIVEWGRYCYSDCHLDMwIDPIIR 910
Cdd:cd14066  160 G------TIGYLAPEYIRTGRVSTKSDVYSFGVVLLELLTGKPAVDenrENASR-KDLVEWVESKGKEELEDI-LDKRLV 231
                        250       260       270
                 ....*....|....*....|....*....|....*....
gi 731385391 911 AQVSSNQNQMVEIMNLALHCTATDPTARPCASDVLKTLE 949
Cdd:cd14066  232 DDDGVEEEEVEALLRLALLCTRSDPSLRPSMKEVVQMLE 270
STK_BAK1_like cd14664
Catalytic domain of the Serine/Threonine Kinase, BRI1 associated kinase 1 and related STKs; ...
695-951 3.80e-42

Catalytic domain of the Serine/Threonine Kinase, BRI1 associated kinase 1 and related STKs; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This subfamily includes three leucine-rich repeat receptor-like kinases (LRR-RLKs): Arabidopsis thaliana BAK1 and CLAVATA1 (CLV1), and Physcomitrella patens CLL1B clavata1-like receptor S/T protein kinase. BAK1 functions in various signaling pathways. It plays a role in BR (brassinosteroid)-regulated plant development as a co-receptor of BRASSINOSTEROID (BR) INSENSITIVE 1 (BRI1), the receptor for BRs, and is required for full activation of BR signaling. It also modulates pathways involved in plant resistance to pathogen infection (pattern-triggered immunity, PTI) and herbivore attack (wound- or herbivore feeding-induced accumulation of jasmonic acid (JA) and JA-isoleucine. CLV1, directly binds small signaling peptides, CLAVATA3 (CLV3) and CLAVATA3/EMBRYO SURROUNDING REGI0N (CLE), to restrict stem cell proliferation: the CLV3-CLV1-WUS (WUSCHEL) module influences stem cell maintenance in the shoot apical meristem, and the CLE40 (CLAVATA3/EMBRYO SURROUNDING REGION40) -ACR4 (CRINKLY4) -CLV1- WOX5 (WUSCHEL-RELATED HOMEOBOX5) module at the root apical meristem. The STK_BAK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271134 [Multi-domain]  Cd Length: 270  Bit Score: 155.35  E-value: 3.80e-42
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTKNGEMqFVVKEINDSNSIPSS--FWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSE 772
Cdd:cd14664    1 IGRGGAGTVYKGVMPNGTL-VAVKRLKGEGTQGGDhgFQAEIQTLGMIRHRNIVRLRGYCSNPTTNLLVYEYMPNGSLGE 79
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 773 VLRS-------LSWERRQKIAIGISKALRFLHCNCSPSMVVGNMSPQKIIIDGKDEPHLR---LSPpLMVCTDFKCIISS 842
Cdd:cd14664   80 LLHSrpesqppLDWETRQRIALGSARGLAYLHHDCSPLIIHRDVKSNNILLDEEFEAHVAdfgLAK-LMDDKDSHVMSSV 158
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 843 A----YFAPETRETKDTTEKSDIYGFGLILIELMTGKSPTDAEFGVHG-SIVEWGRYCYSDCHLDMWIDPiiRAQVSSNQ 917
Cdd:cd14664  159 AgsygYIAPEYAYTGKVSEKSDVYSYGVVLLELITGKRPFDEAFLDDGvDIVDWVRGLLEEKKVEALVDP--DLQGVYKL 236
                        250       260       270
                 ....*....|....*....|....*....|....
gi 731385391 918 NQMVEIMNLALHCTATDPTARPCASDVLKTLESV 951
Cdd:cd14664  237 EEVEQVFQVALLCTQSSPMERPTMREVVRMLEGD 270
LRR COG4886
Leucine-rich repeat (LRR) protein [Transcription];
30-378 1.48e-36

Leucine-rich repeat (LRR) protein [Transcription];


Pssm-ID: 443914 [Multi-domain]  Cd Length: 414  Bit Score: 143.15  E-value: 1.48e-36
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391  30 EIELLLSFKASINDPLGFLSNWNSSVDFCNWYGILCTNSSHVSSIDLSGKNISGEISPVFFGLPYIETVNLSNNALSGGI 109
Cdd:COG4886    3 LLLLSLTLKLLLLLLLELLTTLILLLLLLLLLLALLLLSLLSLLLLLTLLLSLLLRDLLLSSLLLLLSLLLLLLLSLLLL 82
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 110 PGNISLCYSLRYL-NLSNNNLTGSMPRGSASGLEALDLSNNVISgEIPADMGLFSRLKVLDLGGNFLvGKIPNSIANITS 188
Cdd:COG4886   83 SLLLLGLTDLGDLtNLTELDLSGNEELSNLTNLESLDLSGNQLT-DLPEELANLTNLKELDLSNNQL-TDLPEPLGNLTN 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 189 LEFLTLASNQLvGEIPRELGRMKSLKWIYLGYNNLSGgIPKEIGELTSLNHLDLVYNNLTgEIPSSLGNLSDLHFLFLYQ 268
Cdd:COG4886  161 LKSLDLSNNQL-TDLPEELGNLTNLKELDLSNNQITD-LPEPLGNLTNLEELDLSGNQLT-DLPEPLANLTNLETLDLSN 237
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 269 NKLSgSIpPSIFDLKKLISLDLSDNSLSgEIPELvIQLQNLEILHLFANDFTGKIPRALASLPRLQILQLWSNKLSGEIP 348
Cdd:COG4886  238 NQLT-DL-PELGNLTNLEELDLSNNQLT-DLPPL-ANLTNLKTLDLSNNQLTDLKLKELELLLGLNSLLLLLLLLNLLEL 313
                        330       340       350
                 ....*....|....*....|....*....|
gi 731385391 349 KNLGKQNNLTVLDLSTNNLSGEIPESLCNS 378
Cdd:COG4886  314 LILLLLLTTLLLLLLLLKGLLVTLTTLALS 343
LRR COG4886
Leucine-rich repeat (LRR) protein [Transcription];
31-371 3.37e-33

Leucine-rich repeat (LRR) protein [Transcription];


Pssm-ID: 443914 [Multi-domain]  Cd Length: 414  Bit Score: 133.52  E-value: 3.37e-33
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391  31 IELLLSFKASINDPLGFLSNWNSSVDFCNWYGILCTNSSHVSSIDLSGKNISGEIspvFFGLPYIETVNLSNNAlsggip 110
Cdd:COG4886   37 LLLLSLLSLLLLLTLLLSLLLRDLLLSSLLLLLSLLLLLLLSLLLLSLLLLGLTD---LGDLTNLTELDLSGNE------ 107
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 111 gNISLCYSLRYLNLSNNNLTgSMPR--GSASGLEALDLSNNVISgEIPADMGLFSRLKVLDLGGNFLVGkIPNSIANITS 188
Cdd:COG4886  108 -ELSNLTNLESLDLSGNQLT-DLPEelANLTNLKELDLSNNQLT-DLPEPLGNLTNLKSLDLSNNQLTD-LPEELGNLTN 183
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 189 LEFLTLASNQLvGEIPRELGRMKSLKWIYLGYNNLSGgIPKEIGELTSLNHLDLVYNNLTgEIPSsLGNLSDLHFLFLYQ 268
Cdd:COG4886  184 LKELDLSNNQI-TDLPEPLGNLTNLEELDLSGNQLTD-LPEPLANLTNLETLDLSNNQLT-DLPE-LGNLTNLEELDLSN 259
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 269 NKLSgSIPPSiFDLKKLISLDLSDNSLSGEIPELVIQLQNLEILHLFANDFTGKIPRALASLPRLQILQLWSNKLSGEIP 348
Cdd:COG4886  260 NQLT-DLPPL-ANLTNLKTLDLSNNQLTDLKLKELELLLGLNSLLLLLLLLNLLELLILLLLLTTLLLLLLLLKGLLVTL 337
                        330       340
                 ....*....|....*....|...
gi 731385391 349 KNLGKQNNLTVLDLSTNNLSGEI 371
Cdd:COG4886  338 TTLALSLSLLALLTLLLLLNLLS 360
STKc_MAP3K-like cd13999
Catalytic domain of Mitogen-Activated Protein Kinase (MAPK) Kinase Kinase-like Serine ...
695-948 8.86e-29

Catalytic domain of Mitogen-Activated Protein Kinase (MAPK) Kinase Kinase-like Serine/Threonine kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This subfamily is composed mainly of MAP3Ks and similar proteins, including TGF-beta Activated Kinase-1 (TAK1, also called MAP3K7), MAP3K12, MAP3K13, Mixed lineage kinase (MLK), MLK-Like mitogen-activated protein Triple Kinase (MLTK), and Raf (Rapidly Accelerated Fibrosarcoma) kinases. MAP3Ks (MKKKs or MAPKKKs) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Also included in this subfamily is the pseudokinase Kinase Suppressor of Ras (KSR), which is a scaffold protein that functions downstream of Ras and upstream of Raf in the Extracellular signal-Regulated Kinase (ERK) pathway.


Pssm-ID: 270901 [Multi-domain]  Cd Length: 245  Bit Score: 115.71  E-value: 8.86e-29
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTKNGEMqfVVKEI---NDSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLS 771
Cdd:cd13999    1 IGSGSFGEVYKGKWRGTDV--AIKKLkveDDNDELLKEFRREVSILSKLRHPNIVQFIGACLSPPPLCIVTEYMPGGSLY 78
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 772 EVLRS----LSWERRQKIAIGISKALRFLHcncSPSMVVGNMSPQKIIIDgkDEPHLRLSpplmvctDF--KCIISS--- 842
Cdd:cd13999   79 DLLHKkkipLSWSLRLKIALDIARGMNYLH---SPPIIHRDLKSLNILLD--ENFTVKIA-------DFglSRIKNStte 146
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 843 ---------AYFAPETRETKDTTEKSDIYGFGLILIELMTGKSPtdaeFGVHGSIVEWgrycysdchLDMWIDPIIRAQV 913
Cdd:cd13999  147 kmtgvvgtpRWMAPEVLRGEPYTEKADVYSFGIVLWELLTGEVP----FKELSPIQIA---------AAVVQKGLRPPIP 213
                        250       260       270
                 ....*....|....*....|....*....|....*
gi 731385391 914 SSNQNQMVEIMNLalhCTATDPTARPCASDVLKTL 948
Cdd:cd13999  214 PDCPPELSKLIKR---CWNEDPEKRPSFSEIVKRL 245
LRR COG4886
Leucine-rich repeat (LRR) protein [Transcription];
210-596 2.97e-27

Leucine-rich repeat (LRR) protein [Transcription];


Pssm-ID: 443914 [Multi-domain]  Cd Length: 414  Bit Score: 115.80  E-value: 2.97e-27
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 210 MKSLKWIYLGYNNLSGGIPKEIGELTSLNHLDLVYNNLTGEIPSSLGNLSDLHFLFLYQNKLSGsiPPSIFDLKKLISLD 289
Cdd:COG4886   25 ILLLLLLLLLLALLLLSLLSLLLLLTLLLSLLLRDLLLSSLLLLLSLLLLLLLSLLLLSLLLLG--LTDLGDLTNLTELD 102
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 290 LSDNSLSGeipelviQLQNLEILHLFANDFTgKIPRALASLPRLQILQLWSNKLSgEIPKNLGKQNNLTVLDLSTNNLSg 369
Cdd:COG4886  103 LSGNEELS-------NLTNLESLDLSGNQLT-DLPEELANLTNLKELDLSNNQLT-DLPEPLGNLTNLKSLDLSNNQLT- 172
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 370 EIPESLCNSGRLFKLILFSNSLEgEVPKSLSDCRSLRRVRLQSNHFSgELSSEFMKLPLVYFLDISDNNLTgkisdrrwD 449
Cdd:COG4886  173 DLPEELGNLTNLKELDLSNNQIT-DLPEPLGNLTNLEELDLSGNQLT-DLPEPLANLTNLETLDLSNNQLT--------D 242
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 450 MPSLqmlslarnrffGNLPqsfgasKLENLDLSENQFSGAvpSSFGNLSELMQLKLSENMLSGDIPEELSSCKKLVSLNL 529
Cdd:COG4886  243 LPEL-----------GNLT------NLEELDLSNNQLTDL--PPLANLTNLKTLDLSNNQLTDLKLKELELLLGLNSLLL 303
                        330       340       350       360       370       380
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 731385391 530 SHNQLSGHIPASFSDMPVLGQLDLSQNQLSGKIPPNLGRVESLVQVNLSNNHLHGSLPSTGAFLAIN 596
Cdd:COG4886  304 LLLLLNLLELLILLLLLTTLLLLLLLLKGLLVTLTTLALSLSLLALLTLLLLLNLLSLLLTLLLTLG 370
PKc cd00180
Catalytic domain of Protein Kinases; PKs catalyze the transfer of the gamma-phosphoryl group ...
695-871 4.69e-26

Catalytic domain of Protein Kinases; PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. PKs make up a large family of serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and more than 500 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase.


Pssm-ID: 270622 [Multi-domain]  Cd Length: 215  Bit Score: 106.97  E-value: 4.69e-26
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTKNGEMQFVVKEIN--DSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSE 772
Cdd:cd00180    1 LGKGSFGKVYKARDKETGKKVAVKVIPkeKLKKLLEELLREIEILKKLNHPNIVKLYDVFETENFLYLVMEYCEGGSLKD 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 773 VLRS----LSWERRQKIAIGISKALRFLHCNcspSMVVGNMSPQKIIIDGKDEPHL-------RLSPPLMVCTDFKCIIS 841
Cdd:cd00180   81 LLKEnkgpLSEEEALSILRQLLSALEYLHSN---GIIHRDLKPENILLDSDGTVKLadfglakDLDSDDSLLKTTGGTTP 157
                        170       180       190
                 ....*....|....*....|....*....|
gi 731385391 842 SAYFAPETRETKDTTEKSDIYGFGLILIEL 871
Cdd:cd00180  158 PYYAPPELLGGRYYGPKVDIWSLGVILYEL 187
LRR COG4886
Leucine-rich repeat (LRR) protein [Transcription];
261-582 1.98e-23

Leucine-rich repeat (LRR) protein [Transcription];


Pssm-ID: 443914 [Multi-domain]  Cd Length: 414  Bit Score: 104.25  E-value: 1.98e-23
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 261 LHFLFLYQNKLSGSIPPSIFDLKKLISLDLSDNSLSGEIPELVIQLQNLEILHLFANDFTGKIPRALASLPRLQILQLWS 340
Cdd:COG4886    2 LLLLLSLTLKLLLLLLLELLTTLILLLLLLLLLLALLLLSLLSLLLLLTLLLSLLLRDLLLSSLLLLLSLLLLLLLSLLL 81
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 341 NKLSGEIPKNLGKQNNLTVLDLSTNNLSGEIPEslcnsgrLFKLILFSNSLEgEVPKSLSDCRSLRRVRLQSNHFSgELS 420
Cdd:COG4886   82 LSLLLLGLTDLGDLTNLTELDLSGNEELSNLTN-------LESLDLSGNQLT-DLPEELANLTNLKELDLSNNQLT-DLP 152
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 421 SEFMKLPLVYFLDISDNNLTgkisdrrwDMPSlqmlslarnrFFGNLPqsfgasKLENLDLSENQFSgAVPSSFGNLSEL 500
Cdd:COG4886  153 EPLGNLTNLKSLDLSNNQLT--------DLPE----------ELGNLT------NLKELDLSNNQIT-DLPEPLGNLTNL 207
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 501 MQLKLSENMLSgDIPEELSSCKKLVSLNLSHNQLSgHIPaSFSDMPVLGQLDLSQNQLSGkiPPNLGRVESLVQVNLSNN 580
Cdd:COG4886  208 EELDLSGNQLT-DLPEPLANLTNLETLDLSNNQLT-DLP-ELGNLTNLEELDLSNNQLTD--LPPLANLTNLKTLDLSNN 282

                 ..
gi 731385391 581 HL 582
Cdd:COG4886  283 QL 284
SPS1 COG0515
Serine/threonine protein kinase [Signal transduction mechanisms];
694-955 2.46e-23

Serine/threonine protein kinase [Signal transduction mechanisms];


Pssm-ID: 440281 [Multi-domain]  Cd Length: 482  Bit Score: 104.71  E-value: 2.46e-23
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 694 VISRGRKGISYKGKTKNGEMQFVVKEINDSNSIPSS----FWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKN 769
Cdd:COG0515   14 LLGRGGMGVVYLARDLRLGRPVALKVLRPELAADPEarerFRREARALARLNHPNIVRVYDVGEEDGRPYLVMEYVEGES 93
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 770 LSEVLRS---LSWERRQKIAIGISKALRFLHCNcspSMVVGNMSPQKIIIDGKDEPHLrlspplmvcTDF---KCIISS- 842
Cdd:COG0515   94 LADLLRRrgpLPPAEALRILAQLAEALAAAHAA---GIVHRDIKPANILLTPDGRVKL---------IDFgiaRALGGAt 161
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 843 -----------AYFAPETRETKDTTEKSDIYGFGLILIELMTGKSPTDAEfgvhgSIVEWGRycysdCHLDMWIDPI--I 909
Cdd:COG0515  162 ltqtgtvvgtpGYMAPEQARGEPVDPRSDVYSLGVTLYELLTGRPPFDGD-----SPAELLR-----AHLREPPPPPseL 231
                        250       260       270       280
                 ....*....|....*....|....*....|....*....|....*..
gi 731385391 910 RAQVSSnqnqmvEIMNLALHCTATDPTARP-CASDVLKTLESVLRSS 955
Cdd:COG0515  232 RPDLPP------ALDAIVLRALAKDPEERYqSAAELAAALRAVLRSL 272
STKc_TAK1 cd14058
Catalytic domain of the Serine/Threonine Kinase, Transforming Growth Factor beta Activated ...
695-954 3.86e-23

Catalytic domain of the Serine/Threonine Kinase, Transforming Growth Factor beta Activated Kinase-1; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. TAK1 is also known as mitogen-activated protein kinase kinase kinase 7 (MAPKKK7 or MAP3K7), TAK, or MEKK7. As a MAPKKK, it is an important mediator of cellular responses to extracellular signals. It regulates both the c-Jun N-terminal kinase and p38 MAPK cascades by activating the MAPK kinases, MKK4 and MKK3/6. In addition, TAK1 plays diverse roles in immunity and development, in different biological contexts, through many signaling pathways including TGFbeta/BMP, Wnt/Fz, and NF-kB. It is also implicated in the activation of the tumor suppressor kinase, LKB1. The TAK1 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270960 [Multi-domain]  Cd Length: 253  Bit Score: 99.82  E-value: 3.86e-23
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTKNgeMQFVVKEInDSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVL 774
Cdd:cd14058    1 VGRGSFGVVCKARWRN--QIVAVKII-ESESEKKAFEVEVRQLSRVDHPNIIKLYGACSNQKPVCLVMEYAEGGSLYNVL 77
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 775 RS------------LSWerrqkiAIGISKALRFLHCncspsmvvgnMSPQKIIidgkdepHLRLSPP----------LMV 832
Cdd:cd14058   78 HGkepkpiytaahaMSW------ALQCAKGVAYLHS----------MKPKALI-------HRDLKPPnllltnggtvLKI 134
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 833 CtDF--KCII---------SSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSPTDaEFGVHGSIVEWgrycysdchl 901
Cdd:cd14058  135 C-DFgtACDIsthmtnnkgSAAWMAPEVFEGSKYSEKCDVFSWGIILWEVITRRKPFD-HIGGPAFRIMW---------- 202
                        250       260       270       280       290
                 ....*....|....*....|....*....|....*....|....*....|...
gi 731385391 902 dmWIDPIIRAQVSSNQNQMVEimNLALHCTATDPTARPCASDVLKTLESVLRS 954
Cdd:cd14058  203 --AVHNGERPPLIKNCPKPIE--SLMTRCWSKDPEKRPSMKEIVKIMSHLMQF 251
STKc_PknB_like cd14014
Catalytic domain of bacterial Serine/Threonine kinases, PknB and similar proteins; STKs ...
694-950 3.14e-21

Catalytic domain of bacterial Serine/Threonine kinases, PknB and similar proteins; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This subfamily includes many bacterial eukaryotic-type STKs including Staphylococcus aureus PknB (also called PrkC or Stk1), Bacillus subtilis PrkC, and Mycobacterium tuberculosis Pkn proteins (PknB, PknD, PknE, PknF, PknL, and PknH), among others. S. aureus PknB is the only eukaryotic-type STK present in this species, although many microorganisms encode for several such proteins. It is important for the survival and pathogenesis of S. aureus as it is involved in the regulation of purine and pyrimidine biosynthesis, cell wall metabolism, autolysis, virulence, and antibiotic resistance. M. tuberculosis PknB is essential for growth and it acts on diverse substrates including proteins involved in peptidoglycan synthesis, cell division, transcription, stress responses, and metabolic regulation. B. subtilis PrkC is located at the inner membrane of endospores and functions to trigger spore germination. Bacterial STKs in this subfamily show varied domain architectures. The well-characterized members such as S. aureus and M. tuberculosis PknB, and B. subtilis PrkC, contain an N-terminal cytosolic kinase domain, a transmembrane (TM) segment, and mutliple C-terminal extracellular PASTA domains. The PknB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270916 [Multi-domain]  Cd Length: 260  Bit Score: 94.19  E-value: 3.14e-21
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 694 VISRGRKGISYKGKTKNGEMQFVVKEINDSNSIPSSFWTEFAQ----FGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKN 769
Cdd:cd14014    7 LLGRGGMGEVYRARDTLLGRPVAIKVLRPELAEDEEFRERFLRearaLARLSHPNIVRVYDVGEDDGRPYIVMEYVEGGS 86
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 770 LSEVLR---SLSWERRQKIAIGISKALRFLHcncSPSMVVGNMSPQKIIIDGKDEPHLrlspplmvcTDF---------- 836
Cdd:cd14014   87 LADLLRergPLPPREALRILAQIADALAAAH---RAGIVHRDIKPANILLTEDGRVKL---------TDFgiaralgdsg 154
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 837 ----KCII-SSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSPTDAEfgvhgsivEWGRYCYSDCHLDMWIDPIIRA 911
Cdd:cd14014  155 ltqtGSVLgTPAYMAPEQARGGPVDPRSDIYSLGVVLYELLTGRPPFDGD--------SPAAVLAKHLQEAPPPPSPLNP 226
                        250       260       270       280
                 ....*....|....*....|....*....|....*....|
gi 731385391 912 QVSSnqnqmvEIMNLALHCTATDPTARPC-ASDVLKTLES 950
Cdd:cd14014  227 DVPP------ALDAIILRALAKDPEERPQsAAELLAALRA 260
LRR COG4886
Leucine-rich repeat (LRR) protein [Transcription];
66-320 7.56e-21

Leucine-rich repeat (LRR) protein [Transcription];


Pssm-ID: 443914 [Multi-domain]  Cd Length: 414  Bit Score: 96.16  E-value: 7.56e-21
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391  66 TNSSHVSSIDLSGKNISgEISPVFFGLPYIETVNLSNNALSGgIPGNISLCYSLRYLNLSNNNLTgSMPR--GSASGLEA 143
Cdd:COG4886  133 ANLTNLKELDLSNNQLT-DLPEPLGNLTNLKSLDLSNNQLTD-LPEELGNLTNLKELDLSNNQIT-DLPEplGNLTNLEE 209
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 144 LDLSNNVISgEIPADMGLFSRLKVLDLGGNFLVgKIPnSIANITSLEFLTLASNQLvGEIPrELGRMKSLKWIYLGYNNL 223
Cdd:COG4886  210 LDLSGNQLT-DLPEPLANLTNLETLDLSNNQLT-DLP-ELGNLTNLEELDLSNNQL-TDLP-PLANLTNLKTLDLSNNQL 284
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 224 SGGIPKEIGELTSLNHLDLVYNNLTGEIPSSLGNLSDLHFLFLYQNKLSGSIPPSIFDLKKLISLDLSDNSLSGEIPELV 303
Cdd:COG4886  285 TDLKLKELELLLGLNSLLLLLLLLNLLELLILLLLLTTLLLLLLLLKGLLVTLTTLALSLSLLALLTLLLLLNLLSLLLT 364
                        250
                 ....*....|....*..
gi 731385391 304 IQLQNLEILHLFANDFT 320
Cdd:COG4886  365 LLLTLGLLGLLEATLLT 381
LRR COG4886
Leucine-rich repeat (LRR) protein [Transcription];
356-605 8.32e-20

Leucine-rich repeat (LRR) protein [Transcription];


Pssm-ID: 443914 [Multi-domain]  Cd Length: 414  Bit Score: 93.07  E-value: 8.32e-20
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 356 NLTVLDLSTNNLSGEIPESLCNSGRLFKLILFSNSLEGEVPKSLSDCRSLRRVRLQSNHFSGELSSEFMKLPLVYFLDIS 435
Cdd:COG4886    1 LLLLLLSLTLKLLLLLLLELLTTLILLLLLLLLLLALLLLSLLSLLLLLTLLLSLLLRDLLLSSLLLLLSLLLLLLLSLL 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 436 DNNLTGKISDRRWDMPSLQMLSLARNRFFGNLpqsfgaSKLENLDLSENQFSgAVPSSFGNLSELMQLKLSENMLSgDIP 515
Cdd:COG4886   81 LLSLLLLGLTDLGDLTNLTELDLSGNEELSNL------TNLESLDLSGNQLT-DLPEELANLTNLKELDLSNNQLT-DLP 152
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 516 EELSSCKKLVSLNLSHNQLSGhIPASFSDMPVLGQLDLSQNQLSgKIPPNLGRVESLVQVNLSNNHLHgSLPSTGAFL-A 594
Cdd:COG4886  153 EPLGNLTNLKSLDLSNNQLTD-LPEELGNLTNLKELDLSNNQIT-DLPEPLGNLTNLEELDLSGNQLT-DLPEPLANLtN 229
                        250
                 ....*....|.
gi 731385391 595 INSSSVSGNNL 605
Cdd:COG4886  230 LETLDLSNNQL 240
STKc_IRAK1 cd14159
Catalytic domain of the Serine/Threonine kinase, Interleukin-1 Receptor Associated Kinase 1; ...
695-877 6.72e-19

Catalytic domain of the Serine/Threonine kinase, Interleukin-1 Receptor Associated Kinase 1; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. IRAKs are involved in Toll-like receptor (TLR) and interleukin-1 (IL-1) signalling pathways, and are thus critical in regulating innate immune responses and inflammation. IRAKs contain an N-terminal Death domain (DD), a proST region (rich in serines, prolines, and threonines), a central kinase domain, and a C-terminal domain; IRAK-4 lacks the C-terminal domain. Vertebrates contain four IRAKs (IRAK-1, -2, -3 (or -M), and -4) that display distinct functions and patterns of expression and subcellular distribution, and can differentially mediate TLR signaling. IRAK1 plays a role in the activation of IRF3/7, STAT, and NFkB. It mediates IL-6 and IFN-gamma responses following IL-1 and IL-18 stimulation, respectively. It also plays an essential role in IFN-alpha induction downstream of TLR7 and TLR9. The IRAK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271061 [Multi-domain]  Cd Length: 296  Bit Score: 88.34  E-value: 6.72e-19
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTKNGEmqFVVKEIN-----DSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKN 769
Cdd:cd14159    1 IGEGGFGCVYQAVMRNTE--YAVKRLKedselDWSVVKNSFLTEVEKLSRFRHPNIVDLAGYSAQQGNYCLIYVYLPNGS 78
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 770 LSEVLR------SLSWERRQKIAIGISKALRFLHcNCSPSMVVGNMSPQKIIIDGKDEPHL----------RLSPPLMVC 833
Cdd:cd14159   79 LEDRLHcqvscpCLSWSQRLHVLLGTARAIQYLH-SDSPSLIHGDVKSSNILLDAALNPKLgdfglarfsrRPKQPGMSS 157
                        170       180       190       200
                 ....*....|....*....|....*....|....*....|....*..
gi 731385391 834 TDFKCII---SSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSP 877
Cdd:cd14159  158 TLARTQTvrgTLAYLPEEYVKTGTLSVEIDVYSFGVVLLELLTGRRA 204
S_TKc smart00220
Serine/Threonine protein kinases, catalytic domain; Phosphotransferases. Serine or ...
693-946 6.09e-18

Serine/Threonine protein kinases, catalytic domain; Phosphotransferases. Serine or threonine-specific kinase subfamily.


Pssm-ID: 214567 [Multi-domain]  Cd Length: 254  Bit Score: 84.50  E-value: 6.09e-18
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391   693 NVISRGRKGISYKGKTKNGEMQFVVKEIN--DSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNL 770
Cdd:smart00220   5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKkkKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDL 84
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391   771 SEVLRS---LSWERRQKIAIGISKALRFLHCNCspsmVV-GNMSPQKIIIDgkDEPHLRLspplmvcTDF---------- 836
Cdd:smart00220  85 FDLLKKrgrLSEDEARFYLRQILSALEYLHSKG----IVhRDLKPENILLD--EDGHVKL-------ADFglarqldpge 151
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391   837 ---KCIISSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSPtdaeFgvhgsivewgrycYSDCHLDMWIDPIIRAQV 913
Cdd:smart00220 152 kltTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP----F-------------PGDDQLLELFKKIGKPKP 214
                          250       260       270
                   ....*....|....*....|....*....|....*.
gi 731385391   914 SSNQNQMV---EIMNLALHCTATDPTARPCASDVLK 946
Cdd:smart00220 215 PFPPPEWDispEAKDLIRKLLVKDPEKRLTAEEALQ 250
PLN03150 PLN03150
hypothetical protein; Provisional
28-183 1.54e-17

hypothetical protein; Provisional


Pssm-ID: 178695 [Multi-domain]  Cd Length: 623  Bit Score: 87.56  E-value: 1.54e-17
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391  28 REEIELLLSFKASINDPLGFlsnwnssvdfcNWYGILCTNSSHV-SSIDLSGKNISGEIspvffglpYIETVNLSNNALS 106
Cdd:PLN03150 371 LEEVSALQTLKSSLGLPLRF-----------GWNGDPCVPQQHPwSGADCQFDSTKGKW--------FIDGLGLDNQGLR 431
                         90       100       110       120       130       140       150
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 731385391 107 GGIPGNISLCYSLRYLNLSNNNLTGSMPR--GSASGLEALDLSNNVISGEIPADMGLFSRLKVLDLGGNFLVGKIPNSI 183
Cdd:PLN03150 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPslGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
STKc_Mos cd13979
Catalytic domain of the Serine/Threonine kinase, Oocyte maturation factor Mos; STKs catalyze ...
693-877 1.65e-17

Catalytic domain of the Serine/Threonine kinase, Oocyte maturation factor Mos; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. Mos (or c-Mos) is a germ-cell specific kinase that plays roles in both the release of primary arrest and the induction of secondary arrest in oocytes. It is expressed towards the end of meiosis I and is quickly degraded upon fertilization. It is a component of the cytostatic factor (CSF), which is responsible for metaphase II arrest. In addition, Mos activates a phoshorylation cascade that leads to the activation of the p34 subunit of MPF (mitosis-promoting factor or maturation promoting factor), a cyclin-dependent kinase that is responsible for the release of primary arrest in meiosis I. The Mos subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270881 [Multi-domain]  Cd Length: 265  Bit Score: 83.59  E-value: 1.65e-17
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 693 NVISRGRKGISYKGKTKnGEmQFVVKEIN---DSNSIPSSFWTEfAQFGKLRHSNVVKLIGL--CRSQKC-GYLISEYIE 766
Cdd:cd13979    9 EPLGSGGFGSVYKATYK-GE-TVAVKIVRrrrKNRASRQSFWAE-LNAARLRHENIVRVLAAetGTDFASlGLIIMEYCG 85
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 767 GKNLSEVL----RSLSWERRQKIAIGISKALRFLHCNcspSMVVGNMSPQKIIIDGKDEPHL-------RLSPPLMVCTD 835
Cdd:cd13979   86 NGTLQQLIyegsEPLPLAHRILISLDIARALRFCHSH---GIVHLDVKPANILISEQGVCKLcdfgcsvKLGEGNEVGTP 162
                        170       180       190       200
                 ....*....|....*....|....*....|....*....|...
gi 731385391 836 FKCIISS-AYFAPETRETKDTTEKSDIYGFGLILIELMTGKSP 877
Cdd:cd13979  163 RSHIGGTyTYRAPELLKGERVTPKADIYSFGITLWQMLTRELP 205
STKc_RIP cd13978
Catalytic domain of the Serine/Threonine kinase, Receptor Interacting Protein; STKs catalyze ...
695-939 1.73e-17

Catalytic domain of the Serine/Threonine kinase, Receptor Interacting Protein; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. RIP kinases serve as essential sensors of cellular stress. They are involved in regulating NF-kappaB and MAPK signaling, and are implicated in mediating cellular processes such as apoptosis, necroptosis, differentiation, and survival. RIP kinases contain a homologous N-terminal kinase domain and varying C-terminal domains. Higher vertebrates contain multiple RIP kinases, with mammals harboring at least five members. RIP1 and RIP2 harbor C-terminal domains from the Death domain (DD) superfamily while RIP4 contains ankyrin (ANK) repeats. RIP3 contain a RIP homotypic interaction motif (RHIM) that facilitates binding to RIP1. RIP1 and RIP3 are important in apoptosis and necroptosis, while RIP2 and RIP4 play roles in keratinocyte differentiation and inflammatory immune responses. The RIP subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270880 [Multi-domain]  Cd Length: 263  Bit Score: 83.27  E-value: 1.73e-17
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTKNGEMQFVVK--EINDSNSIPSSFWTEFAQ-FGKLRHSNVVKLIGLC-RSQKCGyLISEYIEGKNL 770
Cdd:cd13978    1 LGSGGFGTVSKARHVSWFGMVAIKclHSSPNCIEERKALLKEAEkMERARHSYVLPLLGVCvERRSLG-LVMEYMENGSL 79
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 771 SEVLRSLS----WERRQKIAIGISKALRFLHCnCSPSMVVGNMSPQKIIIDgkDEPHLRLspplmvcTDF---KCIISS- 842
Cdd:cd13978   80 KSLLEREIqdvpWSLRFRIIHEIALGMNFLHN-MDPPLLHHDLKPENILLD--NHFHVKI-------SDFglsKLGMKSi 149
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 843 ---------------AYFAPETRET--KDTTEKSDIYGFGLILIELMTGKSPtdaEFGVHGSIVEWgrYCYSDCHLDMwI 905
Cdd:cd13978  150 sanrrrgtenlggtpIYMAPEAFDDfnKKPTSKSDVYSFAIVIWAVLTRKEP---FENAINPLLIM--QIVSKGDRPS-L 223
                        250       260       270
                 ....*....|....*....|....*....|....
gi 731385391 906 DPIIRAQVSSNQNQMVEIMNLalhCTATDPTARP 939
Cdd:cd13978  224 DDIGRLKQIENVQELISLMIR---CWDGNPDARP 254
PKc_TESK cd14155
Catalytic domain of the Dual-specificity protein kinase, Testicular protein kinase; ...
714-953 3.98e-17

Catalytic domain of the Dual-specificity protein kinase, Testicular protein kinase; Dual-specificity PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine as well as tyrosine residues on protein substrates. TESK proteins phosphorylate cofilin and induce actin cytoskeletal reorganization. In the Drosphila eye, TESK is required for epithelial cell organization. Mammals contain two TESK proteins, TESK1 and TESK2, which are highly expressed in testis and play roles in spermatogenesis. TESK1 is found in testicular germ cells while TESK2 is expressed mainly in nongerminal Sertoli cells. TESK1 is stimulated by integrin-mediated signaling pathways. It regulates cell spreading and focal adhesion formation. The TESK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine PKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271057 [Multi-domain]  Cd Length: 253  Bit Score: 82.14  E-value: 3.98e-17
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 714 QFVVKEINDSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVLRS---LSWERRQKIAIGIS 790
Cdd:cd14155   19 QVMALKMNTLSSNRANMLREVQLMNRLSHPNILRFMGVCVHQGQLHALTEYINGGNLEQLLDSnepLSWTVRVKLALDIA 98
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 791 KALRFLHC-----------NC-------SPSMVVGNMSPQKIIIDGKDEpHLRLSpplmvctdfkcIISSAYF-APETRE 851
Cdd:cd14155   99 RGLSYLHSkgifhrdltskNClikrdenGYTAVVGDFGLAEKIPDYSDG-KEKLA-----------VVGSPYWmAPEVLR 166
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 852 TKDTTEKSDIYGFGLILIELMtGKSPTD-------AEFGVHgsiVEWGRYCYSDCHLDMwidpiiraqvssnqnqmveiM 924
Cdd:cd14155  167 GEPYNEKADVFSYGIILCEII-ARIQADpdylprtEDFGLD---YDAFQHMVGDCPPDF--------------------L 222
                        250       260
                 ....*....|....*....|....*....
gi 731385391 925 NLALHCTATDPTARPCASDVLKTLESVLR 953
Cdd:cd14155  223 QLAFNCCNMDPKSRPSFHDIVKTLEEILE 251
PLN03150 PLN03150
hypothetical protein; Provisional
503-617 1.38e-16

hypothetical protein; Provisional


Pssm-ID: 178695 [Multi-domain]  Cd Length: 623  Bit Score: 84.48  E-value: 1.38e-16
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 503 LKLSENMLSGDIPEELSSCKKLVSLNLSHNQLSGHIPASFSDMPVLGQLDLSQNQLSGKIPPNLGRVESLVQVNLSNNHL 582
Cdd:PLN03150 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSL 502
                         90       100       110
                 ....*....|....*....|....*....|....*...
gi 731385391 583 HGSLPST--GAFLAINSSSVSGN-NLCGgdtTSGLPPC 617
Cdd:PLN03150 503 SGRVPAAlgGRLLHRASFNFTDNaGLCG---IPGLRAC 537
PKc_LIMK_like cd14065
Catalytic domain of the LIM domain kinase-like protein kinases; PKs catalyze the transfer of ...
695-948 1.64e-16

Catalytic domain of the LIM domain kinase-like protein kinases; PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. Members of this subfamily include LIMK, Testicular or testis-specific protein kinase (TESK), and similar proteins. LIMKs are characterized as serine/threonine kinases (STKs) while TESKs are dual-specificity protein kinases. Both LIMK and TESK phosphorylate and inactivate cofilin, an actin depolymerizing factor, to induce the reorganization of the actin cytoskeleton. They are implicated in many cellular functions including cell spreading, motility, morphogenesis, meiosis, mitosis, and spermatogenesis. The LIMK-like subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270967 [Multi-domain]  Cd Length: 252  Bit Score: 80.23  E-value: 1.64e-16
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTKNGEMQFVVKE-INDSNSipSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEV 773
Cdd:cd14065    1 LGKGFFGEVYKVTHRETGKVMVMKElKRFDEQ--RSFLKEVKLMRRLSHPNILRFIGVCVKDNKLNFITEYVNGGTLEEL 78
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 774 LRS----LSWERRQKIAIGISKALRFLHC-----------NCSPSM-------VVGNMSPQKIIIDGKDEPHLRLSPPLM 831
Cdd:cd14065   79 LKSmdeqLPWSQRVSLAKDIASGMAYLHSkniihrdlnskNCLVREanrgrnaVVADFGLAREMPDEKTKKPDRKKRLTV 158
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 832 VctdfkciiSSAYF-APETRETKDTTEKSDIYGFGLILIELMtGKSPTDAEF----GVHGSIVEWGRYCY-SDChldmwi 905
Cdd:cd14065  159 V--------GSPYWmAPEMLRGESYDEKVDVFSFGIVLCEII-GRVPADPDYlprtMDFGLDVRAFRTLYvPDC------ 223
                        250       260       270       280
                 ....*....|....*....|....*....|....*....|...
gi 731385391 906 dPIiraqvssnqnqmvEIMNLALHCTATDPTARPCASDVLKTL 948
Cdd:cd14065  224 -PP-------------SFLPLAIRCCQLDPEKRPSFVELEHHL 252
PTKc cd00192
Catalytic domain of Protein Tyrosine Kinases; PTKs catalyze the transfer of the ...
693-949 8.29e-16

Catalytic domain of Protein Tyrosine Kinases; PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers.The PTK family is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270623 [Multi-domain]  Cd Length: 262  Bit Score: 78.35  E-value: 8.29e-16
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 693 NVISRGRKGISYKGKTKNGEMQFV---VKEINDSNSIP--SSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEG 767
Cdd:cd00192    1 KKLGEGAFGEVYKGKLKGGDGKTVdvaVKTLKEDASESerKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVMEYMEG 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 768 KNLSEVLRS------------LSWERRQKIAIGISKALRFLHcncSPSMVVGNMSPQKIIIDGKDE---------PHLRL 826
Cdd:cd00192   81 GDLLDFLRKsrpvfpspepstLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVvkisdfglsRDIYD 157
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 827 SPPLMVCTDFKCIIssAYFAPETRETKDTTEKSDIYGFGLILIELMT-GKSP----TDAEfgVHGSIVEWGRY-CYSDCH 900
Cdd:cd00192  158 DDYYRKKTGGKLPI--RWMAPESLKDGIFTSKSDVWSFGVLLWEIFTlGATPypglSNEE--VLEYLRKGYRLpKPENCP 233
                        250       260       270       280
                 ....*....|....*....|....*....|....*....|....*....
gi 731385391 901 LDMWidpiiraqvssnqnqmvEIMnlaLHCTATDPTARPCASDVLKTLE 949
Cdd:cd00192  234 DELY-----------------ELM---LSCWQLDPEDRPTFSELVERLE 262
STYKc smart00221
Protein kinase; unclassified specificity; Phosphotransferases. The specificity of this class ...
690-948 1.86e-15

Protein kinase; unclassified specificity; Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.


Pssm-ID: 214568 [Multi-domain]  Cd Length: 258  Bit Score: 77.20  E-value: 1.86e-15
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391   690 TENNVISRG-----RKGIsYKGKTKNGEMQFVVKEINDSNSI--PSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLIS 762
Cdd:smart00221   2 TLGKKLGEGafgevYKGT-LKGKGDGKEVEVAVKTLKEDASEqqIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391   763 EYIEGKNLSEVLRS-----LSWERRQKIAIGISKALRFLHC-----------NCspsmVVGNmspQKII--------IDG 818
Cdd:smart00221  81 EYMPGGDLLDYLRKnrpkeLSLSDLLSFALQIARGMEYLESknfihrdlaarNC----LVGE---NLVVkisdfglsRDL 153
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391   819 KDEPHLRLSPPlmvctdfKCIIssAYFAPETRETKDTTEKSDIYGFGLILIELMT-GKSP----TDAEfgVHGSIVEWGR 893
Cdd:smart00221 154 YDDDYYKVKGG-------KLPI--RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTlGEEPypgmSNAE--VLEYLKKGYR 222
                          250       260       270       280       290
                   ....*....|....*....|....*....|....*....|....*....|....*.
gi 731385391   894 -YCYSDCHLdmwidpiiraqvssnqnqmvEIMNLALHCTATDPTARPCASDVLKTL 948
Cdd:smart00221 223 lPKPPNCPP--------------------ELYKLMLQCWAEDPEDRPTFSELVEIL 258
PLN03150 PLN03150
hypothetical protein; Provisional
141-256 2.27e-15

hypothetical protein; Provisional


Pssm-ID: 178695 [Multi-domain]  Cd Length: 623  Bit Score: 80.63  E-value: 2.27e-15
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 141 LEALDLSNNVISGEIPADMGLFSRLKVLDLGGNFLVGKIPNSIANITSLEFLTLAsnqlvgeiprelgrmkslkwiylgY 220
Cdd:PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLS------------------------Y 475
                         90       100       110
                 ....*....|....*....|....*....|....*.
gi 731385391 221 NNLSGGIPKEIGELTSLNHLDLVYNNLTGEIPSSLG 256
Cdd:PLN03150 476 NSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
STKc_IRAK2 cd14157
Catalytic domain of the Serine/Threonine kinase, Interleukin-1 Receptor Associated Kinase 2; ...
695-881 3.88e-15

Catalytic domain of the Serine/Threonine kinase, Interleukin-1 Receptor Associated Kinase 2; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. IRAKs are involved in Toll-like receptor (TLR) and interleukin-1 (IL-1) signalling pathways, and are thus critical in regulating innate immune responses and inflammation. IRAKs contain an N-terminal Death domain (DD), a proST region (rich in serines, prolines, and threonines), a central kinase domain, and a C-terminal domain; IRAK-4 lacks the C-terminal domain. Vertebrates contain four IRAKs (IRAK-1, -2, -3 (or -M), and -4) that display distinct functions and patterns of expression and subcellular distribution, and can differentially mediate TLR signaling. IRAK2 plays a role in mediating NFkB activation by TLR3, TLR4, and TLR8. It is specifically targeted by the viral protein A52, which is important for virulence, to inhibit all IL-1/TLR pathways, indicating that IRAK2 has a predominant role in NFkB activation. It is redundant with IRAK1 in early signaling but is critical for late and sustained activation. The IRAK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271059 [Multi-domain]  Cd Length: 289  Bit Score: 77.18  E-value: 3.88e-15
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTKNgeMQFVVK-----EINDSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKN 769
Cdd:cd14157    1 ISEGTFADIYKGYRHG--KQYVIKrlketECESPKSTERFFQTEVQICFRCCHPNILPLLGFCVESDCHCLIYPYMPNGS 78
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 770 LSEVLR------SLSWERRQKIAIGISKALRFLHCNcspSMVVGNMSPQKIIIDGKDEPHL-----RLSPP--LMVCTDF 836
Cdd:cd14157   79 LQDRLQqqggshPLPWEQRLSISLGLLKAVQHLHNF---GILHGNIKSSNVLLDGNLLPKLghsglRLCPVdkKSVYTMM 155
                        170       180       190       200
                 ....*....|....*....|....*....|....*....|....*...
gi 731385391 837 KCI---ISSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSPTDAE 881
Cdd:cd14157  156 KTKvlqISLAYLPEDFVRHGQLTEKVDIFSCGVVLAEILTGIKAMDEF 203
TyrKc smart00219
Tyrosine kinase, catalytic domain; Phosphotransferases. Tyrosine-specific kinase subfamily.
690-948 4.65e-15

Tyrosine kinase, catalytic domain; Phosphotransferases. Tyrosine-specific kinase subfamily.


Pssm-ID: 197581 [Multi-domain]  Cd Length: 257  Bit Score: 76.03  E-value: 4.65e-15
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391   690 TENNVISRG-----RKGIsYKGKTKNGEMQFVVKEINDSNSIP--SSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLIS 762
Cdd:smart00219   2 TLGKKLGEGafgevYKGK-LKGKGGKKKVEVAVKTLKEDASEQqiEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVM 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391   763 EYIEGKNLSEVLRS----LSWERRQKIAIGISKALRFLH---C--------NCspsMVVGNMSPqKIiidgkdephlrls 827
Cdd:smart00219  81 EYMEGGDLLSYLRKnrpkLSLSDLLSFALQIARGMEYLEsknFihrdlaarNC---LVGENLVV-KI------------- 143
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391   828 pplmvcTDF-----------------KCIIssAYFAPETRETKDTTEKSDIYGFGLILIELMT-GKSP----TDAEfgVH 885
Cdd:smart00219 144 ------SDFglsrdlydddyyrkrggKLPI--RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTlGEQPypgmSNEE--VL 213
                          250       260       270       280       290       300
                   ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 731385391   886 GSIVEWGR-YCYSDCHLdmwidpiiraqvssnqnqmvEIMNLALHCTATDPTARPCASDVLKTL 948
Cdd:smart00219 214 EYLKNGYRlPQPPNCPP--------------------ELYDLMLQCWAEDPEDRPTFSELVEIL 257
PK_Tyr_Ser-Thr pfam07714
Protein tyrosine and serine/threonine kinase; Protein phosphorylation, which plays a key role ...
699-948 6.30e-15

Protein tyrosine and serine/threonine kinase; Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyze the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyze the reverse process. Protein kinases fall into three broad classes, characterized with respect to substrate specificity; Serine/threonine-protein kinases, tyrosine-protein kinases, and dual specificity protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins). This entry represents the catalytic domain found in a number of serine/threonine- and tyrosine-protein kinases. It does not include the catalytic domain of dual specificity kinases.


Pssm-ID: 462242 [Multi-domain]  Cd Length: 258  Bit Score: 75.61  E-value: 6.30e-15
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391  699 RKGIsYKGKTKNGEMQFVVKEINDSNSIPS--SFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVLR- 775
Cdd:pfam07714  16 YKGT-LKGEGENTKIKVAVKTLKEGADEEEreDFLEEASIMKKLDHPNIVKLLGVCTQGEPLYIVTEYMPGGDLLDFLRk 94
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391  776 ---SLSWERRQKIAIGISKALRFLH---C--------NC--SPSMVVgnmspqKI-------IIDGKDEPHLRLSPPLMV 832
Cdd:pfam07714  95 hkrKLTLKDLLSMALQIAKGMEYLEsknFvhrdlaarNClvSENLVV------KIsdfglsrDIYDDDYYRKRGGGKLPI 168
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391  833 CtdfkciissaYFAPETRETKDTTEKSDIYGFGLILIELMT-GKSP----TDAEfgVHGSIVEWGR-YCYSDCHldmwid 906
Cdd:pfam07714 169 K----------WMAPESLKDGKFTSKSDVWSFGVLLWEIFTlGEQPypgmSNEE--VLEFLEDGYRlPQPENCP------ 230
                         250       260       270       280
                  ....*....|....*....|....*....|....*....|..
gi 731385391  907 piiraqvssnqnqmVEIMNLALHCTATDPTARPCASDVLKTL 948
Cdd:pfam07714 231 --------------DELYDLMKQCWAYDPEDRPTFSELVEDL 258
Pkinase pfam00069
Protein kinase domain;
694-877 6.82e-15

Protein kinase domain;


Pssm-ID: 459660 [Multi-domain]  Cd Length: 217  Bit Score: 74.59  E-value: 6.82e-15
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391  694 VISRGRKGISYKGKTKNGEMQFVVKEIN---DSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNL 770
Cdd:pfam00069   6 KLGSGSFGTVYKAKHRDTGKIVAIKKIKkekIKKKKDKNILREIKILKKLNHPNIVRLYDAFEDKDNLYLVLEYVEGGSL 85
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391  771 SEVLR---SLSWERRQKIAIGISKALRflhcNCSP-SMVVGnmspqkiiidgkdephlrlspplmvctdfkciiSSAYFA 846
Cdd:pfam00069  86 FDLLSekgAFSEREAKFIMKQILEGLE----SGSSlTTFVG---------------------------------TPWYMA 128
                         170       180       190
                  ....*....|....*....|....*....|.
gi 731385391  847 PETRETKDTTEKSDIYGFGLILIELMTGKSP 877
Cdd:pfam00069 129 PEVLGGNPYGPKVDVWSLGCILYELLTGKPP 159
PLN03150 PLN03150
hypothetical protein; Provisional
211-300 3.68e-14

hypothetical protein; Provisional


Pssm-ID: 178695 [Multi-domain]  Cd Length: 623  Bit Score: 76.78  E-value: 3.68e-14
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 211 KSLKWIY--LGYNN--LSGGIPKEIGELTSLNHLDLVYNNLTGEIPSSLGNLSDLHFLFLYQNKLSGSIPPSIFDLKKLI 286
Cdd:PLN03150 414 TKGKWFIdgLGLDNqgLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493
                         90
                 ....*....|....
gi 731385391 287 SLDLSDNSLSGEIP 300
Cdd:PLN03150 494 ILNLNGNSLSGRVP 507
PLN03150 PLN03150
hypothetical protein; Provisional
192-279 5.15e-14

hypothetical protein; Provisional


Pssm-ID: 178695 [Multi-domain]  Cd Length: 623  Bit Score: 76.01  E-value: 5.15e-14
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 192 LTLASNQLVGEIPRELGRMKSLKWIYLGYNNLSGGIPKEIGELTSLNHLDLVYNNLTGEIPSSLGNLSDLHFLFLYQNKL 271
Cdd:PLN03150 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSL 502

                 ....*...
gi 731385391 272 SGSIPPSI 279
Cdd:PLN03150 503 SGRVPAAL 510
STKc_LIMK cd14154
Catalytic domain of the Serine/Threonine Kinase, LIM domain kinase; STKs catalyze the transfer ...
716-951 1.61e-13

Catalytic domain of the Serine/Threonine Kinase, LIM domain kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. LIMKs phosphorylate and inactivate cofilin, an actin depolymerizing factor, to induce the reorganization of the actin cytoskeleton. They act downstream of Rho GTPases and are expressed ubiquitously. As regulators of actin dynamics, they contribute to diverse cellular functions such as cell motility, morphogenesis, differentiation, apoptosis, meiosis, mitosis, and neurite extension. LIMKs contain the LIM (two repeats), PDZ, and catalytic kinase domains. Vertebrate have two members, LIMK1 and LIMK2. The LIMK subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271056 [Multi-domain]  Cd Length: 272  Bit Score: 71.77  E-value: 1.61e-13
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 716 VVKE-INDSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVLRS----LSWERRQKIAIGIS 790
Cdd:cd14154   22 VMKElIRFDEEAQRNFLKEVKVMRSLDHPNVLKFIGVLYKDKKLNLITEYIPGGTLKDVLKDmarpLPWAQRVRFAKDIA 101
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 791 KALRFLHC-----------NC----SPSMVVGNMSPQKIIidgkDEPHLRLSPPLMVCTDFK----------CIISSAYF 845
Cdd:cd14154  102 SGMAYLHSmniihrdlnshNClvreDKTVVVADFGLARLI----VEERLPSGNMSPSETLRHlkspdrkkryTVVGNPYW 177
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 846 -APETRETKDTTEKSDIYGFGLILIELMtGKS-------PTDAEFGVHGSIVeWGRYCySDChldmwidPiiraqvssnq 917
Cdd:cd14154  178 mAPEMLNGRSYDEKVDIFSFGIVLCEII-GRVeadpdylPRTKDFGLNVDSF-REKFC-AGC-------P---------- 237
                        250       260       270
                 ....*....|....*....|....*....|....
gi 731385391 918 nqmVEIMNLALHCTATDPTARPCASDVLKTLESV 951
Cdd:cd14154  238 ---PPFFKLAFLCCDLDPEKRPPFETLEEWLEAL 268
STKc_IRAK4 cd14158
Catalytic domain of the Serine/Threonine kinase, Interleukin-1 Receptor Associated Kinase 4; ...
686-951 2.10e-13

Catalytic domain of the Serine/Threonine kinase, Interleukin-1 Receptor Associated Kinase 4; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. IRAKs are involved in Toll-like receptor (TLR) and interleukin-1 (IL-1) signalling pathways, and are thus critical in regulating innate immune responses and inflammation. IRAKs contain an N-terminal Death domain (DD), a proST region (rich in serines, prolines, and threonines), a central kinase domain, and a C-terminal domain; IRAK-4 lacks the C-terminal domain. Vertebrates contain four IRAKs (IRAK-1, -2, -3 (or -M), and -4) that display distinct functions and patterns of expression and subcellular distribution, and can differentially mediate TLR signaling. IRAK4 plays a critical role in NFkB activation by its interaction with MyD88, which acts as a scaffold that enables IRAK4 to phosphorylate and activate IRAK1 and/or IRAK2. It also plays an important role in type I IFN production induced by TLR7/8/9. The IRAK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271060 [Multi-domain]  Cd Length: 288  Bit Score: 71.76  E-value: 2.10e-13
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 686 LSSTTEN----NVISRGRK------GISYKGKTknGEMQFVVKEINDSNSIPSS-----FWTEFAQFGKLRHSNVVKLIG 750
Cdd:cd14158    4 LKNMTNNfderPISVGGNKlgeggfGVVFKGYI--NDKNVAVKKLAAMVDISTEdltkqFEQEIQVMAKCQHENLVELLG 81
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 751 LCRS--QKCgyLISEYIEGKNLSEVLR------SLSWERRQKIAIGISKALRFLHCNcspSMVVGNMSPQKIIIDGKDEP 822
Cdd:cd14158   82 YSCDgpQLC--LVYTYMPNGSLLDRLAclndtpPLSWHMRCKIAQGTANGINYLHEN---NHIHRDIKSANILLDETFVP 156
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 823 HL------RLSPPLMVCTDFKCII-SSAYFAPETREtKDTTEKSDIYGFGLILIELMTGKSPTDAEFGVHGSIVEWGRYC 895
Cdd:cd14158  157 KIsdfglaRASEKFSQTIMTERIVgTTAYMAPEALR-GEITPKSDIFSFGVVLLEIITGLPPVDENRDPQLLLDIKEEIE 235
                        250       260       270       280       290
                 ....*....|....*....|....*....|....*....|....*....|....*..
gi 731385391 896 YSDCHLDMWIDpiirAQVSSNQNQMVEIM-NLALHCTATDPTARPCASDVLKTLESV 951
Cdd:cd14158  236 DEEKTIEDYVD----KKMGDWDSTSIEAMySVASQCLNDKKNRRPDIAKVQQLLQEL 288
PLN03150 PLN03150
hypothetical protein; Provisional
271-352 2.67e-13

hypothetical protein; Provisional


Pssm-ID: 178695 [Multi-domain]  Cd Length: 623  Bit Score: 73.70  E-value: 2.67e-13
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 271 LSGSIPPSIFDLKKLISLDLSDNSLSGEIPELVIQLQNLEILHLFANDFTGKIPRALASLPRLQILQLWSNKLSGEIPKN 350
Cdd:PLN03150 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAA 509

                 ..
gi 731385391 351 LG 352
Cdd:PLN03150 510 LG 511
PLN03150 PLN03150
hypothetical protein; Provisional
321-410 3.20e-13

hypothetical protein; Provisional


Pssm-ID: 178695 [Multi-domain]  Cd Length: 623  Bit Score: 73.70  E-value: 3.20e-13
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 321 GKIPRALASLPRLQILQLWSNKLSGEIPKNLGKQNNLTVLDLSTNNLSGEIPESLCNSGRLFKLILFSNSLEGEVPKSLS 400
Cdd:PLN03150 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
                         90
                 ....*....|
gi 731385391 401 DcRSLRRVRL 410
Cdd:PLN03150 512 G-RLLHRASF 520
PLN03150 PLN03150
hypothetical protein; Provisional
288-381 3.61e-13

hypothetical protein; Provisional


Pssm-ID: 178695 [Multi-domain]  Cd Length: 623  Bit Score: 73.31  E-value: 3.61e-13
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 288 LDLSDNSLSGEIPELVIQLQNLEILHLFANDFTGKIPRALASLPRLQILQLWSNKLSGEIPKNLGKQNNLTVLDLSTNNL 367
Cdd:PLN03150 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSL 502
                         90
                 ....*....|....
gi 731385391 368 SGEIPESLcnSGRL 381
Cdd:PLN03150 503 SGRVPAAL--GGRL 514
PLN03150 PLN03150
hypothetical protein; Provisional
240-331 8.18e-13

hypothetical protein; Provisional


Pssm-ID: 178695 [Multi-domain]  Cd Length: 623  Bit Score: 72.16  E-value: 8.18e-13
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 240 LDLVYNNLTGEIPSSLGNLSDLHFLFLYQNKLSGSIPPSIFDLKKLISLDLSDNSLSGEIPELVIQLQNLEILHLFANDF 319
Cdd:PLN03150 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSL 502
                         90
                 ....*....|..
gi 731385391 320 TGKIPRALASLP 331
Cdd:PLN03150 503 SGRVPAALGGRL 514
PLN03150 PLN03150
hypothetical protein; Provisional
476-567 8.62e-13

hypothetical protein; Provisional


Pssm-ID: 178695 [Multi-domain]  Cd Length: 623  Bit Score: 72.16  E-value: 8.62e-13
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 476 LENLDLSENQFSGAVPSSFGNLSELMQLKLSENMLSGDIPEELSSCKKLVSLNLSHNQLSGHIPASFSDMPVLGQLDLSQ 555
Cdd:PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499
                         90
                 ....*....|..
gi 731385391 556 NQLSGKIPPNLG 567
Cdd:PLN03150 500 NSLSGRVPAALG 511
PK_IRAK3 cd14160
Pseudokinase domain of Interleukin-1 Receptor Associated Kinase 3; The pseudokinase domain ...
741-950 1.38e-12

Pseudokinase domain of Interleukin-1 Receptor Associated Kinase 3; The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. IRAKs are involved in Toll-like receptor (TLR) and interleukin-1 (IL-1) signalling pathways, and are thus critical in regulating innate immune responses and inflammation. IRAKs contain an N-terminal Death domain (DD), a proST region (rich in serines, prolines, and threonines), a central kinase domain (a pseudokinase in the case of IRAK3), and a C-terminal domain; IRAK-4 lacks the C-terminal domain. Vertebrates contain four IRAKs (IRAK-1, -2, -3 (or -M), and -4) that display distinct functions and patterns of expression and subcellular distribution, and can differentially mediate TLR signaling. IRAK3 (or IRAK-M) is the only IRAK that does not show kinase activity. It is found only in monocytes and macrophages in humans, and functions as a negative regulator of TLR signaling including TLR-2 induced p38 activation. It also negatively regulates the alternative NFkB pathway in a TLR-2 specific manner. IRAK3 is downregulated in the monocytes of obese people, and is associated with high SOD2, a marker of mitochondrial oxidative stress. It is an important inhibitor of inflammation in association with obesity and metabolic syndrome. The IRAK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271062 [Multi-domain]  Cd Length: 276  Bit Score: 69.14  E-value: 1.38e-12
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 741 RHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVLRS------LSWERRQKIAIGISKALRFLHCNCSPSMVVGNMSPQKI 814
Cdd:cd14160   50 QHPNILELAAYFTETEKFCLVYPYMQNGTLFDRLQChgvtkpLSWHERINILIGIAKAIHYLHNSQPCTVICGNISSANI 129
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 815 IIDGKDEPHL------RLSPPLmvcTDFKCII-------SSAYFAPE--TRETKdTTEKSDIYGFGLILIELMTG----- 874
Cdd:cd14160  130 LLDDQMQPKLtdfalaHFRPHL---EDQSCTInmttalhKHLWYMPEeyIRQGK-LSVKTDVYSFGIVIMEVLTGckvvl 205
                        170       180       190       200       210       220       230
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 731385391 875 KSPTDAEF-GVHGSIVEwgRYCYSDC--HLDMWIDPIIRaqvssnqNQMVEIMNLALHCTATDPTARPCASDVLKTLES 950
Cdd:cd14160  206 DDPKHLQLrDLLHELME--KRGLDSClsFLDLKFPPCPR-------NFSAKLFRLAGRCTATKAKLRPDMDEVLQRLES 275
STKc_LIMK2 cd14222
Catalytic domain of the Serine/Threonine Kinase, LIM domain kinase 2; STKs catalyze the ...
716-899 2.09e-12

Catalytic domain of the Serine/Threonine Kinase, LIM domain kinase 2; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. LIMK2 activation is induced by transforming growth factor-beta l (TGFb-l) and shares the same subcellular location as the cofilin family member twinfilin, which may be its biological substrate. LIMK2 plays a role in spermatogenesis, and may contribute to tumor progression and metastasis formation in some cancer cells. LIMKs phosphorylate and inactivate cofilin, an actin depolymerizing factor, to induce the reorganization of the actin cytoskeleton. They act downstream of Rho GTPases and are expressed ubiquitously. As regulators of actin dynamics, they contribute to diverse cellular functions such as cell motility, morphogenesis, differentiation, apoptosis, meiosis, mitosis, and neurite extension. LIMKs contain the LIM (two repeats), PDZ, and catalytic kinase domains. The LIMK2 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271124 [Multi-domain]  Cd Length: 272  Bit Score: 68.43  E-value: 2.09e-12
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 716 VVKE-INDSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVLRS---LSWERRQKIAIGISK 791
Cdd:cd14222   22 VMKElIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKRLNLLTEFIEGGTLKDFLRAddpFPWQQKVSFAKGIAS 101
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 792 ALRFLHC-----------NC----SPSMVVGNMSPQKIIIDGKDEPHLRLSPP---LMVCTDFK---CIISSAYF-APET 849
Cdd:cd14222  102 GMAYLHSmsiihrdlnshNCliklDKTVVVADFGLSRLIVEEKKKPPPDKPTTkkrTLRKNDRKkryTVVGNPYWmAPEM 181
                        170       180       190       200       210
                 ....*....|....*....|....*....|....*....|....*....|....*..
gi 731385391 850 RETKDTTEKSDIYGFGLILIELMtGKSPTDAE-------FGVHGSIVeWGRYCYSDC 899
Cdd:cd14222  182 LNGKSYDEKVDIFSFGIVLCEII-GQVYADPDclprtldFGLNVRLF-WEKFVPKDC 236
PLN03150 PLN03150
hypothetical protein; Provisional
475-549 3.82e-12

hypothetical protein; Provisional


Pssm-ID: 178695 [Multi-domain]  Cd Length: 623  Bit Score: 70.23  E-value: 3.82e-12
                         10        20        30        40        50        60        70
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 731385391 475 KLENLDLSENQFSGAVPSSFGNLSELMQLKLSENMLSGDIPEELSSCKKLVSLNLSHNQLSGHIPASFSDMPVLG 549
Cdd:PLN03150 443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHR 517
STKc_MAP3K12_13 cd14059
Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase ...
695-892 6.60e-12

Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinases 12 and 13; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. MAP3K12 is also called MAPK upstream kinase (MUK), dual leucine zipper-bearing kinase (DLK) or leucine-zipper protein kinase (ZPK). It is involved in the c-Jun N-terminal kinase (JNK) pathway that directly regulates axonal regulation through the phosphorylation of microtubule-associated protein 1B (MAP1B). It also regulates the differentiation of many cell types including adipocytes and may play a role in adipogenesis. MAP3K13, also called leucine zipper-bearing kinase (LZK), directly phosphorylates and activates MKK7, which in turn activates the JNK pathway. It also activates NF-kB through IKK activation and this activity is enhanced by antioxidant protein-1 (AOP-1). MAP3Ks (MKKKs or MAPKKKs) phosphorylate and activate MAP2Ks (MAPKKs or MKKs), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. The MAP3K12/13 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270961 [Multi-domain]  Cd Length: 237  Bit Score: 66.36  E-value: 6.60e-12
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTKNGEMqfVVKEINDSNSipssfwTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVL 774
Cdd:cd14059    1 LGSGAQGAVFLGKFRGEEV--AVKKVRDEKE------TDIKHLRKLNHPNIIKFKGVCTQAPCYCILMEYCPYGQLYEVL 72
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 775 RS---LSWERRQKIAIGISKALRFLHCN-------CSPSMVVGNMSPQKIIIDGKDEPHLRLSpplmvcTDFKCIISSAY 844
Cdd:cd14059   73 RAgreITPSLLVDWSKQIASGMNYLHLHkiihrdlKSPNVLVTYNDVLKISDFGTSKELSEKS------TKMSFAGTVAW 146
                        170       180       190       200
                 ....*....|....*....|....*....|....*....|....*...
gi 731385391 845 FAPETRETKDTTEKSDIYGFGLILIELMTGKSPTDaefGVHGSIVEWG 892
Cdd:cd14059  147 MAPEVIRNEPCSEKVDIWSFGVVLWELLTGEIPYK---DVDSSAIIWG 191
STKc_Cdc7_like cd06627
Catalytic domain of Cell division control protein 7-like Serine/Threonine Kinases; STKs ...
695-946 1.71e-11

Catalytic domain of Cell division control protein 7-like Serine/Threonine Kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases, which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270797 [Multi-domain]  Cd Length: 254  Bit Score: 65.32  E-value: 1.71e-11
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKG-KTKNGEmqFV-VKEInDSNSIPSSFWT----EFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGK 768
Cdd:cd06627    8 IGRGAFGSVYKGlNLNTGE--FVaIKQI-SLEKIPKSDLKsvmgEIDLLKKLNHPNIVKYIGSVKTKDSLYIILEYVENG 84
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 769 NLSEVLRSLSWERRQKIAIGISKALR---FLHcncspsmvvgnmsPQKII---IDG------KDEpHLRLSpplmvctDF 836
Cdd:cd06627   85 SLASIIKKFGKFPESLVAVYIYQVLEglaYLH-------------EQGVIhrdIKGanilttKDG-LVKLA-------DF 143
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 837 -------------KCIISSAYF-APETRETKDTTEKSDIYGFGLILIELMTGKSP------TDAEFgvhgSIVEwgrycy 896
Cdd:cd06627  144 gvatklnevekdeNSVVGTPYWmAPEVIEMSGVTTASDIWSVGCTVIELLTGNPPyydlqpMAALF----RIVQ------ 213
                        250       260       270       280       290
                 ....*....|....*....|....*....|....*....|....*....|
gi 731385391 897 sDCHldmwidPIIRAQVSSnqnqmvEIMNLALHCTATDPTARPCASDVLK 946
Cdd:cd06627  214 -DDH------PPLPENISP------ELRDFLLQCFQKDPTLRPSAKELLK 250
STKc_ULK1 cd14202
Catalytic domain of the Serine/Threonine kinase, Unc-51-like kinase 1; STKs catalyze the ...
690-880 2.12e-11

Catalytic domain of the Serine/Threonine kinase, Unc-51-like kinase 1; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ATG1/ULK complex is conserved from yeast to humans and it plays a critical role in the initiation of autophagy, the intracellular system that leads to the lysosomal degradation of cellular components and their recycling into basic metabolic units. ULK1 is required for efficient amino acid starvation-induced autophagy and mitochondrial clearance. It associates with three autophagy-related proteins (Atg13, FIP200 amd Atg101) to form the ULK1 complex. All fours proteins are essential for autophagosome formation. ULK1 is regulated by both mammalian target-of rapamycin complex 1 (mTORC1) and AMP-activated protein kinase (AMPK). mTORC1 negatively regulates the ULK1 complex in a nutrient-dependent manner while AMPK stimulates autophagy by inhibiting mTORC1. ULK1 also plays neuron-specific roles and is involved in non-clathrin-coated endocytosis in growth cones, filopodia extension, neurite extension, and axon branching. The ULK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271104 [Multi-domain]  Cd Length: 267  Bit Score: 65.42  E-value: 2.12e-11
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 690 TENNVISRGRKGISYKGKTKNG-EMQFVVKEINDSNSIPSS--FWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIE 766
Cdd:cd14202    5 SRKDLIGHGAFAVVFKGRHKEKhDLEVAVKCINKKNLAKSQtlLGKEIKILKELKHENIVALYDFQEIANSVYLVMEYCN 84
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 767 GKNLSEVL---RSLSWERRQKIAIGISKALRFLHcncSPSMVVGNMSPQKIIIDgkdEPHLRLSPPLMVC---TDF---- 836
Cdd:cd14202   85 GGDLADYLhtmRTLSEDTIRLFLQQIAGAMKMLH---SKGIIHRDLKPQNILLS---YSGGRKSNPNNIRikiADFgfar 158
                        170       180       190       200       210
                 ....*....|....*....|....*....|....*....|....*....|...
gi 731385391 837 ---------KCIISSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSPTDA 880
Cdd:cd14202  159 ylqnnmmaaTLCGSPMYMAPEVIMSQHYDAKADLWSIGTIIYQCLTGKAPFQA 211
PLN03150 PLN03150
hypothetical protein; Provisional
432-518 2.26e-11

hypothetical protein; Provisional


Pssm-ID: 178695 [Multi-domain]  Cd Length: 623  Bit Score: 67.53  E-value: 2.26e-11
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 432 LDISDNNLTGKISDRRWDMPSLQMLSLARNRFFGNLPQSFGA-SKLENLDLSENQFSGAVPSSFGNLSELMQLKLSENML 510
Cdd:PLN03150 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSiTSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSL 502

                 ....*...
gi 731385391 511 SGDIPEEL 518
Cdd:PLN03150 503 SGRVPAAL 510
STKc_MLK cd14061
Catalytic domain of the Serine/Threonine Kinases, Mixed Lineage Kinases; STKs catalyze the ...
694-951 4.19e-11

Catalytic domain of the Serine/Threonine Kinases, Mixed Lineage Kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. MLKs act as mitogen-activated protein kinase kinase kinases (MAP3Ks, MKKKs, MAPKKKs), which phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Mammals have four MLKs (MLK1-4), mostly conserved in vertebrates, which contain an SH3 domain, a catalytic kinase domain, a leucine zipper, a proline-rich region, and a CRIB domain that mediates binding to GTP-bound Cdc42 and Rac. MLKs play roles in immunity and inflammation, as well as in cell death, proliferation, and cell cycle regulation. The MLK subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270963 [Multi-domain]  Cd Length: 258  Bit Score: 64.34  E-value: 4.19e-11
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 694 VISRGRKGISYKGKTKNGEMqfVVKEI-----NDSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGK 768
Cdd:cd14061    1 VIGVGGFGKVYRGIWRGEEV--AVKAArqdpdEDISVTLENVRQEARLFWMLRHPNIIALRGVCLQPPNLCLVMEYARGG 78
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 769 NLSEVL--RSLSWERRQKIAIGISKALRFLHCNCSPSMVVGNMSPQKIIIDGKDEPHlRLSPPLMVCTDF-------KCI 839
Cdd:cd14061   79 ALNRVLagRKIPPHVLVDWAIQIARGMNYLHNEAPVPIIHRDLKSSNILILEAIENE-DLENKTLKITDFglarewhKTT 157
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 840 ISS-----AYFAPETRETKDTTEKSDIYGFGLILIELMTGKSPTDaefGVHGSIVEWGrycysdchldmwidpiiraqVS 914
Cdd:cd14061  158 RMSaagtyAWMAPEVIKSSTFSKASDVWSYGVLLWELLTGEVPYK---GIDGLAVAYG--------------------VA 214
                        250       260       270       280
                 ....*....|....*....|....*....|....*....|....
gi 731385391 915 SNQNQM-------VEIMNLALHCTATDPTARPCASDVLKTLESV 951
Cdd:cd14061  215 VNKLTLpipstcpEPFAQLMKDCWQPDPHDRPSFADILKQLENI 258
STKc_LIMK1 cd14221
Catalytic domain of the Serine/Threonine Kinase, LIM domain kinase 1; STKs catalyze the ...
711-953 5.34e-11

Catalytic domain of the Serine/Threonine Kinase, LIM domain kinase 1; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. LIMK1 activation is induced by bone morphogenic protein, vascular endothelial growth factor, and thrombin. It plays roles in microtubule disassembly and cell cycle progression, and is critical in the regulation of neurite outgrowth. LIMK1 knockout mice show abnormalities in dendritic spine morphology and synaptic function. LIMK1 is one of the genes deleted in patients with Williams Syndrome, which is characterized by distinct craniofacial features, cardiovascular problems, as well as behavioral and neurological abnormalities. LIMKs phosphorylate and inactivate cofilin, an actin depolymerizing factor, to induce the reorganization of the actin cytoskeleton. They act downstream of Rho GTPases and are expressed ubiquitously. As regulators of actin dynamics, they contribute to diverse cellular functions such as cell motility, morphogenesis, differentiation, apoptosis, meiosis, mitosis, and neurite extension. LIMKs contain the LIM (two repeats), PDZ, and catalytic kinase domains. The LIMK1 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271123 [Multi-domain]  Cd Length: 267  Bit Score: 64.21  E-value: 5.34e-11
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 711 GEMQFVVKEINDSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVLRSLS----WERRQKIA 786
Cdd:cd14221   18 GEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDshypWSQRVSFA 97
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 787 IGISKALRFLHC-----------NC----SPSMVVGNMSPQKIIIDGKDEPHLRLSPPLMVCTDFKCIISSAYF-APETR 850
Cdd:cd14221   98 KDIASGMAYLHSmniihrdlnshNClvreNKSVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWmAPEMI 177
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 851 ETKDTTEKSDIYGFGLILIELMTGKS------PTDAEFGVHGSIVeWGRYCYSDCHLDMWidPIiraqvssnqnqmveim 924
Cdd:cd14221  178 NGRSYDEKVDVFSFGIVLCEIIGRVNadpdylPRTMDFGLNVRGF-LDRYCPPNCPPSFF--PI---------------- 238
                        250       260
                 ....*....|....*....|....*....
gi 731385391 925 nlALHCTATDPTARPCASDVLKTLESVLR 953
Cdd:cd14221  239 --AVLCCDLDPEKRPSFSKLEHWLETLRM 265
PTK_CCK4 cd05046
Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4; CCK4, also ...
687-882 1.05e-10

Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4; CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor PTK (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain, which shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. The CCK4 subfamily is part of a larger superfamily that includes other pseudokinases and the catalytic domains of active kinases including PTKs, protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 133178 [Multi-domain]  Cd Length: 275  Bit Score: 63.64  E-value: 1.05e-10
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 687 SSTTENNVISRGRKGISYKGKTK-----NGEMQFVVKEIN--DSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGY 759
Cdd:cd05046    5 SNLQEITTLGRGEFGEVFLAKAKgieeeGGETLVLVKALQktKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 760 LISEYIEGKNLSEVLRS------------LSWERRQKIAIGISKAL------RFLHC-----NCspsmVVGNMSPQKIii 816
Cdd:cd05046   85 MILEYTDLGDLKQFLRAtkskdeklkpppLSTKQKVALCTQIALGMdhlsnaRFVHRdlaarNC----LVSSQREVKV-- 158
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 817 dgkdePHLRLSpplmvctdfKCIISSAYF------------APETRETKDTTEKSDIYGFGLILIELMT-GKSP----TD 879
Cdd:cd05046  159 -----SLLSLS---------KDVYNSEYYklrnaliplrwlAPEAVQEDDFSTKSDVWSFGVLMWEVFTqGELPfyglSD 224

                 ...
gi 731385391 880 AEF 882
Cdd:cd05046  225 EEV 227
STKc_RIP4_like cd14025
Catalytic domain of the Serine/Threonine kinases, Receptor Interacting Protein 4 and similar ...
739-950 1.10e-10

Catalytic domain of the Serine/Threonine kinases, Receptor Interacting Protein 4 and similar proteins; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This subfamily is composed of RIP4, ankyrin (ANK) repeat and kinase domain containing 1 (ANKK1), and similar proteins, all of which harbor C-terminal ANK repeats. RIP4, also called Protein Kinase C-associated kinase (PKK), regulates keratinocyte differentiation and cutaneous inflammation. It activates NF-kappaB and is important in the survival of diffuse large B-cell lymphoma cells. The ANKK1 protein, also called PKK2, has not been studied extensively. The ANKK1 gene, located less than 10kb downstream of the D2 dopamine receptor (DRD2) locus, is altered in the Taq1 A1 polymorphism, which is related to a reduced DRD2 binding affinity and consequently, to mental disorders. The RIP4-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270927 [Multi-domain]  Cd Length: 267  Bit Score: 63.28  E-value: 1.10e-10
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 739 KLRHsnVVKLIGLCrSQKCGyLISEYIEGKNLSEVLRS--LSWERRQKIAIGISKALRFLHCnCSPSMVVGNMSPQKIII 816
Cdd:cd14025   53 KFRH--ILPVYGIC-SEPVG-LVMEYMETGSLEKLLASepLPWELRFRIIHETAVGMNFLHC-MKPPLLHLDLKPANILL 127
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 817 DgkDEPHLRLSP-PLMVCTDF--KCIISS-------AYFAPET-RETKDTTE-KSDIYGFGLILIELMTGKSPTDAEFGV 884
Cdd:cd14025  128 D--AHYHVKISDfGLAKWNGLshSHDLSRdglrgtiAYLPPERfKEKNRCPDtKHDVYSFAIVIWGILTQKKPFAGENNI 205
                        170       180       190       200       210       220
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 731385391 885 HGSIVEWGRYCYSDChldmwidPIIRAQVSSNQNQMVEIMNlalHCTATDPTARPCASDVlkTLES 950
Cdd:cd14025  206 LHIMVKVVKGHRPSL-------SPIPRQRPSECQQMICLMK---RCWDQDPRKRPTFQDI--TSET 259
STKc_MAPKKK cd06606
Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase ...
694-946 1.59e-10

Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270783 [Multi-domain]  Cd Length: 258  Bit Score: 62.54  E-value: 1.59e-10
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 694 VISRGRKGISYKGK-TKNGEMqFVVKEINDSNSIPSSFWT---EFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKN 769
Cdd:cd06606    7 LLGKGSFGSVYLALnLDTGEL-MAVKEVELSGDSEEELEAlerEIRILSSLKHPNIVRYLGTERTENTLNIFLEYVPGGS 85
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 770 LSEVLR---SLSWERRQKIAIGISKALRFLHCNCspsmVV-GNMSPQKIIIDGKDEphLRLSpplmvctDF--------- 836
Cdd:cd06606   86 LASLLKkfgKLPEPVVRKYTRQILEGLEYLHSNG----IVhRDIKGANILVDSDGV--VKLA-------DFgcakrlaei 152
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 837 ------KCIISSAYF-APETRETKDTTEKSDIYGFGLILIELMTGKSPtdaefgvhgsiveWgrYCYSDCHLDMW----- 904
Cdd:cd06606  153 atgegtKSLRGTPYWmAPEVIRGEGYGRAADIWSLGCTVIEMATGKPP-------------W--SELGNPVAALFkigss 217
                        250       260       270       280
                 ....*....|....*....|....*....|....*....|...
gi 731385391 905 -IDPIIRAQVSSnqnqmvEIMNLALHCTATDPTARPCASDVLK 946
Cdd:cd06606  218 gEPPPIPEHLSE------EAKDFLRKCLQRDPKKRPTADELLQ 254
STKc_MLK3 cd14147
Catalytic domain of the Serine/Threonine Kinase, Mixed Lineage Kinase 3; STKs catalyze the ...
694-951 7.63e-10

Catalytic domain of the Serine/Threonine Kinase, Mixed Lineage Kinase 3; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. MLK3 is a mitogen-activated protein kinase kinase kinases (MAP3K, MKKK, MAPKKK), which phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MLK3 activates multiple MAPK pathways and plays a role in apoptosis, proliferation, migration, and differentiation, depending on the cellular context. It is highly expressed in breast cancer cells and its signaling through c-Jun N-terminal kinase has been implicated in the migration, invasion, and malignancy of cancer cells. MLK3 also functions as a negative regulator of Inhibitor of Nuclear Factor-KappaB Kinase (IKK) and consequently, it also impacts inflammation and immunity. Mammals have four MLKs, mostly conserved in vertebrates, which contain an SH3 domain, a catalytic kinase domain, a leucine zipper, a proline-rich region, and a CRIB domain that mediates binding to GTP-bound Cdc42 and Rac. MLKs play roles in immunity and inflammation, as well as in cell death, proliferation, and cell cycle regulation.The MLK3 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271049 [Multi-domain]  Cd Length: 267  Bit Score: 60.81  E-value: 7.63e-10
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 694 VISRGRKGISYKGkTKNGEMQFVVKEINDSNSIPS----SFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKN 769
Cdd:cd14147   10 VIGIGGFGKVYRG-SWRGELVAVKAARQDPDEDISvtaeSVRQEARLFAMLAHPNIIALKAVCLEEPNLCLVMEYAAGGP 88
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 770 LSEVL--RSLSWERRQKIAIGISKALRFLHCNCSPSMVVGNMSPQKII----IDGKDEPHLRLSpplmvCTDF------- 836
Cdd:cd14147   89 LSRALagRRVPPHVLVNWAVQIARGMHYLHCEALVPVIHRDLKSNNILllqpIENDDMEHKTLK-----ITDFglarewh 163
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 837 -----KCIISSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSPTDaefGVHGSIVEWGrycysdchldMWIDPIIRA 911
Cdd:cd14147  164 kttqmSAAGTYAWMAPEVIKASTFSKGSDVWSFGVLLWELLTGEVPYR---GIDCLAVAYG----------VAVNKLTLP 230
                        250       260       270       280
                 ....*....|....*....|....*....|....*....|
gi 731385391 912 QVSSNQNQMVEIMnlaLHCTATDPTARPCASDVLKTLESV 951
Cdd:cd14147  231 IPSTCPEPFAQLM---ADCWAQDPHRRPDFASILQQLEAL 267
STKc_ATG1_ULK_like cd14009
Catalytic domain of the Serine/Threonine kinases, Autophagy-related protein 1 and Unc-51-like ...
695-877 8.91e-10

Catalytic domain of the Serine/Threonine kinases, Autophagy-related protein 1 and Unc-51-like kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This subfamily includes yeast ATG1 and metazoan homologs including vertebrate ULK1-3. The ATG1/ULK complex is conserved from yeast to humans and it plays a critical role in the initiation of autophagy, the intracellular system that leads to the lysosomal degradation of cellular components and their recycling into basic metabolic units. It is involved in nutrient sensing and signaling, the assembly of autophagy factors and the execution of autophagy. In metazoans, ATG1 homologs display additional functions. Unc-51 and ULKs have been implicated in neuronal and axonal development. The ATG1/ULK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270911 [Multi-domain]  Cd Length: 251  Bit Score: 60.31  E-value: 8.91e-10
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTKNGEMQFVVKEINDSN---SIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLS 771
Cdd:cd14009    1 IGRGSFATVWKGRHKQTGEVVAIKEISRKKlnkKLQENLESEIAILKSIKHPNIVRLYDVQKTEDFIYLVLEYCAGGDLS 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 772 EVLRslsweRRQKIAIGISK--------ALRFLHcncSPSMVVGNMSPQKIIIDGKDE-PHLR---------LSPPLM-- 831
Cdd:cd14009   81 QYIR-----KRGRLPEAVARhfmqqlasGLKFLR---SKNIIHRDLKPQNLLLSTSGDdPVLKiadfgfarsLQPASMae 152
                        170       180       190       200
                 ....*....|....*....|....*....|....*....|....*..
gi 731385391 832 -VCTdfkciiSSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSP 877
Cdd:cd14009  153 tLCG------SPLYMAPEILQFQKYDAKADLWSVGAILFEMLVGKPP 193
STKc_FA2-like cd08529
Catalytic domain of the Serine/Threonine Kinases, Chlamydomonas reinhardtii FA2 and similar ...
693-947 1.38e-09

Catalytic domain of the Serine/Threonine Kinases, Chlamydomonas reinhardtii FA2 and similar proteins; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family, which includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily contains FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270868 [Multi-domain]  Cd Length: 256  Bit Score: 59.73  E-value: 1.38e-09
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 693 NVISRGRKGISYKGKTKNGEMQFVVKEINDSN---SIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKN 769
Cdd:cd08529    6 NKLGKGSFGVVYKVVRKVDGRVYALKQIDISRmsrKMREEAIDEARVLSKLNSPYVIKYYDSFVDKGKLNIVMEYAENGD 85
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 770 LSEVL-----RSLSWERRQKIAIGISKALRFLHC---------------NCSPSMVVGNMSPQKIIIDGKDEPHLrlspp 829
Cdd:cd08529   86 LHSLIksqrgRPLPEDQIWKFFIQTLLGLSHLHSkkilhrdiksmniflDKGDNVKIGDLGVAKILSDTTNFAQT----- 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 830 lMVCTDFkciissaYFAPETRETKDTTEKSDIYGFGLILIELMTGKSPTDAEfgVHGSIVE---WGRYcysdchldmwid 906
Cdd:cd08529  161 -IVGTPY-------YLSPELCEDKPYNEKSDVWALGCVLYELCTGKHPFEAQ--NQGALILkivRGKY------------ 218
                        250       260       270       280
                 ....*....|....*....|....*....|....*....|.
gi 731385391 907 PIIRAQVSSNQNQMVEImnlalhCTATDPTARPCASDVLKT 947
Cdd:cd08529  219 PPISASYSQDLSQLIDS------CLTKDYRQRPDTTELLRN 253
PLN03150 PLN03150
hypothetical protein; Provisional
343-428 1.46e-09

hypothetical protein; Provisional


Pssm-ID: 178695 [Multi-domain]  Cd Length: 623  Bit Score: 61.76  E-value: 1.46e-09
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 343 LSGEIPKNLGKQNNLTVLDLSTNNLSGEIPESLCNSGRLFKLILFSNSLEGEVPKSLSDCRSLRRVRLQSNHFSGELSSE 422
Cdd:PLN03150 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAA 509

                 ....*.
gi 731385391 423 FMKLPL 428
Cdd:PLN03150 510 LGGRLL 515
LRRNT_2 pfam08263
Leucine rich repeat N-terminal domain; Leucine Rich Repeats pfam00560 are short sequence ...
29-66 1.53e-09

Leucine rich repeat N-terminal domain; Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats.


Pssm-ID: 462411 [Multi-domain]  Cd Length: 41  Bit Score: 54.22  E-value: 1.53e-09
                          10        20        30
                  ....*....|....*....|....*....|....*....
gi 731385391   29 EEIELLLSFKASINDPLGFLSNWN-SSVDFCNWYGILCT 66
Cdd:pfam08263   3 DDGQALLAFKSSLNDPPGALSSWNsSSSDPCSWTGVTCD 41
STKc_MLK1 cd14145
Catalytic domain of the Serine/Threonine Kinase, Mixed Lineage Kinase 1; STKs catalyze the ...
737-951 1.77e-09

Catalytic domain of the Serine/Threonine Kinase, Mixed Lineage Kinase 1; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. MLK1 is a mitogen-activated protein kinase kinase kinase (MAP3K, MKKK, MAPKKK) and is also called MAP3K9. MAP3Ks phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Little is known about the specific function of MLK1. It is capable of activating the c-Jun N-terminal kinase pathway. Mice lacking both MLK1 and MLK2 are viable, fertile, and have normal life spans. There could be redundancy in the function of MLKs. Mammals have four MLKs, mostly conserved in vertebrates, which contain an SH3 domain, a catalytic kinase domain, a leucine zipper, a proline-rich region, and a CRIB domain that mediates binding to GTP-bound Cdc42 and Rac. MLKs play roles in immunity and inflammation, as well as in cell death, proliferation, and cell cycle regulation. The MLK1 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271047 [Multi-domain]  Cd Length: 270  Bit Score: 59.67  E-value: 1.77e-09
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 737 FGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVLRS--------LSWerrqkiAIGISKALRFLHCNCSPSMVVGN 808
Cdd:cd14145   59 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGkrippdilVNW------AVQIARGMNYLHCEAIVPVIHRD 132
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 809 MSPQKIIIDGKDEpHLRLSPPLMVCTDF------------KCIISSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKS 876
Cdd:cd14145  133 LKSSNILILEKVE-NGDLSNKILKITDFglarewhrttkmSAAGTYAWMAPEVIRSSMFSKGSDVWSYGVLLWELLTGEV 211
                        170       180       190       200       210       220       230
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 731385391 877 PTDaefGVHGSIVEWGrycysdCHLDMWIDPIiraqVSSNQNQMVEIMNlalHCTATDPTARPCASDVLKTLESV 951
Cdd:cd14145  212 PFR---GIDGLAVAYG------VAMNKLSLPI----PSTCPEPFARLME---DCWNPDPHSRPPFTNILDQLTAI 270
PK_GC cd13992
Pseudokinase domain of membrane Guanylate Cyclase receptors; The pseudokinase domain shows ...
704-948 2.08e-09

Pseudokinase domain of membrane Guanylate Cyclase receptors; The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. Membrane (or particulate) GCs consist of an extracellular ligand-binding domain, a single transmembrane region, and an intracellular tail that contains a PK-like domain, an amphiphatic region and a catalytic GC domain that catalyzes the conversion of GTP into cGMP and pyrophosphate. Membrane GCs act as receptors that transduce an extracellular signal to the intracellular production of cGMP, which has been implicated in many processes including cell proliferation, phototransduction, and muscle contractility, through its downstream effectors such as PKG. The PK-like domain of GCs lack a critical aspartate involved in ATP binding and does not exhibit kinase activity. It functions as a negative regulator of the catalytic GC domain and may also act as a docking site for interacting proteins such as GC-activating proteins. The GC subfamily is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270894 [Multi-domain]  Cd Length: 268  Bit Score: 59.33  E-value: 2.08e-09
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 704 YKGKTKNGEMQFV-VKEINDSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVLR----SLS 778
Cdd:cd13992   16 YVKKVGVYGGRTVaIKHITFSRTEKRTILQELNQLKELVHDNLNKFIGICINPPNIAVVTEYCTRGSLQDVLLnreiKMD 95
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 779 WERRQKIAIGISKALRFLHcnCSPSMVVGNMSPQKIIIDGKdephlrlspplMVC--TDFKC--IISSA----------- 843
Cdd:cd13992   96 WMFKSSFIKDIVKGMNYLH--SSSIGYHGRLKSSNCLVDSR-----------WVVklTDFGLrnLLEEQtnhqldedaqh 162
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 844 ----YFAPETRETKDT----TEKSDIYGFGLILIELMTGKSPTDAEFGVHGSIVEwgrycysdcHLDMWIDPIIRAQVSS 915
Cdd:cd13992  163 kkllWTAPELLRGSLLevrgTQKGDVYSFAIILYEILFRSDPFALEREVAIVEKV---------ISGGNKPFRPELAVLL 233
                        250       260       270
                 ....*....|....*....|....*....|...
gi 731385391 916 NQnQMVEIMNLALHCTATDPTARPCASDVLKTL 948
Cdd:cd13992  234 DE-FPPRLVLLVKQCWAENPEKRPSFKQIKKTL 265
PK_eIF2AK_GCN2_rpt1 cd14012
Pseudokinase domain, repeat 1, of eukaryotic translation Initiation Factor 2-Alpha Kinase 4 or ...
732-875 2.93e-09

Pseudokinase domain, repeat 1, of eukaryotic translation Initiation Factor 2-Alpha Kinase 4 or General Control Non-derepressible-2; The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. EIF2AKs phosphorylate the alpha subunit of eIF-2, resulting in the overall downregulation of protein synthesis. eIF-2 phosphorylation is induced in response to cellular stresses including virus infection, heat shock, nutrient deficiency, and the accummulation of unfolded proteins, among others. There are four distinct kinases that phosphorylate eIF-2 and control protein synthesis under different stress conditions: GCN2, protein kinase regulated by RNA (PKR), heme-regulated inhibitor kinase (HRI), and PKR-like endoplasmic reticulum kinase (PERK). GCN2 is activated by amino acid or serum starvation and UV irradiation. It induces GCN4, a transcriptional activator of amino acid biosynthetic genes, leading to increased production of amino acids under amino acid-deficient conditions. In serum-starved cells, GCN2 activation induces translation of the stress-responsive transcription factor ATF4, while under UV stress, GCN2 triggers transcriptional rescue via NF-kappaB signaling. GCN2 contains an N-terminal RWD, a degenerate kinase-like (repeat 1), the catalytic kinase (repeat 2), a histidyl-tRNA synthetase (HisRS)-like, and a C-terminal ribosome-binding and dimerization (RB/DD) domains. The degenerate pseudokinase domain of GCN2 may function as a regulatory domain. The GCN2 subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270914 [Multi-domain]  Cd Length: 254  Bit Score: 58.91  E-value: 2.93e-09
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 732 TEFAQFGKLRHSNVVKLIGLCRSQKCG------YLISEYIEGKNLSEVL---RSLSWERRQKIAIGISKALRFLHCNcsp 802
Cdd:cd14012   47 KELESLKKLRHPNLVSYLAFSIERRGRsdgwkvYLLTEYAPGGSLSELLdsvGSVPLDTARRWTLQLLEALEYLHRN--- 123
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 803 SMVVGNMSPQKIIID-GKDEPHLRLS------PPLMVCTDFKCII--SSAYFAPE-TRETKDTTEKSDIYGFGLILIELM 872
Cdd:cd14012  124 GVVHKSLHAGNVLLDrDAGTGIVKLTdyslgkTLLDMCSRGSLDEfkQTYWLPPElAQGSKSPTRKTDVWDLGLLFLQML 203

                 ...
gi 731385391 873 TGK 875
Cdd:cd14012  204 FGL 206
PknB_PASTA_kin NF033483
Stk1 family PASTA domain-containing Ser/Thr kinase;
739-953 4.39e-09

Stk1 family PASTA domain-containing Ser/Thr kinase;


Pssm-ID: 468045 [Multi-domain]  Cd Length: 563  Bit Score: 60.19  E-value: 4.39e-09
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 739 KLRHSNVVKL--IGlcRSQKCGYLISEYIEGKNLSEVLRS---LSWERRQKIAIGISKALRFLHCNcspSMVVGNMSPQK 813
Cdd:NF033483  63 SLSHPNIVSVydVG--EDGGIPYIVMEYVDGRTLKDYIREhgpLSPEEAVEIMIQILSALEHAHRN---GIVHRDIKPQN 137
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 814 III--DGKdephlrlsppLMVcTDF--------------KCIISSA-YFAPETRETKDTTEKSDIYGFGLILIELMTGKS 876
Cdd:NF033483 138 ILItkDGR----------VKV-TDFgiaralssttmtqtNSVLGTVhYLSPEQARGGTVDARSDIYSLGIVLYEMLTGRP 206
                        170       180       190       200       210       220       230
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 731385391 877 PTDAEFGVhgSIVewgrycYSdcHLDmwiDPIIRA-QVSSNQNQMVEimNLALHCTATDPTARP-CASDVLKTLESVLR 953
Cdd:NF033483 207 PFDGDSPV--SVA------YK--HVQ---EDPPPPsELNPGIPQSLD--AVVLKATAKDPDDRYqSAAEMRADLETALS 270
PTKc_Csk_like cd05039
Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases; PTKs catalyze the ...
695-877 6.48e-09

Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases; PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. This subfamily is composed of Csk, Chk, and similar proteins. They are cytoplasmic (or nonreceptor) PTKs containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. The Csk-like subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270635 [Multi-domain]  Cd Length: 256  Bit Score: 57.75  E-value: 6.48e-09
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTKNgemQFV-VKEINDSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEV 773
Cdd:cd05039   14 IGKGEFGDVMLGDYRG---QKVaVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLEGNGLYIVTEYMAKGSLVDY 90
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 774 LRS---LSWERRQKI--AIGISKALRFLHcncSPSMVVGNMSPQKIIIDgkDEPHLRLSpplmvctDFKCIISSAY---- 844
Cdd:cd05039   91 LRSrgrAVITRKDQLgfALDVCEGMEYLE---SKKFVHRDLAARNVLVS--EDNVAKVS-------DFGLAKEASSnqdg 158
                        170       180       190       200
                 ....*....|....*....|....*....|....*....|.
gi 731385391 845 -------FAPETRETKDTTEKSDIYGFGLILIELMT-GKSP 877
Cdd:cd05039  159 gklpikwTAPEALREKKFSTKSDVWSFGILLWEIYSfGRVP 199
STKc_ACVR2 cd14053
Catalytic domain of the Serine/Threonine Kinase, Activin Type II Receptor; STKs catalyze the ...
694-954 8.26e-09

Catalytic domain of the Serine/Threonine Kinase, Activin Type II Receptor; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. ACVR2 belongs to a group of receptors for the TGFbeta family of secreted signaling molecules that includes TGFbeta, bone morphogenetic proteins (BMPs), activins, growth and differentiation factors (GDFs), and anti-Mullerian hormone, among others. These receptors contain an extracellular domain that binds ligands, a single transmembrane region, and a cytoplasmic catalytic kinase domain. Type II receptors, such as ACVR2, are high-affinity receptors which bind ligands, autophosphorylate, as well as trans-phosphorylate and activate low-affinity type I receptors. ACVR2 acts primarily as the receptors for activins, nodal, myostatin, GDF11, and a subset of BMPs. ACVR2 signaling impacts many cellular and physiological processes including reproductive and gonadal functions, myogenesis, bone remodeling and tooth development, kidney organogenesis, apoptosis, fibrosis, inflammation, and neurogenesis. Vertebrates contain two ACVR2 proteins, ACVR2a (or ActRIIA) and ACVR2b (or ActRIIB). The ACVR2 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270955 [Multi-domain]  Cd Length: 290  Bit Score: 58.11  E-value: 8.26e-09
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 694 VISRGRKGISYKGKTKNgemQFV-VKEINDSNSipSSFWTEFAQFG--KLRHSNVVKLIGlcrSQKCG-------YLISE 763
Cdd:cd14053    2 IKARGRFGAVWKAQYLN---RLVaVKIFPLQEK--QSWLTEREIYSlpGMKHENILQFIG---AEKHGesleaeyWLITE 73
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 764 YIEGKNLSEVL--RSLSWERRQKIAIGISKALRFLHCNCSPSmvvgNMSPQKIII--DGKDEPHLrLSPPLMVC-TDF-- 836
Cdd:cd14053   74 FHERGSLCDYLkgNVISWNELCKIAESMARGLAYLHEDIPAT----NGGHKPSIAhrDFKSKNVL-LKSDLTACiADFgl 148
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 837 KCIISSA--------------YFAPETRE-----TKDTTEKSDIYGFGLILIELMTGKS-----------PTDAEFGVHG 886
Cdd:cd14053  149 ALKFEPGkscgdthgqvgtrrYMAPEVLEgainfTRDAFLRIDMYAMGLVLWELLSRCSvhdgpvdeyqlPFEEEVGQHP 228
                        250       260       270       280       290       300       310
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 887 SIVEWGRYCysdCHLDMwiDPIIRAQVSSNQ--NQMVEIMNlalHCTATDPTARPCASDVLKTLESVLRS 954
Cdd:cd14053  229 TLEDMQECV---VHKKL--RPQIRDEWRKHPglAQLCETIE---ECWDHDAEARLSAGCVEERLSQLSRS 290
STKc_MEKK4 cd06626
Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein (MAP) ...
692-946 1.27e-08

Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein (MAP)/Extracellular signal-Regulated Kinase (ERK) Kinase Kinase 4; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. MEKK4 is a MAPK kinase kinase that phosphorylates and activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270796 [Multi-domain]  Cd Length: 265  Bit Score: 56.93  E-value: 1.27e-08
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 692 NNVISRGRKGISYKG-KTKNGEMqFVVKEI----NDSNSIPSsFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIE 766
Cdd:cd06626    5 GNKIGEGTFGKVYTAvNLDTGEL-MAMKEIrfqdNDPKTIKE-IADEMKVLEGLDHPNLVRYYGVEVHREEVYIFMEYCQ 82
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 767 GKNLSEVLRS---LSWERRQKIAIGISKALRFLHCNcspSMVVGNMSPQKIIIDGKDephlrlsppLMVCTDFKC--IIS 841
Cdd:cd06626   83 EGTLEELLRHgriLDEAVIRVYTLQLLEGLAYLHEN---GIVHRDIKPANIFLDSNG---------LIKLGDFGSavKLK 150
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 842 S-----------------AYFAPETRETKDTTEK---SDIYGFGLILIELMTGKSPTdAEFGVHGSIVewgrYcysdcHL 901
Cdd:cd06626  151 NntttmapgevnslvgtpAYMAPEVITGNKGEGHgraADIWSLGCVVLEMATGKRPW-SELDNEWAIM----Y-----HV 220
                        250       260       270       280
                 ....*....|....*....|....*....|....*....|....*..
gi 731385391 902 DMWIDPII--RAQVSSNQNQMVEimnlalHCTATDPTARPCASDVLK 946
Cdd:cd06626  221 GMGHKPPIpdSLQLSPEGKDFLS------RCLESDPKKRPTASELLD 261
LRR_8 pfam13855
Leucine rich repeat;
474-534 1.64e-08

Leucine rich repeat;


Pssm-ID: 404697 [Multi-domain]  Cd Length: 61  Bit Score: 51.76  E-value: 1.64e-08
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 731385391  474 SKLENLDLSENQFSGAVPSSFGNLSELMQLKLSENMLSGDIPEELSSCKKLVSLNLSHNQL 534
Cdd:pfam13855   1 PNLRSLDLSNNRLTSLDDGAFKGLSNLKVLDLSNNLLTTLSPGAFSGLPSLRYLDLSGNRL 61
STKc_MLK2 cd14148
Catalytic domain of the Serine/Threonine Kinase, Mixed Lineage Kinase 2; STKs catalyze the ...
694-951 1.93e-08

Catalytic domain of the Serine/Threonine Kinase, Mixed Lineage Kinase 2; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. MLK2 is a mitogen-activated protein kinase kinase kinase (MAP3K, MKKK, MAPKKK) and is also called MAP3K10. MAP3Ks phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MLK2 is abundant in brain, skeletal muscle, and testis. It functions upstream of the MAPK, c-Jun N-terminal kinase. It binds hippocalcin, a calcium-sensor protein that protects neurons against calcium-induced cell death. Both MLK2 and hippocalcin may be associated with the pathogenesis of Parkinson's disease. MLK2 also binds to normal huntingtin (Htt), which is important in neuronal transcription, development, and survival. MLK2 does not bind to the polyglutamine-expanded Htt, which is implicated in the pathogeneis of Huntington's disease, leading to neuronal toxicity. Mammals have four MLKs, mostly conserved in vertebrates, which contain an SH3 domain, a catalytic kinase domain, a leucine zipper, a proline-rich region, and a CRIB domain that mediates binding to GTP-bound Cdc42 and Rac. MLKs play roles in immunity and inflammation, as well as in cell death, proliferation, and cell cycle regulation. The MLK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K).


Pssm-ID: 271050 [Multi-domain]  Cd Length: 258  Bit Score: 56.53  E-value: 1.93e-08
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 694 VISRGRKGISYKGKTKNGEMqfVVKEI-----NDSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGK 768
Cdd:cd14148    1 IIGVGGFGKVYKGLWRGEEV--AVKAArqdpdEDIAVTAENVRQEARLFWMLQHPNIIALRGVCLNPPHLCLVMEYARGG 78
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 769 NLSEVLRS--------LSWerrqkiAIGISKALRFLHCNCSPSMVVGNMSPQKIIIDGKDEPHlRLSPPLMVCTDF---- 836
Cdd:cd14148   79 ALNRALAGkkvpphvlVNW------AVQIARGMNYLHNEAIVPIIHRDLKSSNILILEPIEND-DLSGKTLKITDFglar 151
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 837 --------KCIISSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSPTDAefgVHGSIVEWGrycysdCHLDMWIDPI 908
Cdd:cd14148  152 ewhkttkmSAAGTYAWMAPEVIRLSLFSKSSDVWSFGVLLWELLTGEVPYRE---IDALAVAYG------VAMNKLTLPI 222
                        250       260       270       280
                 ....*....|....*....|....*....|....*....|...
gi 731385391 909 iraqVSSNQNQMVEIMNlalHCTATDPTARPCASDVLKTLESV 951
Cdd:cd14148  223 ----PSTCPEPFARLLE---ECWDPDPHGRPDFGSILKRLEDI 258
STKc_MLK4 cd14146
Catalytic domain of the Serine/Threonine Kinase, Mixed Lineage Kinase 4; STKs catalyze the ...
722-951 2.21e-08

Catalytic domain of the Serine/Threonine Kinase, Mixed Lineage Kinase 4; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. MLK4 is a mitogen-activated protein kinase kinase kinase (MAP3K, MKKK, MAPKKK), which phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. The specific function of MLK4 is yet to be determined. Mutations in the kinase domain of MLK4 have been detected in colorectal cancers. Mammals have four MLKs, mostly conserved in vertebrates, which contain an SH3 domain, a catalytic kinase domain, a leucine zipper, a proline-rich region, and a CRIB domain that mediates binding to GTP-bound Cdc42 and Rac. MLKs play roles in immunity and inflammation, as well as in cell death, proliferation, and cell cycle regulation.The MLK4 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271048 [Multi-domain]  Cd Length: 268  Bit Score: 56.58  E-value: 2.21e-08
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 722 DSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVL----RSLSWERRQKI--------AIGI 789
Cdd:cd14146   32 DIKATAESVRQEAKLFSMLRHPNIIKLEGVCLEEPNLCLVMEFARGGTLNRALaaanAAPGPRRARRIpphilvnwAVQI 111
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 790 SKALRFLHCNCSPSMVVGNMSPQKIIIDGKDEpHLRLSPPLMVCTDF------------KCIISSAYFAPETRETKDTTE 857
Cdd:cd14146  112 ARGMLYLHEEAVVPILHRDLKSSNILLLEKIE-HDDICNKTLKITDFglarewhrttkmSAAGTYAWMAPEVIKSSLFSK 190
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 858 KSDIYGFGLILIELMTGKSPTDaefGVHGSIVEWGrycysdchldMWIDPIIRAQVSSNQNQMVEIMNlalHCTATDPTA 937
Cdd:cd14146  191 GSDIWSYGVLLWELLTGEVPYR---GIDGLAVAYG----------VAVNKLTLPIPSTCPEPFAKLMK---ECWEQDPHI 254
                        250
                 ....*....|....
gi 731385391 938 RPCASDVLKTLESV 951
Cdd:cd14146  255 RPSFALILEQLTAI 268
PKc_LIMK_like_unk cd14156
Catalytic domain of an unknown subfamily of LIM domain kinase-like protein kinases; PKs ...
733-951 3.28e-08

Catalytic domain of an unknown subfamily of LIM domain kinase-like protein kinases; PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. This group is composed of uncharacterized proteins with similarity to LIMK and Testicular or testis-specific protein kinase (TESK). LIMKs are characterized as serine/threonine kinases (STKs) while TESKs are dual-specificity protein kinases. Both LIMK and TESK phosphorylate and inactivate cofilin, an actin depolymerizing factor, to induce the reorganization of the actin cytoskeleton. They are implicated in many cellular functions including cell spreading, motility, morphogenesis, meiosis, mitosis, and spermatogenesis. The LIMK-like subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271058 [Multi-domain]  Cd Length: 256  Bit Score: 55.60  E-value: 3.28e-08
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 733 EFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVLR----SLSWERRQKIAIGISKALRFLHC---------- 798
Cdd:cd14156   38 EISLLQKLSHPNIVRYLGICVKDEKLHPILEYVSGGCLEELLAreelPLSWREKVELACDISRGMVYLHSkniyhrdlns 117
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 799 -NC----SP------------SMVVGNMSPqkiiidgkDEPHLRLSpplmvctdfkcIISSAYF-APETRETKDTTEKSD 860
Cdd:cd14156  118 kNClirvTPrgreavvtdfglAREVGEMPA--------NDPERKLS-----------LVGSAFWmAPEMLRGEPYDRKVD 178
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 861 IYGFGLILIELMtGKSPTDAEfgVHGSIVEWGrycysdchLDMwidPIIRAQVSSNQNQMVEimnLALHCTATDPTARPC 940
Cdd:cd14156  179 VFSFGIVLCEIL-ARIPADPE--VLPRTGDFG--------LDV---QAFKEMVPGCPEPFLD---LAASCCRMDAFKRPS 241
                        250
                 ....*....|.
gi 731385391 941 ASDVLKTLESV 951
Cdd:cd14156  242 FAELLDELEDI 252
STKc_Kin1_2 cd14077
Catalytic domain of Kin1, Kin2, and simlar Serine/Threonine Kinases; STKs catalyze the ...
740-899 3.48e-08

Catalytic domain of Kin1, Kin2, and simlar Serine/Threonine Kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This subfamily is composed of yeast Kin1, Kin2, and similar proteins. Fission yeast Kin1 is a membrane-associated kinase that is involved in regulating cell surface cohesiveness during interphase. It also plays a role during mitosis, linking actomyosin ring assembly with septum synthesis and membrane closure to ensure separation of daughter cells. Budding yeast Kin1 and Kin2 act downstream of the Rab-GTPase Sec4 and are associated with the exocytic apparatus; they play roles in the secretory pathway. The Kin1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270979 [Multi-domain]  Cd Length: 267  Bit Score: 55.92  E-value: 3.48e-08
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 740 LRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVLRS---LSWERRQKIAIGISKALRFLHCNcspSMVVGNMSPQKIII 816
Cdd:cd14077   70 LNHPHICRLRDFLRTPNHYYMLFEYVDGGQLLDYIIShgkLKEKQARKFARQIASALDYLHRN---SIVHRDLKIENILI 146
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 817 DGKDEPHL---RLSPPLMVCTDFKCIISSAYF-APETRETKD-TTEKSDIYGFGLILIELMTGKSPTDAEF--GVHGSI- 888
Cdd:cd14077  147 SKSGNIKIidfGLSNLYDPRRLLRTFCGSLYFaAPELLQAQPyTGPEVDVWSFGVVLYVLVCGKVPFDDENmpALHAKIk 226
                        170
                 ....*....|....
gi 731385391 889 ---VEWGRYCYSDC 899
Cdd:cd14077  227 kgkVEYPSYLSSEC 240
LRR_RI cd00116
Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 ...
188-463 5.31e-08

Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).


Pssm-ID: 238064 [Multi-domain]  Cd Length: 319  Bit Score: 55.82  E-value: 5.31e-08
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 188 SLEFLTLaSNQLVGEIPRELGRMKSLKwiyLGYNNLSGG----IPKEIGELTSLNHLDLVYNNlTGEIPSSLGNLsdLHF 263
Cdd:cd00116    4 SLKGELL-KTERATELLPKLLCLQVLR---LEGNTLGEEaakaLASALRPQPSLKELCLSLNE-TGRIPRGLQSL--LQG 76
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 264 LflyqnklsGSIPpsifdlkKLISLDLSDNSLSGEIPELVIQLQ---NLEILHLFAN----DFTGKIPRALASL-PRLQI 335
Cdd:cd00116   77 L--------TKGC-------GLQELDLSDNALGPDGCGVLESLLrssSLQELKLNNNglgdRGLRLLAKGLKDLpPALEK 141
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 336 LQLWSNKLSGE----IPKNLGKQNNLTVLDLSTNNLSGEIPESLCNSGR----LFKLILFSNSLEGEVPKSLSDC----R 403
Cdd:cd00116  142 LVLGRNRLEGAsceaLAKALRANRDLKELNLANNGIGDAGIRALAEGLKancnLEVLDLNNNGLTDEGASALAETlaslK 221
                        250       260       270       280       290       300
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 731385391 404 SLRRVRLQSNHFSGELSSEF---MKLPL--VYFLDISDNNLT--GKISDRRW--DMPSLQMLSLARNRF 463
Cdd:cd00116  222 SLEVLNLGDNNLTDAGAAALasaLLSPNisLLTLSLSCNDITddGAKDLAEVlaEKESLLELDLRGNKF 290
STKc_ULK1_2-like cd14120
Catalytic domain of the Serine/Threonine kinases, Unc-51-like kinases 1 and 2, and similar ...
695-880 6.54e-08

Catalytic domain of the Serine/Threonine kinases, Unc-51-like kinases 1 and 2, and similar proteins; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ATG1/ULK complex is conserved from yeast to humans and it plays a critical role in the initiation of autophagy, the intracellular system that leads to the lysosomal degradation of cellular components and their recycling into basic metabolic units. ULK1 is required for efficient amino acid starvation-induced autophagy and mitochondrial clearance. ULK2 is ubiquitously expressed and is essential in autophagy induction. ULK1 and ULK2 have unique and cell-type specific roles, but also display partially redundant roles in starvation-induced autophagy. They both display neuron-specific functions: ULK1 is involved in non-clathrin-coated endocytosis in growth cones, filopodia extension, and axon branching; ULK2 plays a role in axon development. The ULK1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271022 [Multi-domain]  Cd Length: 256  Bit Score: 54.68  E-value: 6.54e-08
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTKNGEMQFV-VKEINDSN-SIPSSFWT-EFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLS 771
Cdd:cd14120    1 IGHGAFAVVFKGRHRKKPDLPVaIKCITKKNlSKSQNLLGkEIKILKELSHENVVALLDCQETSSSVYLVMEYCNGGDLA 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 772 EVL---RSLSWERRQKIAIGISKALRFLHcncSPSMVVGNMSPQKIII--DGKDEPH---LR-----------LSPPLMV 832
Cdd:cd14120   81 DYLqakGTLSEDTIRVFLQQIAAAMKALH---SKGIVHRDLKPQNILLshNSGRKPSpndIRlkiadfgfarfLQDGMMA 157
                        170       180       190       200
                 ....*....|....*....|....*....|....*....|....*...
gi 731385391 833 CTdfKCiISSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSPTDA 880
Cdd:cd14120  158 AT--LC-GSPMYMAPEVIMSLQYDAKADLWSIGTIVYQCLTGKAPFQA 202
STKc_LRRK cd14000
Catalytic domain of the Serine/Threonine kinase, Leucine-Rich Repeat Kinase; STKs catalyze the ...
713-950 7.22e-08

Catalytic domain of the Serine/Threonine kinase, Leucine-Rich Repeat Kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. LRRKs are also classified as ROCO proteins because they contain a ROC (Ras of complex proteins)/GTPase domain followed by a COR (C-terminal of ROC) domain of unknown function. In addition, LRRKs contain a catalytic kinase domain and protein-protein interaction motifs including a WD40 domain, LRRs and ankyrin (ANK) repeats. LRRKs possess both GTPase and kinase activities, with the ROC domain acting as a molecular switch for the kinase domain, cycling between a GTP-bound state which drives kinase activity and a GDP-bound state which decreases the activity. Vertebrates contain two members, LRRK1 and LRRK2, which show complementary expression in the brain. Mutations in LRRK2 are linked to both familial and sporadic forms of Parkinson's disease. The normal roles of LRRKs are not clearly defined. They may be involved in mitogen-activated protein kinase (MAPK) pathways, protein translation control, programmed cell death pathways, and cytoskeletal dynamics. The LRRK subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270902 [Multi-domain]  Cd Length: 275  Bit Score: 54.93  E-value: 7.22e-08
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 713 MQFVVKEINDSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCgyLISEYIEGKNLSEVLR-------SLSWERRQKI 785
Cdd:cd14000   40 TMLRHLRATDAMKNFRLLRQELTVLSHLHHPSIVYLLGIGIHPLM--LVLELAPLGSLDHLLQqdsrsfaSLGRTLQQRI 117
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 786 AIGISKALRFLHcncSPSMVVGNMSPQKIII---DGKDEPHLRLSpplmvctDF----KCIISSA--------YFAPETR 850
Cdd:cd14000  118 ALQVADGLRYLH---SAMIIYRDLKSHNVLVwtlYPNSAIIIKIA-------DYgisrQCCRMGAkgsegtpgFRAPEIA 187
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 851 ETKDT-TEKSDIYGFGLILIELMTGKSPTDAEFGVHGSIVEWGRycysdchldmwIDPIIRaqvSSNQNQMVEIMNLALH 929
Cdd:cd14000  188 RGNVIyNEKVDVFSFGMLLYEILSGGAPMVGHLKFPNEFDIHGG-----------LRPPLK---QYECAPWPEVEVLMKK 253
                        250       260
                 ....*....|....*....|.
gi 731385391 930 CTATDPTARPCASDVLKTLES 950
Cdd:cd14000  254 CWKENPQQRPTAVTVVSILNS 274
PPP1R42 cd21340
protein phosphatase 1 regulatory subunit 42; Protein phosphatase 1 regulatory subunit 42 ...
234-416 7.23e-08

protein phosphatase 1 regulatory subunit 42; Protein phosphatase 1 regulatory subunit 42 (PPP1R42), also known as leucine-rich repeat-containing protein 67 (lrrc67) or testis leucine-rich repeat (TLRR) protein, plays a role in centrosome separation. PPP1R42 has been shown to interact with the well-conserved signaling protein phosphatase-1 (PP1) and thereby increasing PP1's activity, which counters centrosome separation. Inhibition of PPP1R42 expression increases the number of centrosomes per cell while its depletion reduces the activity of PP1 leading to activation of NEK2, the kinase responsible for phosphorylation of centrosomal linker proteins promoting centrosome separation.


Pssm-ID: 411060 [Multi-domain]  Cd Length: 220  Bit Score: 54.02  E-value: 7.23e-08
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 234 LTSLNHLDLVYNNLTgeipsSLGNLS---DLHFLFLYQNKLSgSIPPSIFdLKKLISLDLSDNSLSgEIPELViQLQNLE 310
Cdd:cd21340    1 LKRITHLYLNDKNIT-----KIDNLSlckNLKVLYLYDNKIT-KIENLEF-LTNLTHLYLQNNQIE-KIENLE-NLVNLK 71
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 311 ILHLFANdftgKIPR--ALASLPRLQILQLWSNKL-SGEI----PKNL-GKQNNLTVLDLSTNNLSgeIPESLCNSGRLF 382
Cdd:cd21340   72 KLYLGGN----RISVveGLENLTNLEELHIENQRLpPGEKltfdPRSLaALSNSLRVLNISGNNID--SLEPLAPLRNLE 145
                        170       180       190
                 ....*....|....*....|....*....|....*.
gi 731385391 383 KLILFSNSLE--GEVPKSLSDCRSLRRVRLQSNHFS 416
Cdd:cd21340  146 QLDASNNQISdlEELLDLLSSWPSLRELDLTGNPVC 181
STKc_ASK cd06624
Catalytic domain of the Serine/Threonine Kinase, Apoptosis signal-regulating kinase; STKs ...
694-945 8.34e-08

Catalytic domain of the Serine/Threonine Kinase, Apoptosis signal-regulating kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. Members of this subfamily are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs) and include ASK1, ASK2, and MAPKKK15. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270794 [Multi-domain]  Cd Length: 268  Bit Score: 54.72  E-value: 8.34e-08
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 694 VISRGRKGISYKGKTKNGEMQFVVKEI---NDSNSIPssFWTEFAQFGKLRHSNVVKLIGlCRSQKCGYLI-SEYIEGKN 769
Cdd:cd06624   15 VLGKGTFGVVYAARDLSTQVRIAIKEIperDSREVQP--LHEEIALHSRLSHKNIVQYLG-SVSEDGFFKIfMEQVPGGS 91
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 770 LSEVLRSlSWE--RRQKIAIG-----ISKALRFLHCN-------CSPSMVVGNMSPQKIIID-GKDEphlRLSPPLMVCT 834
Cdd:cd06624   92 LSALLRS-KWGplKDNENTIGyytkqILEGLKYLHDNkivhrdiKGDNVLVNTYSGVVKISDfGTSK---RLAGINPCTE 167
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 835 DFKCIISsaYFAPET--RETKDTTEKSDIYGFGLILIELMTGKSPTDAEFGVHGSIVEWGRYcysdchldmWIDPIIRAQ 912
Cdd:cd06624  168 TFTGTLQ--YMAPEVidKGQRGYGPPADIWSLGCTIIEMATGKPPFIELGEPQAAMFKVGMF---------KIHPEIPES 236
                        250       260       270
                 ....*....|....*....|....*....|...
gi 731385391 913 VSSNQNqmveimNLALHCTATDPTARPCASDVL 945
Cdd:cd06624  237 LSEEAK------SFILRCFEPDPDKRATASDLL 263
PHA02988 PHA02988
hypothetical protein; Provisional
704-949 1.37e-07

hypothetical protein; Provisional


Pssm-ID: 165291 [Multi-domain]  Cd Length: 283  Bit Score: 53.98  E-value: 1.37e-07
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 704 YKGKTKNGE--MQFVVKEINDSNSIPSSFWTEFAQFGKLRHSNVVKLIG--------LCRsqkcGYLISEYIEGKNLSEV 773
Cdd:PHA02988  37 YKGIFNNKEviIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGfiidivddLPR----LSLILEYCTRGYLREV 112
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 774 L---RSLSWERRQKIAIGISKALRFLH--------CNCSPSMVVGNMSPQKIIIDGKDEphLRLSPPlmvctdFKCIISS 842
Cdd:PHA02988 113 LdkeKDLSFKTKLDMAIDCCKGLYNLYkytnkpykNLTSVSFLVTENYKLKIICHGLEK--ILSSPP------FKNVNFM 184
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 843 AYFAPetRETKDT----TEKSDIYGFGLILIELMTGKSPTD--AEFGVHGSIVE--WGRYCYSDCHLdmwidpiiraqvs 914
Cdd:PHA02988 185 VYFSY--KMLNDIfseyTIKDDIYSLGVVLWEIFTGKIPFEnlTTKEIYDLIINknNSLKLPLDCPL------------- 249
                        250       260       270
                 ....*....|....*....|....*....|....*
gi 731385391 915 snqnqmvEIMNLALHCTATDPTARPCASDVLKTLE 949
Cdd:PHA02988 250 -------EIKCIVEACTSHDSIKRPNIKEILYNLS 277
STKc_16 cd13986
Catalytic domain of Serine/Threonine Kinase 16; STKs catalyze the transfer of the ...
739-952 1.64e-07

Catalytic domain of Serine/Threonine Kinase 16; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. STK16 is associated with many names including Myristylated and Palmitylated Serine/threonine Kinase 1 (MPSK1), Kinase related to cerevisiae and thaliana (Krct), and Protein Kinase expressed in day 12 fetal liver (PKL12). It is widely expressed in mammals with highest levels found in liver, testis, and kidney. It is localized in the Golgi but is translocated to the nucleus upon disorganization of the Golgi. STK16 is constitutively active and is capable of phosphorylating itself and other substrates. It may be involved in regulating stromal-epithelial interactions during mammary gland ductal morphogenesis. It may also function as a transcriptional co-activator of type-C natriuretic peptide and VEGF. The STK16 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270888 [Multi-domain]  Cd Length: 282  Bit Score: 53.84  E-value: 1.64e-07
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 739 KLRHSNVVKLIGLCRSQKCG-----YLISEYIEGKNLSEVLRSLSWE-------RRQKIAIGISKALRFLHCNCSPSMVV 806
Cdd:cd13986   53 LFNHPNILRLLDSQIVKEAGgkkevYLLLPYYKRGSLQDEIERRLVKgtffpedRILHIFLGICRGLKAMHEPELVPYAH 132
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 807 GNMSPQKIIIDGKDEPHL----------------RLSPPLMVCTDFKCIISsaYFAPE--TRETKDT-TEKSDIYGFGLI 867
Cdd:cd13986  133 RDIKPGNVLLSEDDEPILmdlgsmnparieiegrREALALQDWAAEHCTMP--YRAPElfDVKSHCTiDEKTDIWSLGCT 210
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 868 LIELMTGKSPTDAEFGVHGSI---VEWGRYCYSDCHLdmwidpiiraqVSSnqnqmvEIMNLALHCTATDPTARPCASDV 944
Cdd:cd13986  211 LYALMYGESPFERIFQKGDSLalaVLSGNYSFPDNSR-----------YSE------ELHQLVKSMLVVNPAERPSIDDL 273

                 ....*...
gi 731385391 945 LKTLESVL 952
Cdd:cd13986  274 LSRVHDLI 281
STKc_ULK2 cd14201
Catalytic domain of the Serine/Threonine kinase, Unc-51-like kinase 2; STKs catalyze the ...
690-880 1.83e-07

Catalytic domain of the Serine/Threonine kinase, Unc-51-like kinase 2; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ATG1/ULK complex is conserved from yeast to humans and it plays a critical role in the initiation of autophagy, the intracellular system that leads to the lysosomal degradation of cellular components and their recycling into basic metabolic units. ULK2 is ubiquitously expressed and is essential in autophagy induction. It displays partially redundant functions with ULK1 and is able to compensate for the loss of ULK1 in non-selective autophagy. It also displays neuron-specific functions and is important in axon development. The ULK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271103 [Multi-domain]  Cd Length: 271  Bit Score: 53.47  E-value: 1.83e-07
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 690 TENNVISRGRKGISYKGK-TKNGEMQFVVKEINDSNSIPSSFW--TEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIE 766
Cdd:cd14201    9 SRKDLVGHGAFAVVFKGRhRKKTDWEVAIKSINKKNLSKSQILlgKEIKILKELQHENIVALYDVQEMPNSVFLVMEYCN 88
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 767 GKNLSEVLRSLSWERRQKIAI---GISKALRFLHcncSPSMVVGNMSPQKIIIDGKDEPHLRLSPPLMVCTDF------- 836
Cdd:cd14201   89 GGDLADYLQAKGTLSEDTIRVflqQIAAAMRILH---SKGIIHRDLKPQNILLSYASRKKSSVSGIRIKIADFgfarylq 165
                        170       180       190       200       210
                 ....*....|....*....|....*....|....*....|....*....|
gi 731385391 837 ------KCIISSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSPTDA 880
Cdd:cd14201  166 snmmaaTLCGSPMYMAPEVIMSQHYDAKADLWSIGTVIYQCLVGKPPFQA 215
PPP1R42 cd21340
protein phosphatase 1 regulatory subunit 42; Protein phosphatase 1 regulatory subunit 42 ...
111-336 3.61e-07

protein phosphatase 1 regulatory subunit 42; Protein phosphatase 1 regulatory subunit 42 (PPP1R42), also known as leucine-rich repeat-containing protein 67 (lrrc67) or testis leucine-rich repeat (TLRR) protein, plays a role in centrosome separation. PPP1R42 has been shown to interact with the well-conserved signaling protein phosphatase-1 (PP1) and thereby increasing PP1's activity, which counters centrosome separation. Inhibition of PPP1R42 expression increases the number of centrosomes per cell while its depletion reduces the activity of PP1 leading to activation of NEK2, the kinase responsible for phosphorylation of centrosomal linker proteins promoting centrosome separation.


Pssm-ID: 411060 [Multi-domain]  Cd Length: 220  Bit Score: 52.10  E-value: 3.61e-07
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 111 GNISLCYSLRYLNLSNNNLTgSMPR-GSASGLEALDLSNNVISgEIPaDMGLFSRLKVLDLGGNflvgkipnSIANITSL 189
Cdd:cd21340   18 DNLSLCKNLKVLYLYDNKIT-KIENlEFLTNLTHLYLQNNQIE-KIE-NLENLVNLKKLYLGGN--------RISVVEGL 86
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 190 EFLTlasnQLvgeipRELgrmkslkwiYLGYNNLSGGIPKEIGELT------SLNHLDLVYNNLTgeipsslgNLSDLHF 263
Cdd:cd21340   87 ENLT----NL-----EEL---------HIENQRLPPGEKLTFDPRSlaalsnSLRVLNISGNNID--------SLEPLAP 140
                        170       180       190       200       210       220       230
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 731385391 264 LflyqnklsgsippsifdlKKLISLDLSDNSLS--GEIPELVIQLQNLEILHLFANDFTgKIPR----ALASLPRLQIL 336
Cdd:cd21340  141 L------------------RNLEQLDASNNQISdlEELLDLLSSWPSLRELDLTGNPVC-KKPKyrdkIILASKSLEVL 200
PTK_Jak1_rpt1 cd05077
Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1; Jak1 is widely ...
712-939 3.75e-07

Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1; Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits, common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Jak1 is a cytoplasmic (or nonreceptor) PTK containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. The Jak1 subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270662 [Multi-domain]  Cd Length: 266  Bit Score: 52.63  E-value: 3.75e-07
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 712 EMQFVVKEINDSN-SIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNL-------SEVLrSLSWerRQ 783
Cdd:cd05077   36 EIKVILKVLDPSHrDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLdlfmhrkSDVL-TTPW--KF 112
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 784 KIAIGISKALRFLHcncSPSMVVGNMSPQKII-----IDGKDEPHLRLSPP---LMVCTDFKCIISSAYFAPE-TRETKD 854
Cdd:cd05077  113 KVAKQLASALSYLE---DKDLVHGNVCTKNILlaregIDGECGPFIKLSDPgipITVLSRQECVERIPWIAPEcVEDSKN 189
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 855 TTEKSDIYGFGLILIEL-MTGKSPTDAEfgvhgSIVEWGRYCYSDCHLdmwidpiiraqVSSNQNQMVEIMNlalHCTAT 933
Cdd:cd05077  190 LSIAADKWSFGTTLWEIcYNGEIPLKDK-----TLAEKERFYEGQCML-----------VTPSCKELADLMT---HCMNY 250

                 ....*.
gi 731385391 934 DPTARP 939
Cdd:cd05077  251 DPNQRP 256
STKc_RIP2 cd14026
Catalytic domain of the Serine/Threonine kinase, Receptor Interacting Protein 2; STKs catalyze ...
739-877 7.45e-07

Catalytic domain of the Serine/Threonine kinase, Receptor Interacting Protein 2; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. RIP2, also called RICK or CARDIAK, harbors a C-terminal Caspase Activation and Recruitment domain (CARD) belonging to the Death domain (DD) superfamily. It functions as an effector kinase downstream of the pattern recognition receptors from the Nod-like (NLR) family, Nod1 and Nod2, which recognizes bacterial peptidoglycans released upon infection. RIP2 may also be involved in regulating wound healing and keratinocyte proliferation. RIP kinases serve as essential sensors of cellular stress. The RIP2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270928 [Multi-domain]  Cd Length: 284  Bit Score: 51.84  E-value: 7.45e-07
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 739 KLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVLR------SLSWERRQKIAIGISKALRFLHcNCSPSMVVGNMSPQ 812
Cdd:cd14026   53 KARFSYILPILGICNEPEFLGIVTEYMTNGSLNELLHekdiypDVAWPLRLRILYEIALGVNYLH-NMSPPLLHHDLKTQ 131
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 813 KIIIDgkDEPHLR-----LSPPLMVCTDFKCIISSA-------YFAPETRETKDTTE---KSDIYGFGLILIELMTGKSP 877
Cdd:cd14026  132 NILLD--GEFHVKiadfgLSKWRQLSISQSRSSKSApeggtiiYMPPEEYEPSQKRRasvKHDIYSYAIIMWEVLSRKIP 209
PTKc_EphR cd05033
Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases; PTKs catalyze the transfer of ...
687-877 7.66e-07

Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases; PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor PTKs (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EphB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis.The EphR subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270629 [Multi-domain]  Cd Length: 266  Bit Score: 51.60  E-value: 7.66e-07
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 687 SSTTENNVISRGRKGISYKG---KTKNGEMQFVVKEIND--SNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLI 761
Cdd:cd05033    4 SYVTIEKVIGGGEFGEVCSGslkLPGKKEIDVAIKTLKSgySDKQRLDFLTEASIMGQFDHPNVIRLEGVVTKSRPVMIV 83
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 762 SEYIEGKNLSEVLR----SLSWERRQKIAIGISKALRFL------HCNCSPSMVVGNMSPQKIIIDGKDEPHLRLSPPLM 831
Cdd:cd05033   84 TEYMENGSLDKFLRendgKFTVTQLVGMLRGIASGMKYLsemnyvHRDLAARNILVNSDLVCKVSDFGLSRRLEDSEATY 163
                        170       180       190       200
                 ....*....|....*....|....*....|....*....|....*..
gi 731385391 832 VCTDFKciISSAYFAPETRETKDTTEKSDIYGFGLILIELMT-GKSP 877
Cdd:cd05033  164 TTKGGK--IPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSyGERP 208
STKc_Rim15_like cd05611
Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases; STKs catalyze the ...
695-881 7.80e-07

Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. The Rim15-like subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270762 [Multi-domain]  Cd Length: 263  Bit Score: 51.71  E-value: 7.80e-07
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTKNGEMQFVVKEINDSNSIPSSFWTEFAQFGKLRHS-----NVVKLIGLCRSQKCGYLISEYIEGKN 769
Cdd:cd05611    4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIqgespYVAKLYYSFQSKDYLYLVMEYLNGGD 83
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 770 LSEVLRSL-----SWERrqKIAIGISKALRFLHCNcspSMVVGNMSPQKIIIDgkDEPHLRLspplmvcTDF-------- 836
Cdd:cd05611   84 CASLIKTLgglpeDWAK--QYIAEVVLGVEDLHQR---GIIHRDIKPENLLID--QTGHLKL-------TDFglsrngle 149
                        170       180       190       200       210
                 ....*....|....*....|....*....|....*....|....*....|
gi 731385391 837 -----KCIISSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSPTDAE 881
Cdd:cd05611  150 krhnkKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 199
PTKc_Fes_like cd05041
Catalytic domain of Fes-like Protein Tyrosine Kinases; Protein Tyrosine Kinase (PTK) family; ...
695-948 8.01e-07

Catalytic domain of Fes-like Protein Tyrosine Kinases; Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions.


Pssm-ID: 270637 [Multi-domain]  Cd Length: 251  Bit Score: 51.29  E-value: 8.01e-07
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTKNGEMQFVVKEINDSnsIPSSFWTEFAQFGKL----RHSNVVKLIGLCRSQKCGYLISEYIEGKNL 770
Cdd:cd05041    3 IGRGNFGDVYRGVLKPDNTEVAVKTCRET--LPPDLKRKFLQEARIlkqyDHPNIVKLIGVCVQKQPIMIVMELVPGGSL 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 771 SEVLR----SLSWERRQKIAIGISKALRFL---HC--------NCspsmVVGNMSPQKIIIDG--KDEphlrlSPPLMVC 833
Cdd:cd05041   81 LTFLRkkgaRLTVKQLLQMCLDAAAGMEYLeskNCihrdlaarNC----LVGENNVLKISDFGmsREE-----EDGEYTV 151
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 834 TDFKCIISSAYFAPETRETKDTTEKSDIYGFGLILIELMT-GKSPtdaefgvhgsivewgrycYSDchldmWIDPIIRAQ 912
Cdd:cd05041  152 SDGLKQIPIKWTAPEALNYGRYTSESDVWSFGILLWEIFSlGATP------------------YPG-----MSNQQTREQ 208
                        250       260       270       280
                 ....*....|....*....|....*....|....*....|..
gi 731385391 913 VSSN------QNQMVEIMNLALHCTATDPTARPCASDVLKTL 948
Cdd:cd05041  209 IESGyrmpapELCPEAVYRLMLQCWAYDPENRPSFSEIYNEL 250
PTKc_Csk cd05082
Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase; PTKs catalyze the ...
721-877 1.00e-06

Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase; PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Csk is a cytoplasmic (or nonreceptor) PTK containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. The Csk subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 133213 [Multi-domain]  Cd Length: 256  Bit Score: 51.14  E-value: 1.00e-06
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 721 NDSNSipSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCG-YLISEYIEGKNLSEVLRS-----LSWERRQKIAIGISKALR 794
Cdd:cd05082   39 NDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGlYIVTEYMAKGSLVDYLRSrgrsvLGGDCLLKFSLDVCEAME 116
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 795 FLHCNcspSMVVGNMSPQKIIIdgkDEPHLRLSPPLMVCTDFKCIISSA-----YFAPETRETKDTTEKSDIYGFGLILI 869
Cdd:cd05082  117 YLEGN---NFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQDTGklpvkWTAPEALREKKFSTKSDVWSFGILLW 190

                 ....*....
gi 731385391 870 ELMT-GKSP 877
Cdd:cd05082  191 EIYSfGRVP 199
STKc_CAMK cd05117
The catalytic domain of CAMK family Serine/Threonine Kinases; STKs catalyze the transfer of ...
693-946 1.15e-06

The catalytic domain of CAMK family Serine/Threonine Kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. CaMKs are multifunctional calcium and calmodulin (CaM) stimulated STKs involved in cell cycle regulation. There are several types of CaMKs including CaMKI, CaMKII, and CaMKIV. CaMKI proteins are monomeric and they play pivotal roles in the nervous system, including long-term potentiation, dendritic arborization, neurite outgrowth, and the formation of spines, synapses, and axons. CaMKII is a signaling molecule that translates upstream calcium and reactive oxygen species (ROS) signals into downstream responses that play important roles in synaptic function and cardiovascular physiology. CAMKIV is implicated in regulating several transcription factors like CREB, MEF2, and retinoid orphan receptors, as well as in T-cell development and signaling. The CAMK family also consists of other related kinases including the Phosphorylase kinase Gamma subunit (PhKG), the C-terminal kinase domains of Ribosomal S6 kinase (RSK) and Mitogen and stress-activated kinase (MSK), Doublecortin-like kinase (DCKL), and the MAPK-activated protein kinases MK2, MK3, and MK5, among others. The CAMK family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270687 [Multi-domain]  Cd Length: 258  Bit Score: 50.94  E-value: 1.15e-06
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 693 NVISRGRKGISYKGKTKNGEMQFVVKEINDSNSIPSS---FWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKN 769
Cdd:cd05117    6 KVLGRGSFGVVRLAVHKKTGEEYAVKIIDKKKLKSEDeemLRREIEILKRLDHPNIVKLYEVFEDDKNLYLVMELCTGGE 85
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 770 LSEVL---RSLSWERRQKIAIGISKALRFLHCNCspsmVVG-NMSPQKIIIDGKDEphlrlSPPLMVCtDF---KCIISS 842
Cdd:cd05117   86 LFDRIvkkGSFSEREAAKIMKQILSAVAYLHSQG----IVHrDLKPENILLASKDP-----DSPIKII-DFglaKIFEEG 155
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 843 ----------AYFAPETRETKDTTEKSDIYGFGLILIELMTGKSPTDAEfgVHGSIVEWGRYCYSDCHLDMWIDpiiraq 912
Cdd:cd05117  156 eklktvcgtpYYVAPEVLKGKGYGKKCDIWSLGVILYILLCGYPPFYGE--TEQELFEKILKGKYSFDSPEWKN------ 227
                        250       260       270
                 ....*....|....*....|....*....|....
gi 731385391 913 VSSnqnqmvEIMNLALHCTATDPTARPCASDVLK 946
Cdd:cd05117  228 VSE------EAKDLIKRLLVVDPKKRLTAAEALN 255
STKc_ULK3 cd14121
Catalytic domain of the Serine/Threonine kinase, Unc-51-like kinase 3; STKs catalyze the ...
704-877 1.54e-06

Catalytic domain of the Serine/Threonine kinase, Unc-51-like kinase 3; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ATG1/ULK complex is conserved from yeast to humans and it plays a critical role in the initiation of autophagy, the intracellular system that leads to the lysosomal degradation of cellular components and their recycling into basic metabolic units. ULK3 mRNA is up-regulated in fibroblasts after Ras-induced senescence, and its overexpression induces both autophagy and senescence in a fibroblast cell line. ULK3, through its kinase activity, positively regulates Gli proteins, mediators of the Sonic hedgehog (Shh) signaling pathway that is implicated in tissue homeostasis maintenance and neurogenesis. It is inhibited by binding to Suppressor of Fused (Sufu). The ULK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271023 [Multi-domain]  Cd Length: 252  Bit Score: 50.75  E-value: 1.54e-06
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 704 YKGKTKNGEMQFV-VKEINDSNSIPSS---FWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVLRSlsw 779
Cdd:cd14121   12 YKAYRKSGAREVVaVKCVSKSSLNKAStenLLTEIELLKKLKHPHIVELKDFQWDEEHIYLIMEYCSGGDLSRFIRS--- 88
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 780 eRR-----------QKIAigisKALRFLHCNCSPSMvvgNMSPQKIIIDGKDEPHLRLS----PPLMVCTDFKCII--SS 842
Cdd:cd14121   89 -RRtlpestvrrflQQLA----SALQFLREHNISHM---DLKPQNLLLSSRYNPVLKLAdfgfAQHLKPNDEAHSLrgSP 160
                        170       180       190
                 ....*....|....*....|....*....|....*
gi 731385391 843 AYFAPETRETKDTTEKSDIYGFGLILIELMTGKSP 877
Cdd:cd14121  161 LYMAPEMILKKKYDARVDLWSVGVILYECLFGRAP 195
STKc_CDK2_3 cd07860
Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3; ...
695-881 1.69e-06

Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270844 [Multi-domain]  Cd Length: 284  Bit Score: 50.97  E-value: 1.69e-06
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTKNGEMQFVVKEIN---DSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISE-------- 763
Cdd:cd07860    8 IGEGTYGVVYKARNKLTGEVVALKKIRldtETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEflhqdlkk 87
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 764 YIEGKNLSEVLRSLSWERRQKIAIGIS--KALRFLHcncspsmvvGNMSPQKIIIDgkDEPHLRLSP---------PLMV 832
Cdd:cd07860   88 FMDASALTGIPLPLIKSYLFQLLQGLAfcHSHRVLH---------RDLKPQNLLIN--TEGAIKLADfglarafgvPVRT 156
                        170       180       190       200       210
                 ....*....|....*....|....*....|....*....|....*....|..
gi 731385391 833 CTDFkcIISSAYFAPET-RETKDTTEKSDIYGFGLILIELMTGKS--PTDAE 881
Cdd:cd07860  157 YTHE--VVTLWYRAPEIlLGCKYYSTAVDIWSLGCIFAEMVTRRAlfPGDSE 206
LRR COG4886
Leucine-rich repeat (LRR) protein [Transcription];
73-267 2.10e-06

Leucine-rich repeat (LRR) protein [Transcription];


Pssm-ID: 443914 [Multi-domain]  Cd Length: 414  Bit Score: 51.09  E-value: 2.10e-06
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391  73 SIDLSGKNISgEISPVFFGLPYIETVNLSNNALSGgIPgNISLCYSLRYLNLSNNNLTGSMPRGSASGLEALDLSNNVIS 152
Cdd:COG4886  209 ELDLSGNQLT-DLPEPLANLTNLETLDLSNNQLTD-LP-ELGNLTNLEELDLSNNQLTDLPPLANLTNLKTLDLSNNQLT 285
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 153 GEIPADMGLFSRLKVLDLGGNFLVGKIPNSIANITSLEFLTLASNQLVGEIPRELGRMKSLKWIYLGYNNLSGGIPKEIG 232
Cdd:COG4886  286 DLKLKELELLLGLNSLLLLLLLLNLLELLILLLLLTTLLLLLLLLKGLLVTLTTLALSLSLLALLTLLLLLNLLSLLLTL 365
                        170       180       190
                 ....*....|....*....|....*....|....*
gi 731385391 233 ELTSLNHLDLVYNNLTGEIPSSLGNLSDLHFLFLY 267
Cdd:COG4886  366 LLTLGLLGLLEATLLTLALLLLTLLLLLLTTTAGV 400
PK_KSR2 cd14153
Pseudokinase domain of Kinase Suppressor of Ras 2; The pseudokinase domain shows similarity to ...
693-951 2.61e-06

Pseudokinase domain of Kinase Suppressor of Ras 2; The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. KSR2 interacts with the protein phosphatase calcineurin and functions in calcium-mediated ERK signaling. It also functions in energy metabolism by regulating AMP kinase and AMPK-dependent processes such as glucose uptake and fatty acid oxidation. KSR proteins act as scaffold proteins that function downstream of Ras and upstream of Raf in the Extracellular signal-Regulated Kinase (ERK) pathway that regulates many cellular processes including cycle regulation, proliferation, differentiation, survival, and apoptosis. KSR proteins regulate the assembly and activation of the Raf/MEK/ERK module upon Ras activation at the membrane by direct association of its components. They are widely regarded as pseudokinases. The KSR2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271055 [Multi-domain]  Cd Length: 270  Bit Score: 50.01  E-value: 2.61e-06
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 693 NVISRGRKGISYKGKTkNGEMQFVVKEIN-DSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLS 771
Cdd:cd14153    6 ELIGKGRFGQVYHGRW-HGEVAIRLIDIErDNEEQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLY 84
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 772 EVLRS----LSWERRQKIAIGISKALRFLHcncSPSMVVGNMSPQKIIID--------------------GKDEPHLRLs 827
Cdd:cd14153   85 SVVRDakvvLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDngkvvitdfglftisgvlqaGRREDKLRI- 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 828 PPLMVCTDFKCIISSayFAPETRETK-DTTEKSDIYGFGLILIELMTGKSPTDAEfgvHGSIVEWgrycysdcHLDMWID 906
Cdd:cd14153  161 QSGWLCHLAPEIIRQ--LSPETEEDKlPFSKHSDVFAFGTIWYELHAREWPFKTQ---PAEAIIW--------QVGSGMK 227
                        250       260       270       280
                 ....*....|....*....|....*....|....*....|....*
gi 731385391 907 PIIrAQVSSNQnqmvEIMNLALHCTATDPTARPCASDVLKTLESV 951
Cdd:cd14153  228 PNL-SQIGMGK----EISDILLFCWAYEQEERPTFSKLMEMLEKL 267
STKc_CDKL2_3 cd07846
Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3; ...
739-874 6.32e-06

Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The CDKL2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270836 [Multi-domain]  Cd Length: 286  Bit Score: 48.96  E-value: 6.32e-06
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 739 KLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVLR---SLSWERRQKIAIGISKALRFLHCNcspSMVVGNMSPQKII 815
Cdd:cd07846   56 QLRHENLVNLIEVFRRKKRWYLVFEFVDHTVLDDLEKypnGLDESRVRKYLFQILRGIDFCHSH---NIIHRDIKPENIL 132
                         90       100       110       120       130       140
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 731385391 816 IDGKDEPHL-------RLSPPLMVCTDFkcIISSAYFAPETReTKDTT--EKSDIYGFGLILIELMTG 874
Cdd:cd07846  133 VSQSGVVKLcdfgfarTLAAPGEVYTDY--VATRWYRAPELL-VGDTKygKAVDVWAVGCLVTEMLTG 197
PTKc_c-ros cd05044
Catalytic domain of the Protein Tyrosine Kinase, C-ros; PTKs catalyze the transfer of the ...
693-949 6.80e-06

Catalytic domain of the Protein Tyrosine Kinase, C-ros; PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. This subfamily contains c-ros, Sevenless, and similar proteins. The proto-oncogene c-ros encodes an orphan receptor PTK (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. The c-ros subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270640 [Multi-domain]  Cd Length: 268  Bit Score: 48.95  E-value: 6.80e-06
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 693 NVISRGRKGISYKGKTKN------GEMQFVVKEINDSNSIP--SSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEY 764
Cdd:cd05044    1 KFLGSGAFGEVFEGTAKDilgdgsGETKVAVKTLRKGATDQekAEFLKEAHLMSNFKHPNILKLLGVCLDNDPQYIILEL 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 765 IEGKNLSEVLRSLSWERRQ----------KIAIGISKA------LRFLH-----CNCSPSMVVGNMSPQKIiidgkdeph 823
Cdd:cd05044   81 MEGGDLLSYLRAARPTAFTpplltlkdllSICVDVAKGcvyledMHFVHrdlaaRNCLVSSKDYRERVVKI--------- 151
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 824 lrlspplmvcTDF---KCIISSAYF-------------APETRETKDTTEKSDIYGFGLILIELMT-GKSPTDAEfgvhg 886
Cdd:cd05044  152 ----------GDFglaRDIYKNDYYrkegegllpvrwmAPESLVDGVFTTQSDVWAFGVLMWEILTlGQQPYPAR----- 216
                        250       260       270       280       290       300
                 ....*....|....*....|....*....|....*....|....*....|....*....|...
gi 731385391 887 SIVEWGRYCYSDCHLDmwidpiiraqvsSNQNQMVEIMNLALHCTATDPTARPCASDVLKTLE 949
Cdd:cd05044  217 NNLEVLHFVRAGGRLD------------QPDNCPDDLYELMLRCWSTDPEERPSFARILEQLQ 267
STKc_KSR1 cd14152
Catalytic domain of the Serine/Threonine Kinase, Kinase Suppressor of Ras 1; STKs catalyze the ...
695-877 6.83e-06

Catalytic domain of the Serine/Threonine Kinase, Kinase Suppressor of Ras 1; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. KSR1 functions as a transducer of TNFalpha-stimulated C-Raf activation of ERK1/2 and NF-kB. Detected activity of KSR1 is cell type specific and context dependent. It is inactive in normal colon epithelial cells and becomes activated at the onset of inflammatory bowel disease (IBD). Similarly, KSR1 activity is undetectable prior to stimulation by EGF or ceramide in COS-7 or YAMC cells, respectively. KSR proteins are widely regarded as pseudokinases, however, this matter is up for debate as catalytic activity has been detected for KSR1 in some systems. The KSR1 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271054 [Multi-domain]  Cd Length: 279  Bit Score: 48.81  E-value: 6.83e-06
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTkNGEMQFVVKEINDSNSIPSS-FWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEV 773
Cdd:cd14152    8 IGQGRWGKVHRGRW-HGEVAIRLLEIDGNNQDHLKlFKKEVMNYRQTRHENVVLFMGACMHPPHLAIITSFCKGRTLYSF 86
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 774 LR----SLSWERRQKIAIGISKALRFLHCNC--------------SPSMVV---GNMSPQKIIIDGKDEPHLRLSpplmv 832
Cdd:cd14152   87 VRdpktSLDINKTRQIAQEIIKGMGYLHAKGivhkdlksknvfydNGKVVItdfGLFGISGVVQEGRRENELKLP----- 161
                        170       180       190       200       210
                 ....*....|....*....|....*....|....*....|....*....|....
gi 731385391 833 cTDFKCiissaYFAPE-TRET-----KDT---TEKSDIYGFGLILIELMTGKSP 877
Cdd:cd14152  162 -HDWLC-----YLAPEiVREMtpgkdEDClpfSKAADVYAFGTIWYELQARDWP 209
STKc_Nek2 cd08217
Catalytic domain of the Serine/Threonine Kinase, Never In Mitosis gene A (NIMA)-related kinase ...
693-880 7.62e-06

Catalytic domain of the Serine/Threonine Kinase, Never In Mitosis gene A (NIMA)-related kinase 2; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Nek2 is one in a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. It The Nek family is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270857 [Multi-domain]  Cd Length: 265  Bit Score: 48.69  E-value: 7.62e-06
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 693 NVISRGRKGISYKGKTKNGEMQFVVKEIN-------DSNSIPSsfwtEFAQFGKLRHSNVVKLIG--LCRSQKCGYLISE 763
Cdd:cd08217    6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDygkmsekEKQQLVS----EVNILRELKHPNIVRYYDriVDRANTTLYIVME 81
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 764 YIEGKNLSEVLRSLSWERRQ-------KIAIGISKALRFLHCNCSPSMVV--GNMSPQKIIIDGKdePHLRLSpplmvct 834
Cdd:cd08217   82 YCEGGDLAQLIKKCKKENQYipeefiwKIFTQLLLALYECHNRSVGGGKIlhRDLKPANIFLDSD--NNVKLG------- 152
                        170       180       190       200       210       220
                 ....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 835 DF---KCIISSAYFA-----------PETRETKDTTEKSDIYGFGLILIELMTGKSPTDA 880
Cdd:cd08217  153 DFglaRVLSHDSSFAktyvgtpyymsPELLNEQSYDEKSDIWSLGCLIYELCALHPPFQA 212
STKc_RSK1_C cd14175
C-terminal catalytic domain of the Serine/Threonine Kinase, Ribosomal S6 kinase 1 (also called ...
709-877 8.81e-06

C-terminal catalytic domain of the Serine/Threonine Kinase, Ribosomal S6 kinase 1 (also called Ribosomal protein S6 kinase alpha-1 or 90kDa ribosomal protein S6 kinase 1); STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. RSK1 is also called S6K-alpha-1, RPS6KA1, p90RSK1 or MAPK-activated protein kinase 1a (MAPKAPK-1a). It is a component of the insulin transduction pathway, regulating the function of IRS1. It also interacts with PKA and promotes its inactivation. RSK1 is one of four RSK isoforms (RSK1-4) from distinct genes present in vertebrates. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. The RSK1 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271077 [Multi-domain]  Cd Length: 291  Bit Score: 48.48  E-value: 8.81e-06
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 709 KNGEMQFVVKEINDSNSIPSSFWTEFAQFGKlrHSNVVKLIGLCRSQKCGYLISEYIEGKNL-SEVLRSLSWERRQKIAI 787
Cdd:cd14175   23 KATNMEYAVKVIDKSKRDPSEEIEILLRYGQ--HPNIITLKDVYDDGKHVYLVTELMRGGELlDKILRQKFFSEREASSV 100
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 788 --GISKALRFLHcncSPSMVVGNMSPQKII-IDGKDEP------------HLRLSPPLMVCTDFkciiSSAYFAPETRET 852
Cdd:cd14175  101 lhTICKTVEYLH---SQGVVHRDLKPSNILyVDESGNPeslricdfgfakQLRAENGLLMTPCY----TANFVAPEVLKR 173
                        170       180
                 ....*....|....*....|....*
gi 731385391 853 KDTTEKSDIYGFGLILIELMTGKSP 877
Cdd:cd14175  174 QGYDEGCDIWSLGILLYTMLAGYTP 198
PK_ILK cd14057
Pseudokinase domain of Integrin Linked Kinase; The pseudokinase domain shows similarity to ...
695-949 1.26e-05

Pseudokinase domain of Integrin Linked Kinase; The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. ILK contains N-terminal ankyrin repeats, a Pleckstrin Homology (PH) domain, and a C-terminal pseudokinase domain. It is a component of the IPP (ILK/PINCH/Parvin) complex that couples beta integrins to the actin cytoskeleton, and plays important roles in cell adhesion, spreading, invasion, and migration. ILK was initially thought to be an active kinase despite the lack of key conserved residues because of in vitro studies showing that it can phosphorylate certain protein substrates. However, in vivo experiments in Caenorhabditis elegans, Drosophila melanogaster, and mice (ILK-null and knock-in) proved that ILK is not an active kinase. In addition to actin cytoskeleton regulation, ILK also influences the microtubule network and mitotic spindle orientation. The pseudokinase domain of ILK binds several adaptor proteins including the parvins and paxillin. The ILK subfamily is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270959 [Multi-domain]  Cd Length: 251  Bit Score: 47.87  E-value: 1.26e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTKNGEMQFVVKEIND-SNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEV 773
Cdd:cd14057    3 INETHSGELWKGRWQGNDIVAKILKVRDvTTRISRDFNEEYPRLRIFSHPNVLPVLGACNSPPNLVVISQYMPYGSLYNV 82
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 774 LR---SLSWERRQ--KIAIGISKALRFLHcNCSPSMVVGNMSPQKIIIDgkDEPHLRLSpplMVCT--DFKC---IISSA 843
Cdd:cd14057   83 LHegtGVVVDQSQavKFALDIARGMAFLH-TLEPLIPRHHLNSKHVMID--EDMTARIN---MADVkfSFQEpgkMYNPA 156
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 844 YFAPET--RETKDTTEKS-DIYGFGLILIELMTGKSP----TDAEFGVHGSIVEwgrycysdchldmwIDPIIRAQVSSN 916
Cdd:cd14057  157 WMAPEAlqKKPEDINRRSaDMWSFAILLWELVTREVPfadlSNMEIGMKIALEG--------------LRVTIPPGISPH 222
                        250       260       270
                 ....*....|....*....|....*....|...
gi 731385391 917 QNQMVEImnlalhCTATDPTARPCASDVLKTLE 949
Cdd:cd14057  223 MCKLMKI------CMNEDPGKRPKFDMIVPILE 249
RNA1 COG5238
Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Translation, ...
64-244 1.50e-05

Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Translation, ribosomal structure and biogenesis];


Pssm-ID: 444072 [Multi-domain]  Cd Length: 434  Bit Score: 48.63  E-value: 1.50e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391  64 LCTNSShVSSIDLSGKNIS-GEISPVFFGLPY---IETVNLSNN--------ALSGGIPGNISLcyslRYLNLSNNNLTG 131
Cdd:COG5238  232 LKGNKS-LTTLDLSNNQIGdEGVIALAEALKNnttVETLYLSGNqigaegaiALAKALQGNTTL----TSLDLSVNRIGD 306
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 132 SMPRGSASGLE------ALDLSNNVISGE----IPADMGLFSRLKVLDLGGNFL----VGKIPNSIANITSLEFLTLASN 197
Cdd:COG5238  307 EGAIALAEGLQgnktlhTLNLAYNGIGAQgaiaLAKALQENTTLHSLDLSDNQIgdegAIALAKYLEGNTTLRELNLGKN 386
                        170       180       190       200       210
                 ....*....|....*....|....*....|....*....|....*....|
gi 731385391 198 QLVGEIPRELGRM---KSLKWIYLGYNNLSGGIPKEIGELtsLNHLDLVY 244
Cdd:COG5238  387 NIGKQGAEALIDAlqtNRLHTLILDGNLIGAEAQQRLEQL--LERIKSVY 434
PK_GC-A_B cd14042
Pseudokinase domain of the membrane Guanylate Cyclase receptors, GC-A and GC-B; The ...
740-951 1.83e-05

Pseudokinase domain of the membrane Guanylate Cyclase receptors, GC-A and GC-B; The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity and/or ATP binding. GC-A binds and is activated by the atrial and B-type natriuretic peptides, ANP and BNP, which are important in blood pressure regulation and cardiac pathophysiology. GC-B binds the C-type natriuretic peptide, CNP, which is a potent vasorelaxant and functions in vascular remodeling and bone growth regulation. Membrane (or particulate) GCs consist of an extracellular ligand-binding domain, a single transmembrane region, and an intracellular tail that contains a PK-like domain, an amphiphatic region and a catalytic GC domain that catalyzes the conversion of GTP into cGMP and pyrophosphate. Membrane GCs act as receptors that transduce an extracellular signal to the intracellular production of cGMP, which has been implicated in many processes including cell proliferation, phototransduction, and muscle contractility, through its downstream effectors such as PKG. The PK-like domain of GCs functions as a negative regulator of the catalytic GC domain and may also act as a docking site for interacting proteins such as GC-activating proteins. The GC-A/B subfamily is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270944 [Multi-domain]  Cd Length: 279  Bit Score: 47.59  E-value: 1.83e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 740 LRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVLRS----LSWERRQKIAIGISKALRFLHCncSPSMVVGNMSPQKII 815
Cdd:cd14042   59 LQHDNLTRFIGACVDPPNICILTEYCPKGSLQDILENedikLDWMFRYSLIHDIVKGMHYLHD--SEIKSHGNLKSSNCV 136
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 816 IDGK------DE--PHLRlspplmvCTDFKCIISSAYF------APET-RETKDT---TEKSDIYGFGLILIELMTGKSP 877
Cdd:cd14042  137 VDSRfvlkitDFglHSFR-------SGQEPPDDSHAYYakllwtAPELlRDPNPPppgTQKGDVYSFGIILQEIATRQGP 209
                        170       180       190       200       210       220       230
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 731385391 878 ---TDAEFGVHGSIVEWGRYCYSdchldmwidPIIRAQVSSNQ--NQMVEIMNLalhCTATDPTARPCASDVLKTLESV 951
Cdd:cd14042  210 fyeEGPDLSPKEIIKKKVRNGEK---------PPFRPSLDELEcpDEVLSLMQR---CWAEDPEERPDFSTLRNKLKKL 276
PLN03150 PLN03150
hypothetical protein; Provisional
391-476 1.98e-05

hypothetical protein; Provisional


Pssm-ID: 178695 [Multi-domain]  Cd Length: 623  Bit Score: 48.27  E-value: 1.98e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 391 LEGEVPKSLSDCRSLRRVRLQSNHFSGELSSEFMKLPLVYFLDISDNNLTGKISDRRWDMPSLQMLSLARNRFFGNLPQS 470
Cdd:PLN03150 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAA 509

                 ....*.
gi 731385391 471 FGASKL 476
Cdd:PLN03150 510 LGGRLL 515
STKc_Aurora-A cd14116
Catalytic domain of the Serine/Threonine kinase, Aurora-A kinase; STKs catalyze the transfer ...
740-881 2.26e-05

Catalytic domain of the Serine/Threonine kinase, Aurora-A kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. Aurora kinases are key regulators of mitosis and are essential for the accurate and equal division of genomic material from parent to daughter cells. Vertebrates contain at least 2 Aurora kinases (A and B); mammals contains a third Aurora kinase gene (C). Aurora-A regulates cell cycle events from the late S-phase through the M-phase including centrosome maturation, mitotic entry, centrosome separation, spindle assembly, chromosome alignment, cytokinesis, and mitotic exit. Aurora-A activation depends on its autophosphorylation and binding to the microtubule-associated protein TPX2, which also localizes the kinase to spindle microtubules. Aurora-A is overexpressed in many cancer types such as prostate, ovarian, breast, bladder, gastric, and pancreatic. The Aurora subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271018 [Multi-domain]  Cd Length: 258  Bit Score: 47.26  E-value: 2.26e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 740 LRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVLRSLSWERRQKIAIGISK---ALRFLHcncSPSMVVGNMSPQKIII 816
Cdd:cd14116   62 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITElanALSYCH---SKRVIHRDIKPENLLL 138
                         90       100       110       120       130       140       150
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 731385391 817 DGKDE---------PHLRLSPPLMVCTDFKciissaYFAPETRETKDTTEKSDIYGFGLILIELMTGKSPTDAE 881
Cdd:cd14116  139 GSAGElkiadfgwsVHAPSSRRTTLCGTLD------YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 206
LRR_8 pfam13855
Leucine rich repeat;
498-558 2.42e-05

Leucine rich repeat;


Pssm-ID: 404697 [Multi-domain]  Cd Length: 61  Bit Score: 42.90  E-value: 2.42e-05
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 731385391  498 SELMQLKLSENMLSGDIPEELSSCKKLVSLNLSHNQLSGHIPASFSDMPVLGQLDLSQNQL 558
Cdd:pfam13855   1 PNLRSLDLSNNRLTSLDDGAFKGLSNLKVLDLSNNLLTTLSPGAFSGLPSLRYLDLSGNRL 61
STKc_WNK4 cd14033
Catalytic domain of the Serine/Threonine protein kinase, With No Lysine (WNK) 4; STKs catalyze ...
730-877 2.63e-05

Catalytic domain of the Serine/Threonine protein kinase, With No Lysine (WNK) 4; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. WNK4 shows a restricted expression pattern and is usually found in epithelial cells. It is expressed in nephrons and in extrarenal tissues including intestine, eye, mammary glands, and prostate. WNK4 regulates a variety of ion transport proteins including apical or basolateral ion transporters, ion channels in the transcellular pathway, and claudins in the paracellular pathway. Mutations in WNK4 cause PseudoHypoAldosteronism type II (PHAII), characterized by hypertension and hyperkalemia. WNK4 inhibits the activity of the thiazide-sensitive Na-Cl cotransporter (NCC), which is responsible for about 15% of NaCl reabsorption in the kidney. It also inhibits the renal outer medullary potassium channel (ROMK) and decreases its surface expression. Hypertension and hyperkalemia in PHAII patients with WNK4 mutations may be partly due to increased NaCl reabsorption through NCC and impaired renal potassium secretion by ROMK, respectively. The WNK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270935 [Multi-domain]  Cd Length: 261  Bit Score: 46.92  E-value: 2.63e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 730 FWTEFAQFGKLRHSNVVKLI----GLCRSQKCGYLISEYIEGKNLSEVL---RSLSWERRQKIAIGISKALRFLHCNCSP 802
Cdd:cd14033   47 FSEEVEMLKGLQHPNIVRFYdswkSTVRGHKCIILVTELMTSGTLKTYLkrfREMKLKLLQRWSRQILKGLHFLHSRCPP 126
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 803 sMVVGNMSPQKIIIDGKDEP----HLRLSPpLMVCTDFKCIISSAYF-APETRETKdTTEKSDIYGFGLILIELMTGKSP 877
Cdd:cd14033  127 -ILHRDLKCDNIFITGPTGSvkigDLGLAT-LKRASFAKSVIGTPEFmAPEMYEEK-YDEAVDVYAFGMCILEMATSEYP 203
PTKc_Itk cd05112
Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase; PTKs ...
695-890 2.63e-05

Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase; PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk, also known as Tsk or Emt, is a member of the Tec-like subfamily of proteins, which are cytoplasmic (or nonreceptor) PTKs with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members except Rlk also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. The Itk subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 133243 [Multi-domain]  Cd Length: 256  Bit Score: 46.87  E-value: 2.63e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTKNgEMQFVVKEINDSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVL 774
Cdd:cd05112   12 IGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL 90
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 775 RS----LSWERRQKIAIGISKALRFLHCNC-------SPSMVVGNMSPQKIIIDGKDEPHLRLSPPLMVCTDFKCIISSa 843
Cdd:cd05112   91 RTqrglFSAETLLGMCLDVCEGMAYLEEASvihrdlaARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSS- 169
                        170       180       190       200
                 ....*....|....*....|....*....|....*....|....*...
gi 731385391 844 yfaPETRETKDTTEKSDIYGFGLILIELMT-GKSPTDAEfgVHGSIVE 890
Cdd:cd05112  170 ---PEVFSFSRYSSKSDVWSFGVLMWEVFSeGKIPYENR--SNSEVVE 212
PTKc_Tec_Rlk cd05114
Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular ...
695-952 2.91e-05

Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase; PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec-like subfamily of proteins, which are cytoplasmic (or nonreceptor) PTKs with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members except Rlk also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec-like subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. The Tec/Rlk subfamily is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270685 [Multi-domain]  Cd Length: 260  Bit Score: 46.78  E-value: 2.91e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTKnGEMQFVVKEINDSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVL 774
Cdd:cd05114   12 LGSGLFGVVRLGKWR-AQYKVAIKAIREGAMSEEDFIEEAKVMMKLTHPKLVQLYGVCTQQKPIYIVTEFMENGCLLNYL 90
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 775 RSLSWERRQKIAIG----ISKALRFLHCNcspSMVVGNMSPQKIIIDgkDEPHLRLSPPLM---VCTDFKCIISSAYF-- 845
Cdd:cd05114   91 RQRRGKLSRDMLLSmcqdVCEGMEYLERN---NFIHRDLAARNCLVN--DTGVVKVSDFGMtryVLDDQYTSSSGAKFpv 165
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 846 ---APETRETKDTTEKSDIYGFGLILIELMT-GKSPTD--AEFGVHGSIVEWGRycysdchldmwidpIIRAQVSSnqNQ 919
Cdd:cd05114  166 kwsPPEVFNYSKFSSKSDVWSFGVLMWEVFTeGKMPFEskSNYEVVEMVSRGHR--------------LYRPKLAS--KS 229
                        250       260       270
                 ....*....|....*....|....*....|...
gi 731385391 920 MVEIMnlaLHCTATDPTARPCASDVLKTLESVL 952
Cdd:cd05114  230 VYEVM---YSCWHEKPEGRPTFADLLRTITEIA 259
STKc_RSK2_C cd14176
C-terminal catalytic domain of the Serine/Threonine Kinase, Ribosomal S6 kinase 2 (also called ...
709-877 2.97e-05

C-terminal catalytic domain of the Serine/Threonine Kinase, Ribosomal S6 kinase 2 (also called 90kDa ribosomal protein S6 kinase 3 or Ribosomal protein S6 kinase alpha-3); STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. RSK2 is also called p90RSK3, RPS6KA3, S6K-alpha-3, or MAPK-activated protein kinase 1b (MAPKAPK-1b). RSK2 is expressed highly in the regions of the brain with high synaptic activity. It plays a role in the maintenance and consolidation of excitatory synapses. It is a specific modulator of phospholipase D in calcium-regulated exocytosis. Mutations in the RSK2 gene, RPS6KA3, cause Coffin-Lowry syndrome (CLS), a rare syndromic form of X-linked mental retardation characterized by growth and psychomotor retardation and skeletal abnormalities. RSK2 is one of four RSK isoforms (RSK1-4) from distinct genes present in vertebrates. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. The RSK2 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271078 [Multi-domain]  Cd Length: 339  Bit Score: 47.32  E-value: 2.97e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 709 KNGEMQFVVKEINDSNSIPSSFWTEFAQFGKlrHSNVVKLIGLCRSQKCGYLISEYIEGKNL-SEVLRSLSWERRQKIAI 787
Cdd:cd14176   41 KATNMEFAVKIIDKSKRDPTEEIEILLRYGQ--HPNIITLKDVYDDGKYVYVVTELMKGGELlDKILRQKFFSEREASAV 118
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 788 --GISKALRFLHC------NCSPSMVV-----GNmsPQKI-IIDGKDEPHLRLSPPLMVCTDFkciiSSAYFAPETRETK 853
Cdd:cd14176  119 lfTITKTVEYLHAqgvvhrDLKPSNILyvdesGN--PESIrICDFGFAKQLRAENGLLMTPCY----TANFVAPEVLERQ 192
                        170       180
                 ....*....|....*....|....
gi 731385391 854 DTTEKSDIYGFGLILIELMTGKSP 877
Cdd:cd14176  193 GYDAACDIWSLGVLLYTMLTGYTP 216
STKc_CaMKI_gamma cd14166
Catalytic domain of the Serine/Threonine kinase, Calcium/calmodulin-dependent protein kinase ...
715-877 3.48e-05

Catalytic domain of the Serine/Threonine kinase, Calcium/calmodulin-dependent protein kinase Type I gamma; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. CaMKs are multifunctional calcium and calmodulin (CaM) stimulated STKs involved in cell cycle regulation. The CaMK family includes CaMKI, CaMKII, CaMKIV, and CaMK kinase (CaMKK). In vertebrates, there are four CaMKI proteins encoded by different genes (alpha, beta, gamma, and delta), each producing at least one variant. CaMKs contain an N-terminal catalytic domain and a C-terminal regulatory domain that harbors a CaM binding site. CaMKI proteins are monomeric and they play pivotal roles in the nervous system, including long-term potentiation, dendritic arborization, neurite outgrowth, and the formation of spines, synapses, and axons. In addition, they may be involved in osteoclast differentiation and bone resorption. The CaMKI-gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271068 [Multi-domain]  Cd Length: 285  Bit Score: 46.91  E-value: 3.48e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 715 FVVKEINDSNSI-PSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVL--RSLSWERRQKIAIG-IS 790
Cdd:cd14166   31 YALKCIKKSPLSrDSSLENEIAVLKRIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIleRGVYTEKDASRVINqVL 110
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 791 KALRFLHCNcspSMVVGNMSPQKIIIDGKDEphlrlSPPLMVcTDFKC-------IISSA-----YFAPETRETKDTTEK 858
Cdd:cd14166  111 SAVKYLHEN---GIVHRDLKPENLLYLTPDE-----NSKIMI-TDFGLskmeqngIMSTAcgtpgYVAPEVLAQKPYSKA 181
                        170
                 ....*....|....*....
gi 731385391 859 SDIYGFGLILIELMTGKSP 877
Cdd:cd14166  182 VDCWSIGVITYILLCGYPP 200
STKc_RSK4_C cd14177
C-terminal catalytic domain of the Serine/Threonine Kinase, Ribosomal S6 kinase 4 (also called ...
713-877 3.61e-05

C-terminal catalytic domain of the Serine/Threonine Kinase, Ribosomal S6 kinase 4 (also called Ribosomal protein S6 kinase alpha-6 or 90kDa ribosomal protein S6 kinase 6); STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. RSK4 is also called S6K-alpha-6, RPS6KA6, p90RSK6 or pp90RSK4. RSK4 is a substrate of ERK and is a modulator of p53-dependent proliferation arrest in human cells. Deletion of the RSK4 gene, RPS6KA6, frequently occurs in patients of X-linked deafness type 3, mental retardation and choroideremia. Studies of RSK4 in cancer cells and tissues suggest that it may be oncogenic or tumor suppressive depending on many factors. RSK4 is one of four RSK isoforms (RSK1-4) from distinct genes present in vertebrates. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. The RSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271079 [Multi-domain]  Cd Length: 295  Bit Score: 46.93  E-value: 3.61e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 713 MQFVVKEINDSNSIPSSFWTEFAQFGKlrHSNVVKLIGLCRSQKCGYLISEYIEGKNL-SEVLRSLSWERRQKIAI--GI 789
Cdd:cd14177   30 MEFAVKIIDKSKRDPSEEIEILMRYGQ--HPNIITLKDVYDDGRYVYLVTELMKGGELlDRILRQKFFSEREASAVlyTI 107
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 790 SKALRFLHC------NCSPSMVV---GNMSPQKI-IIDGKDEPHLRLSPPLMVCTDFkciiSSAYFAPETRETKDTTEKS 859
Cdd:cd14177  108 TKTVDYLHCqgvvhrDLKPSNILymdDSANADSIrICDFGFAKQLRGENGLLLTPCY----TANFVAPEVLMRQGYDAAC 183
                        170
                 ....*....|....*...
gi 731385391 860 DIYGFGLILIELMTGKSP 877
Cdd:cd14177  184 DIWSLGVLLYTMLAGYTP 201
STKc_WNK cd13983
Catalytic domain of the Serine/Threonine kinase, With No Lysine (WNK) kinase; STKs catalyze ...
728-877 4.47e-05

Catalytic domain of the Serine/Threonine kinase, With No Lysine (WNK) kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. WNKs comprise a subfamily of STKs with an unusual placement of a catalytic lysine relative to all other protein kinases. They are critical in regulating ion balance and are thus, important components in the control of blood pressure. They are also involved in cell signaling, survival, proliferation, and organ development. WNKs are activated by hyperosmotic or low-chloride hypotonic stress and they function upstream of SPAK and OSR1 kinases, which regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. There are four vertebrate WNKs which show varying expression patterns. WNK1 and WNK2 are widely expressed while WNK3 and WNK4 show a more restricted expression pattern. Because mutations in human WNK1 and WNK4 cause PseudoHypoAldosteronism type II (PHAII), characterized by hypertension (due to increased sodium reabsorption) and hyperkalemia (due to impaired renal potassium secretion), there are more studies conducted on these two proteins, compared to WNK2 and WNK3. The WNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270885 [Multi-domain]  Cd Length: 258  Bit Score: 46.06  E-value: 4.47e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 728 SSFWTEFAQFGKLRHSNVVKLIG--LCRSQKCGYLISEYIEGKNLSEVLRSL---------SWERRqkiaigISKALRFL 796
Cdd:cd13983   45 QRFKQEIEILKSLKHPNIIKFYDswESKSKKEVIFITELMTSGTLKQYLKRFkrlklkvikSWCRQ------ILEGLNYL 118
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 797 HcNCSPSMVVGNMSPQKIIIDGK-------DephLRLSppLMVCTDFK--CIISSAYFAPETRETKdTTEKSDIYGFGLI 867
Cdd:cd13983  119 H-TRDPPIIHRDLKCDNIFINGNtgevkigD---LGLA--TLLRQSFAksVIGTPEFMAPEMYEEH-YDEKVDIYAFGMC 191
                        170
                 ....*....|
gi 731385391 868 LIELMTGKSP 877
Cdd:cd13983  192 LLEMATGEYP 201
STKc_PAK cd06614
Catalytic domain of the Serine/Threonine Kinase, p21-activated kinase; STKs catalyze the ...
694-877 4.67e-05

Catalytic domain of the Serine/Threonine Kinase, p21-activated kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270789 [Multi-domain]  Cd Length: 255  Bit Score: 46.05  E-value: 4.67e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 694 VISRGRKGISYKGKTKNGEMQFVVKEINDSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEV 773
Cdd:cd06614    7 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKECKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDI 86
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 774 LR----SLSWERRQKIAIGISKALRFLHC-NC------SPSMVVGNmspqkiiiDGkdepHLRLspplmvcTDF------ 836
Cdd:cd06614   87 ITqnpvRMNESQIAYVCREVLQGLEYLHSqNVihrdikSDNILLSK--------DG----SVKL-------ADFgfaaql 147
                        170       180       190       200
                 ....*....|....*....|....*....|....*....|....*....
gi 731385391 837 -------KCIISSAYF-APETRETKDTTEKSDIYGFGLILIELMTGKSP 877
Cdd:cd06614  148 tkekskrNSVVGTPYWmAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 196
LRR_8 pfam13855
Leucine rich repeat;
235-295 5.91e-05

Leucine rich repeat;


Pssm-ID: 404697 [Multi-domain]  Cd Length: 61  Bit Score: 41.74  E-value: 5.91e-05
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 731385391  235 TSLNHLDLVYNNLTGEIPSSLGNLSDLHFLFLYQNKLSGSIPPSIFDLKKLISLDLSDNSL 295
Cdd:pfam13855   1 PNLRSLDLSNNRLTSLDDGAFKGLSNLKVLDLSNNLLTTLSPGAFSGLPSLRYLDLSGNRL 61
STKc_PRKX_like cd05612
Catalytic domain of PRKX-like Protein Serine/Threonine Kinases; STKs catalyze the transfer of ...
739-910 6.02e-05

Catalytic domain of PRKX-like Protein Serine/Threonine Kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. The PRKX-like subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270763 [Multi-domain]  Cd Length: 292  Bit Score: 45.89  E-value: 6.02e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 739 KLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVLRSlswERRQKIAIG------ISKALRFLHcncSPSMVVGNMSPQ 812
Cdd:cd05612   57 EVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN---SGRFSNSTGlfyaseIVCALEYLH---SKEIVYRDLKPE 130
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 813 KIIIDgkDEPHLRLspplmvcTDF---KCII--------SSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSP--TD 879
Cdd:cd05612  131 NILLD--KEGHIKL-------TDFgfaKKLRdrtwtlcgTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPffDD 201
                        170       180       190
                 ....*....|....*....|....*....|....*
gi 731385391 880 AEFGVHGSI----VEWGRycysdcHLDMWIDPIIR 910
Cdd:cd05612  202 NPFGIYEKIlagkLEFPR------HLDLYAKDLIK 230
STKc_Unc-89_rpt2 cd14112
Catalytic kinase domain, second repeat, of the Giant Serine/Threonine Kinase Uncoordinated ...
695-877 6.09e-05

Catalytic kinase domain, second repeat, of the Giant Serine/Threonine Kinase Uncoordinated protein 89; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nematode Unc-89 gene, through alternative promoter use and splicing, encodes at least six major isoforms (Unc-89A to Unc-89F) of giant muscle proteins that are homologs for the vetebrate obscurin. In flies, five isoforms of Unc-89 have been detected: four in the muscles of adult flies (two in the indirect flight muscle and two in other muscles) and another isoform in the larva. Unc-89 in nematodes is required for normal muscle cell architecture. In flies, it is necessary for the development of a symmetrical sarcomere in the flight muscles. Unc-89 proteins contain several adhesion and signaling domains including multiple copies of the immunoglobulin (Ig) domain, as well as fibronectin type III (FN3), SH3, RhoGEF, and PH domains. The nematode Unc-89 isoforms D, C, D, and F contain two kinase domain with B and F having two complete kinase domains while the first repeat of C and D are partial domains. Homology modeling suggests that the first kinase repeat of Unc-89 may be catalytically inactive, a pseudokinase, while the second kinase repeat may be active. The Unc-89 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271014 [Multi-domain]  Cd Length: 259  Bit Score: 45.99  E-value: 6.09e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTKNGEM-QFVVKEINDSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEv 773
Cdd:cd14112   11 IFRGRFSVIVKAVDSTTETdAHCAVKIFEVSDEASEAVREFESLRTLQHENVQRLIAAFKPSNFAYLVMEKLQEDVFTR- 89
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 774 LRSLSWERRQKIAIGISK---ALRFL------HCNCSPS--MVVGNMSPQKIIID-GKDEPhlrLSPPLMVCTDFkciiS 841
Cdd:cd14112   90 FSSNDYYSEEQVATTVRQildALHYLhfkgiaHLDVQPDniMFQSVRSWQVKLVDfGRAQK---VSKLGKVPVDG----D 162
                        170       180       190
                 ....*....|....*....|....*....|....*..
gi 731385391 842 SAYFAPETRETK-DTTEKSDIYGFGLILIELMTGKSP 877
Cdd:cd14112  163 TDWASPEFHNPEtPITVQSDIWGLGVLTFCLLSGFHP 199
PK_SCY1_like cd14011
Pseudokinase domain of Scy1-like proteins; The pseudokinase domain shows similarity to protein ...
733-881 6.13e-05

Pseudokinase domain of Scy1-like proteins; The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. This subfamily is composed of the catalytically inactive kinases with similarity to yeast Scy1. It includes four mammalian proteins called SCY1-like protein 1 (SCYL1), SCYL2, SCYL3, as well as Testis-EXpressed protein 14 (TEX14). SCYL1 binds to and co-localizes with the membrane trafficking coatomer I (COPI) complex, and regulates COPI-mediated vesicle trafficking. Null mutations in the SCYL1 gene are responsible for the pathology in mdf (muscle-deficient) mice which display progressive motor neuropathy. SCYL2, also called coated vesicle-associated kinase of 104 kDa (CVAK104), is involved in the trafficking of clathrin-coated vesicles. It also binds the HIV-1 accessory protein Vpu and acts as a regulatory factor that promotes the dephosphorylation of Vpu, facilitating the restriction of HIV-1 release. SCYL3, also called ezrin-binding protein PACE-1, may be involved in regulating cell adhesion and migration. TEX14 is required for spermatogenesis and male fertility. It localizes to kinetochores (KT) during mitosis and is a target of the mitotic kinase PLK1. It regulates the maturation of the outer KT and the KT-microtubule attachment. The SCY1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270913 [Multi-domain]  Cd Length: 287  Bit Score: 46.16  E-value: 6.13e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 733 EFAQFGKLRHSNVVKLI-GLCRSQKCGYLISEYIEGkNLSEVLR---------------SLSWERRQKIAIGISKALRFL 796
Cdd:cd14011   52 GVKQLTRLRHPRILTVQhPLEESRESLAFATEPVFA-SLANVLGerdnmpspppelqdyKLYDVEIKYGLLQISEALSFL 130
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 797 HCNCSpsMVVGNMSPQKIIIDGKDEPHL-----------RLSPPLMVCTDFKCIISSA-----YFAPETRETKDTTEKSD 860
Cdd:cd14011  131 HNDVK--LVHGNICPESVVINSNGEWKLagfdfcisseqATDQFPYFREYDPNLPPLAqpnlnYLAPEYILSKTCDPASD 208
                        170       180
                 ....*....|....*....|..
gi 731385391 861 IYGFGLILIELM-TGKSPTDAE 881
Cdd:cd14011  209 MFSLGVLIYAIYnKGKPLFDCV 230
STKc_DCKL3 cd14185
Catalytic domain of the Serine/Threonine Kinase, Doublecortin-like kinase 3 (also called ...
740-877 6.78e-05

Catalytic domain of the Serine/Threonine Kinase, Doublecortin-like kinase 3 (also called Doublecortin-like and CAM kinase-like 3); STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. DCKL3 (or DCAMKL3) belongs to the doublecortin (DCX) family of proteins which are involved in neuronal migration, neurogenesis, and eye receptor development, among others. Family members typically contain tandem doublecortin (DCX) domains at the N-terminus; DCX domains can bind microtubules and serve as protein-interaction platforms. DCKL3 contains a single DCX domain (instead of a tandem) and a C-terminal kinase domain with similarity to CAMKs. It has been shown to interact with tubulin and JIP1/2. The DCKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271087 [Multi-domain]  Cd Length: 258  Bit Score: 45.71  E-value: 6.78e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 740 LRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVL-RSLSWERRQK--IAIGISKALRFLHcncSPSMVVGNMSPQKIII 816
Cdd:cd14185   55 LSHPNIVKLFEVYETEKEIYLILEYVRGGDLFDAIiESVKFTEHDAalMIIDLCEALVYIH---SKHIVHRDLKPENLLV 131
                         90       100       110       120       130       140       150
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 731385391 817 DGKDEPH--LRLS----------PPLMVCTdfkciiSSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSP 877
Cdd:cd14185  132 QHNPDKSttLKLAdfglakyvtgPIFTVCG------TPTYVAPEILSEKGYGLEVDMWAAGVILYILLCGFPP 198
LRR_8 pfam13855
Leucine rich repeat;
523-582 7.27e-05

Leucine rich repeat;


Pssm-ID: 404697 [Multi-domain]  Cd Length: 61  Bit Score: 41.36  E-value: 7.27e-05
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391  523 KLVSLNLSHNQLSGHIPASFSDMPVLGQLDLSQNQLSGKIPPNLGRVESLVQVNLSNNHL 582
Cdd:pfam13855   2 NLRSLDLSNNRLTSLDDGAFKGLSNLKVLDLSNNLLTTLSPGAFSGLPSLRYLDLSGNRL 61
STKc_WNK3 cd14031
Catalytic domain of the Serine/Threonine protein kinase, With No Lysine (WNK) 3; STKs catalyze ...
695-877 7.31e-05

Catalytic domain of the Serine/Threonine protein kinase, With No Lysine (WNK) 3; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. WNK3 shows a restricted expression pattern; it is found at high levels in the pituary glands and is also expressed in the kidney and brain. It has been shown to regulate many ion transporters including members of the SLC12A family of cation-chloride cotransporters such as NCC and NKCC2, the renal potassium channel ROMK, and the epithelial calcium channels TRPV5 and TRPV6. WNK3 appears to sense low-chloride hypotonic stress and under these conditions, it activates SPAK, which directly interacts and phosphorylates cation-chloride cotransporters. WNK3 has also been shown to promote cell survival, possibly through interaction with procaspase-3 and HSP70. WNKs comprise a subfamily of STKs with an unusual placement of the catalytic lysine relative to all other protein kinases. The WNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270933 [Multi-domain]  Cd Length: 275  Bit Score: 45.87  E-value: 7.31e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTKNGEMQFVVKEIND---SNSIPSSFWTEFAQFGKLRHSNVVKLI----GLCRSQKCGYLISEYIEG 767
Cdd:cd14031   18 LGRGAFKTVYKGLDTETWVEVAWCELQDrklTKAEQQRFKEEAEMLKGLQHPNIVRFYdsweSVLKGKKCIVLVTELMTS 97
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 768 KNLSEVLRSL---------SWERRqkiaigISKALRFLHCNcSPSMVVGNMSPQKIIIDGKDEP----HLRLSPpLMVCT 834
Cdd:cd14031   98 GTLKTYLKRFkvmkpkvlrSWCRQ------ILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSvkigDLGLAT-LMRTS 169
                        170       180       190       200
                 ....*....|....*....|....*....|....*....|....
gi 731385391 835 DFKCIISSAYF-APETREtKDTTEKSDIYGFGLILIELMTGKSP 877
Cdd:cd14031  170 FAKSVIGTPEFmAPEMYE-EHYDESVDVYAFGMCMLEMATSEYP 212
LRR_8 pfam13855
Leucine rich repeat;
331-391 1.04e-04

Leucine rich repeat;


Pssm-ID: 404697 [Multi-domain]  Cd Length: 61  Bit Score: 40.97  E-value: 1.04e-04
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 731385391  331 PRLQILQLWSNKLSGEIPKNLGKQNNLTVLDLSTNNLSGEIPESLCNSGRLFKLILFSNSL 391
Cdd:pfam13855   1 PNLRSLDLSNNRLTSLDDGAFKGLSNLKVLDLSNNLLTTLSPGAFSGLPSLRYLDLSGNRL 61
PLN03150 PLN03150
hypothetical protein; Provisional
360-443 1.11e-04

hypothetical protein; Provisional


Pssm-ID: 178695 [Multi-domain]  Cd Length: 623  Bit Score: 45.96  E-value: 1.11e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 360 LDLSTNNLSGEIPESLCNSGRLFKLILFSNSLEGEVPKSLSDCRSLRRVRLQSNHFSGELSSEFMKLPLVYFLDISDNNL 439
Cdd:PLN03150 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSL 502

                 ....
gi 731385391 440 TGKI 443
Cdd:PLN03150 503 SGRV 506
PKc_MKK3_6 cd06617
Catalytic domain of the dual-specificity Protein Kinases, Mitogen-activated protein Kinase ...
784-879 1.14e-04

Catalytic domain of the dual-specificity Protein Kinases, Mitogen-activated protein Kinase Kinases 3 and 6; PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine (ST) or tyrosine residues on protein substrates. MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 play roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. The MKK3/6 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 173729 [Multi-domain]  Cd Length: 283  Bit Score: 45.11  E-value: 1.14e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 784 KIAIGISKALRFLHCNCS-------PSMVVGNMSPQKIIIDGKDEPHLRLSpplMVCT-DFKCiisSAYFAPE----TRE 851
Cdd:cd06617  107 KIAVSIVKALEYLHSKLSvihrdvkPSNVLINRNGQVKLCDFGISGYLVDS---VAKTiDAGC---KPYMAPErinpELN 180
                         90       100
                 ....*....|....*....|....*...
gi 731385391 852 TKDTTEKSDIYGFGLILIELMTGKSPTD 879
Cdd:cd06617  181 QKGYDVKSDVWSLGITMIELATGRFPYD 208
STKc_RSK3_C cd14178
C-terminal catalytic domain of the Serine/Threonine Kinase, Ribosomal S6 kinase 3 (also called ...
709-877 1.24e-04

C-terminal catalytic domain of the Serine/Threonine Kinase, Ribosomal S6 kinase 3 (also called Ribosomal protein S6 kinase alpha-2 or 90kDa ribosomal protein S6 kinase 2); STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. RSK3 is also called S6K-alpha-2, RPS6KA2, p90RSK2 or MAPK-activated protein kinase 1c (MAPKAPK-1c). RSK3 binds muscle A-kinase anchoring protein (mAKAP)-b directly and regulates concentric cardiac myocyte growth. The RSK3 gene, RPS6KA2, is a putative tumor suppressor gene in sporadic epithelial ovarian cancer and variations to the gene may be associated with rectal cancer risk. RSK3 is one of four RSK isoforms (RSK1-4) from distinct genes present in vertebrates. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. The RSK3 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271080 [Multi-domain]  Cd Length: 293  Bit Score: 45.01  E-value: 1.24e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 709 KNGEMQFVVKEINDSNSIPSSFWTEFAQFGKlrHSNVVKLIGLCRSQKCGYLISEYIEGKNL-SEVLRSLSWERRQKIAI 787
Cdd:cd14178   25 KATSTEYAVKIIDKSKRDPSEEIEILLRYGQ--HPNIITLKDVYDDGKFVYLVMELMRGGELlDRILRQKCFSEREASAV 102
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 788 --GISKALRFLHcncSPSMVVGNMSPQKII-IDGKDEP------------HLRLSPPLMVCTDFkciiSSAYFAPETRET 852
Cdd:cd14178  103 lcTITKTVEYLH---SQGVVHRDLKPSNILyMDESGNPesiricdfgfakQLRAENGLLMTPCY----TANFVAPEVLKR 175
                        170       180
                 ....*....|....*....|....*
gi 731385391 853 KDTTEKSDIYGFGLILIELMTGKSP 877
Cdd:cd14178  176 QGYDAACDIWSLGILLYTMLAGFTP 200
STKc_AGC cd05123
Catalytic domain of AGC family Serine/Threonine Kinases; STKs catalyze the transfer of the ...
739-877 1.25e-04

Catalytic domain of AGC family Serine/Threonine Kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. The AGC family is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase.


Pssm-ID: 270693 [Multi-domain]  Cd Length: 250  Bit Score: 44.82  E-value: 1.25e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 739 KLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVLR---SLSWERRQKIAIGISKALRFLHcncSPSMVVGNMSPQKII 815
Cdd:cd05123   49 RVNHPFIVKLHYAFQTEEKLYLVLDYVPGGELFSHLSkegRFPEERARFYAAEIVLALEYLH---SLGIIYRDLKPENIL 125
                         90       100       110       120       130       140       150
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 731385391 816 IDgkDEPHLRLspplmvcTDF---KCIISSA-----------YFAPETRETKDTTEKSDIYGFGLILIELMTGKSP 877
Cdd:cd05123  126 LD--SDGHIKL-------TDFglaKELSSDGdrtytfcgtpeYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
LRR_8 pfam13855
Leucine rich repeat;
187-247 1.31e-04

Leucine rich repeat;


Pssm-ID: 404697 [Multi-domain]  Cd Length: 61  Bit Score: 40.59  E-value: 1.31e-04
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 731385391  187 TSLEFLTLASNQLVGEIPRELGRMKSLKWIYLGYNNLSGGIPKEIGELTSLNHLDLVYNNL 247
Cdd:pfam13855   1 PNLRSLDLSNNRLTSLDDGAFKGLSNLKVLDLSNNLLTTLSPGAFSGLPSLRYLDLSGNRL 61
STKc_MAP3K8 cd13995
Catalytic domain of the Serine/Threonine kinase, Mitogen-Activated Protein Kinase (MAPK) ...
740-877 1.35e-04

Catalytic domain of the Serine/Threonine kinase, Mitogen-Activated Protein Kinase (MAPK) Kinase Kinase 8; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. MAP3K8 is also called Tumor progression locus 2 (Tpl2) or Cancer Osaka thyroid (Cot), and was first identified as a proto-oncogene in T-cell lymphoma induced by MoMuL virus and in breast carcinoma induced by MMTV. Activated MAP3K8 induces various MAPK pathways including Extracellular Regulated Kinase (ERK) 1/2, c-Jun N-terminal kinase (JNK), and p38. It plays a pivotal role in innate immunity, linking Toll-like receptors to the production of TNF and the activation of ERK in macrophages. It is also required in interleukin-1beta production and is critical in host defense against Gram-positive bacteria. MAP3Ks (MKKKs or MAPKKKs) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. The MAP3K8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270897 [Multi-domain]  Cd Length: 256  Bit Score: 44.62  E-value: 1.35e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 740 LRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVLRSLSWERRQKI---AIGISKALRFLHC------NCSPSMVVgNMS 810
Cdd:cd13995   53 FRHENIAELYGALLWEETVHLFMEAGEGGSVLEKLESCGPMREFEIiwvTKHVLKGLDFLHSkniihhDIKPSNIV-FMS 131
                         90       100       110       120       130       140
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 731385391 811 PQKIIID-GKDephLRLSPPLMVCTDFKCiiSSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSP 877
Cdd:cd13995  132 TKAVLVDfGLS---VQMTEDVYVPKDLRG--TEIYMSPEVILCRGHNTKADIYSLGATIIHMQTGSPP 194
PK_GC-C cd14044
Pseudokinase domain of the membrane Guanylate Cyclase receptor, GC-C; The pseudokinase domain ...
716-875 1.40e-04

Pseudokinase domain of the membrane Guanylate Cyclase receptor, GC-C; The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity and/or ATP binding. GC-C binds and is activated by the intestinal hormones, guanylin (GN) and uroguanylin (UGN), which are secreted after salty meals to inhibit sodium absorption and induce the secretion of chloride, bicarbonate, and water. GN and UGN are also present in the kidney, where they induce increased salt and water secretion. This prevents the development of hypernatremia and hypervolemia after ingestion of high amounts of salt. Membrane (or particulate) GCs consist of an extracellular ligand-binding domain, a single transmembrane region, and an intracellular tail that contains a PK-like domain, an amphiphatic region and a catalytic GC domain that catalyzes the conversion of GTP into cGMP and pyrophosphate. Membrane GCs act as receptors that transduce an extracellular signal to the intracellular production of cGMP, which has been implicated in many processes including cell proliferation, phototransduction, and muscle contractility, through its downstream effectors such as PKG. The PK-like domain of GCs functions as a negative regulator of the catalytic GC domain and may also act as a docking site for interacting proteins such as GC-activating proteins. The GC-C subfamily is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270946 [Multi-domain]  Cd Length: 271  Bit Score: 44.88  E-value: 1.40e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 716 VVKEI-NDSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVLRS---------LSWERRQKI 785
Cdd:cd14044   35 ILKDLkNNEGNFTEKQKIELNKLLQIDYYNLTKFYGTVKLDTMIFGVIEYCERGSLRDVLNDkisypdgtfMDWEFKISV 114
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 786 AIGISKALRFLHCncSPSMVVGNMSPQKIIIDGKdephlrlspplMVC--TDFKC--IISSA---YFAPETRETKDTTEK 858
Cdd:cd14044  115 MYDIAKGMSYLHS--SKTEVHGRLKSTNCVVDSR-----------MVVkiTDFGCnsILPPSkdlWTAPEHLRQAGTSQK 181
                        170
                 ....*....|....*..
gi 731385391 859 SDIYGFGLILIELMTGK 875
Cdd:cd14044  182 GDVYSYGIIAQEIILRK 198
PTKc_Abl cd05052
Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase; PTKs catalyze the transfer of ...
698-877 1.44e-04

Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase; PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) PTK that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. The Abl subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270645 [Multi-domain]  Cd Length: 263  Bit Score: 44.72  E-value: 1.44e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 698 GRKGISYKGKTKNGEMQFVVKEINDSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVLRSL 777
Cdd:cd05052   17 GQYGEVYEGVWKKYNLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMPYGNLLDYLREC 96
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 778 SWER---------RQKIAIGIS--KALRFLH-----CNCspsmVVGNMSPQKIIIDGkdephlrLSPplMVCTDFKCIIS 841
Cdd:cd05052   97 NREElnavvllymATQIASAMEylEKKNFIHrdlaaRNC----LVGENHLVKVADFG-------LSR--LMTGDTYTAHA 163
                        170       180       190       200
                 ....*....|....*....|....*....|....*....|..
gi 731385391 842 SAYF-----APETRETKDTTEKSDIYGFGLILIELMT-GKSP 877
Cdd:cd05052  164 GAKFpikwtAPESLAYNKFSIKSDVWAFGVLLWEIATyGMSP 205
PTKc_Tec_like cd05059
Catalytic domain of Tec-like Protein Tyrosine Kinases; PTKs catalyze the transfer of the ...
695-800 1.49e-04

Catalytic domain of Tec-like Protein Tyrosine Kinases; PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Tec-like subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. They are cytoplasmic (or nonreceptor) PTKs with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members except Rlk also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nonreceptor PTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. Tec kinases play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). The Tec-like subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 173637 [Multi-domain]  Cd Length: 256  Bit Score: 44.75  E-value: 1.49e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTKnGEMQFVVKEINDSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVL 774
Cdd:cd05059   12 LGSGQFGVVHLGKWR-GKIDVAIKMIKEGSMSEDDFIEEAKVMMKLSHPKLVQLYGVCTKQRPIFIVTEYMANGCLLNYL 90
                         90       100       110
                 ....*....|....*....|....*....|....
gi 731385391 775 RslswERRQK--------IAIGISKALRFLHCNC 800
Cdd:cd05059   91 R----ERRGKfqteqlleMCKDVCEAMEYLESNG 120
STKc_LRRK1 cd14067
Catalytic domain of the Serine/Threonine Kinase, Leucine-Rich Repeat Kinase 1; STKs catalyze ...
728-878 2.26e-04

Catalytic domain of the Serine/Threonine Kinase, Leucine-Rich Repeat Kinase 1; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. LRRK1 is one of two vertebrate LRRKs which show complementary expression in the brain. It can form heterodimers with LRRK2, and may influence the age of onset of LRRK2-associated Parkinson's disease. LRRKs are also classified as ROCO proteins because they contain a ROC (Ras of complex proteins)/GTPase domain followed by a COR (C-terminal of ROC) domain of unknown function. In addition, LRRKs contain a catalytic kinase domain and protein-protein interaction motifs including a WD40 domain, LRRs and ankyrin (ANK) repeats. LRRKs possess both GTPase and kinase activities, with the ROC domain acting as a molecular switch for the kinase domain, cycling between a GTP-bound state which drives kinase activity and a GDP-bound state which decreases the activity. The LRRK1 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270969 [Multi-domain]  Cd Length: 276  Bit Score: 44.19  E-value: 2.26e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 728 SSFWTEFAQFGKLRHSNVVKLIG-----LCRSQKCGYL--ISEYIEGKNLSEVLRSLSWERRQKIAIGISKALRFLHcnc 800
Cdd:cd14067   55 SEFRQEASMLHSLQHPCIVYLIGisihpLCFALELAPLgsLNTVLEENHKGSSFMPLGHMLTFKIAYQIAAGLAYLH--- 131
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 801 SPSMVVGNMSPQKIII---DGKDEPHLRLSPPLMVCTDFKCII-----SSAYFAPETRETKDTTEKSDIYGFGLILIELM 872
Cdd:cd14067  132 KKNIIFCDLKSDNILVwslDVQEHINIKLSDYGISRQSFHEGAlgvegTPGYQAPEIRPRIVYDEKVDMFSYGMVLYELL 211

                 ....*.
gi 731385391 873 TGKSPT 878
Cdd:cd14067  212 SGQRPS 217
LRR_RI cd00116
Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 ...
64-239 2.37e-04

Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).


Pssm-ID: 238064 [Multi-domain]  Cd Length: 319  Bit Score: 44.27  E-value: 2.37e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391  64 LCTNSSHVSSIDLSGKNISGE----ISPVFFGLPYIETVNLSNNALSGgiPGNISLCYSLRylnlsnnnltgsmprgSAS 139
Cdd:cd00116  132 LKDLPPALEKLVLGRNRLEGAsceaLAKALRANRDLKELNLANNGIGD--AGIRALAEGLK----------------ANC 193
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 140 GLEALDLSNNVISGEIPADM-GLFSRLK---VLDLGGNFLVGKIPNSIANI-----TSLEFLTLASNQLVGEIPRELGR- 209
Cdd:cd00116  194 NLEVLDLNNNGLTDEGASALaETLASLKsleVLNLGDNNLTDAGAAALASAllspnISLLTLSLSCNDITDDGAKDLAEv 273
                        170       180       190
                 ....*....|....*....|....*....|...
gi 731385391 210 ---MKSLKWIYLGYNNLSGGIPKEIGELTSLNH 239
Cdd:cd00116  274 laeKESLLELDLRGNKFGEEGAQLLAESLLEPG 306
STKc_TGFbR2_like cd14055
Catalytic domain of the Serine/Threonine Kinase, Transforming Growth Factor beta Type II ...
694-873 2.82e-04

Catalytic domain of the Serine/Threonine Kinase, Transforming Growth Factor beta Type II Receptor; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. TGFbR2 belongs to a group of receptors for the TGFbeta family of secreted signaling molecules that includes TGFbeta, bone morphogenetic proteins, activins, growth and differentiation factors, and anti-Mullerian hormone, among others. These receptors contain an extracellular domain that binds ligands, a single transmembrane region, and a cytoplasmic catalytic kinase domain. Type II receptors, such as TGFbR2, are high-affinity receptors which bind ligands, autophosphorylate, as well as trans-phosphorylate and activate low-affinity type I receptors. TGFbR2 acts as the receptor for TGFbeta, which is crucial in growth control and homeostasis in many different tissues. It plays roles in regulating apoptosis and in maintaining the balance between self renewal and cell loss. It also plays a key role in maintaining vascular integrity and in regulating responses to genotoxic stress. Mutations in TGFbR2 can cause aortic aneurysm disorders such as Loeys-Dietz and Marfan syndromes. The TGFbR2 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270957 [Multi-domain]  Cd Length: 295  Bit Score: 43.90  E-value: 2.82e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 694 VISRGRKGISYKGK-TKNGEMQFV---VKEINDSNSipSSFWTEFAQFG--KLRHSNVVKLIG----LCRSQKCGYLISE 763
Cdd:cd14055    2 LVGKGRFAEVWKAKlKQNASGQYEtvaVKIFPYEEY--ASWKNEKDIFTdaSLKHENILQFLTaeerGVGLDRQYWLITA 79
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 764 YIEGKNLSEVLRS--LSWERRQKIAIGISKALRFLHCNCSPSMVvgnmspQKIIIDGKDephLRLSPPLMVCtDFKCII- 840
Cdd:cd14055   80 YHENGSLQDYLTRhiLSWEDLCKMAGSLARGLAHLHSDRTPCGR------PKIPIAHRD---LKSSNILVKN-DGTCVLa 149
                        170       180       190       200       210       220
                 ....*....|....*....|....*....|....*....|....*....|....*....|...
gi 731385391 841 ------------------------SSAYFAPETRETK------DTTEKSDIYGFGLILIELMT 873
Cdd:cd14055  150 dfglalrldpslsvdelansgqvgTARYMAPEALESRvnledlESFKQIDVYSMALVLWEMAS 212
STKc_EIF2AK cd13996
Catalytic domain of the Serine/Threonine kinase, eukaryotic translation Initiation Factor ...
694-871 3.00e-04

Catalytic domain of the Serine/Threonine kinase, eukaryotic translation Initiation Factor 2-Alpha Kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. EIF2AKs phosphorylate the alpha subunit of eIF-2, resulting in the downregulation of protein synthesis. eIF-2 phosphorylation is induced in response to cellular stresses including virus infection, heat shock, nutrient deficiency, and the accummulation of unfolded proteins, among others. There are four distinct kinases that phosphorylate eIF-2 and control protein synthesis under different stress conditions: General Control Non-derepressible-2 (GCN2) which is activated during amino acid or serum starvation; protein kinase regulated by RNA (PKR) which is activated by double stranded RNA; heme-regulated inhibitor kinase (HRI) which is activated under heme-deficient conditions; and PKR-like endoplasmic reticulum kinase (PERK) which is activated when misfolded proteins accumulate in the ER. The EIF2AK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270898 [Multi-domain]  Cd Length: 273  Bit Score: 43.82  E-value: 3.00e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 694 VISRGRKGISYKGKTKNGEMQFVVKEI--NDSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLS 771
Cdd:cd13996   13 LLGSGGFGSVYKVRNKVDGVTYAIKKIrlTEKSSASEKVLREVKALAKLNHPNIVRYYTAWVEEPPLYIQMELCEGGTLR 92
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 772 EVL-RSLSWERRQK-----IAIGISKALRFLHCNC------SPSMVVGNMSPQ--KI--------IIDGKDEPHLRLSPP 829
Cdd:cd13996   93 DWIdRRNSSSKNDRklaleLFKQILKGVSYIHSKGivhrdlKPSNIFLDNDDLqvKIgdfglatsIGNQKRELNNLNNNN 172
                        170       180       190       200
                 ....*....|....*....|....*....|....*....|...
gi 731385391 830 LMVCTDFKCIISSA-YFAPETRETKDTTEKSDIYGFGLILIEL 871
Cdd:cd13996  173 NGNTSNNSVGIGTPlYASPEQLDGENYNEKADIYSLGIILFEM 215
STKc_WNK1 cd14030
Catalytic domain of the Serine/Threonine protein kinase, With No Lysine (WNK) 1; STKs catalyze ...
695-877 3.15e-04

Catalytic domain of the Serine/Threonine protein kinase, With No Lysine (WNK) 1; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. WNK1 is widely expressed and is most abundant in the testis. In hyperosmotic or hypotonic low-chloride stress conditions, WNK1 is activated and it phosphorylates its substrates including SPAK and OSR1 kinases, which regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. Mutations in WNK1 cause PseudoHypoAldosteronism type II (PHAII), characterized by hypertension and hyperkalemia. WNK1 negates WNK4-mediated inhibition of the sodium-chloride cotransporter NCC and activates the epithelial sodium channel ENaC by activating SGK1. WNK1 also decreases the surface expression of renal outer medullary potassium channel (ROMK) by stimulating their endocytosis. Hypertension and hyperkalemia in PHAII patients with WNK1 mutations may be due partly to increased activity of NCC and ENaC, and impaired renal potassium secretion by ROMK, respectively. In addition, WNK1 interacts with MEKK2/3 and acts as an activator of extracellular signal-regulated kinase (ERK) 5. It also negatively regulates TGFbeta signaling. WNKs comprise a subfamily of STKs with an unusual placement of the catalytic lysine relative to all other protein kinases. The WNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270932 [Multi-domain]  Cd Length: 289  Bit Score: 43.89  E-value: 3.15e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTKNGEMQFVVKEIND---SNSIPSSFWTEFAQFGKLRHSNVVKLI----GLCRSQKCGYLISEYIEG 767
Cdd:cd14030   33 IGRGSFKTVYKGLDTETTVEVAWCELQDrklSKSERQRFKEEAGMLKGLQHPNIVRFYdsweSTVKGKKCIVLVTELMTS 112
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 768 KNLSEVLRSL---------SWERRqkiaigISKALRFLHCNcSPSMVVGNMSPQKIIIDGKDEP----HLRLSPpLMVCT 834
Cdd:cd14030  113 GTLKTYLKRFkvmkikvlrSWCRQ------ILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSvkigDLGLAT-LKRAS 184
                        170       180       190       200
                 ....*....|....*....|....*....|....*....|....
gi 731385391 835 DFKCIISSAYF-APETRETKdTTEKSDIYGFGLILIELMTGKSP 877
Cdd:cd14030  185 FAKSVIGTPEFmAPEMYEEK-YDESVDVYAFGMCMLEMATSEYP 227
STKc_CDK_like cd07829
Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases; STKs ...
695-799 3.69e-04

Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270823 [Multi-domain]  Cd Length: 282  Bit Score: 43.62  E-value: 3.69e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTKNGEMQFVVKEI---NDSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEgKNLS 771
Cdd:cd07829    7 LGEGTYGVVYKAKDKKTGEIVALKKIrldNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTENKLYLVFEYCD-QDLK 85
                         90       100       110
                 ....*....|....*....|....*....|..
gi 731385391 772 EVLRS----LSWERRQKIAIGISKALRFLHCN 799
Cdd:cd07829   86 KYLDKrpgpLPPNLIKSIMYQLLRGLAYCHSH 117
STKc_CDKL cd07833
Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases; STKs ...
694-874 4.18e-04

Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270827 [Multi-domain]  Cd Length: 288  Bit Score: 43.46  E-value: 4.18e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 694 VISRGRKGISYKGKTKN-GEMQFV--VKEINDSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEgKNL 770
Cdd:cd07833    8 VVGEGAYGVVLKCRNKAtGEIVAIkkFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVE-RTL 86
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 771 SEVL----RSLSWERRQKIAIGISKALRFLHCNcspSMVVGNMSPQKIIIDGKDEphLRL----------SPPLMVCTDF 836
Cdd:cd07833   87 LELLeaspGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGV--LKLcdfgfaraltARPASPLTDY 161
                        170       180       190       200
                 ....*....|....*....|....*....|....*....|
gi 731385391 837 kcIISSAYFAPETReTKDTT--EKSDIYGFGLILIELMTG 874
Cdd:cd07833  162 --VATRWYRAPELL-VGDTNygKPVDVWAIGCIMAELLDG 198
PPP1R42 cd21340
protein phosphatase 1 regulatory subunit 42; Protein phosphatase 1 regulatory subunit 42 ...
282-556 4.25e-04

protein phosphatase 1 regulatory subunit 42; Protein phosphatase 1 regulatory subunit 42 (PPP1R42), also known as leucine-rich repeat-containing protein 67 (lrrc67) or testis leucine-rich repeat (TLRR) protein, plays a role in centrosome separation. PPP1R42 has been shown to interact with the well-conserved signaling protein phosphatase-1 (PP1) and thereby increasing PP1's activity, which counters centrosome separation. Inhibition of PPP1R42 expression increases the number of centrosomes per cell while its depletion reduces the activity of PP1 leading to activation of NEK2, the kinase responsible for phosphorylation of centrosomal linker proteins promoting centrosome separation.


Pssm-ID: 411060 [Multi-domain]  Cd Length: 220  Bit Score: 42.85  E-value: 4.25e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 282 LKKLISLDLSDNSLSgEIPELvIQLQNLEILHLFANDFTgKIPrALASLPRLQILQLWSNKLSgEIPkNLGKQNNLTVLD 361
Cdd:cd21340    1 LKRITHLYLNDKNIT-KIDNL-SLCKNLKVLYLYDNKIT-KIE-NLEFLTNLTHLYLQNNQIE-KIE-NLENLVNLKKLY 74
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 362 LSTNNLSgeipeslcnsgrlfklilfsnSLEGevpksLSDCRSLRrvrlqsnhfsgELSSEFMKLPLVYFLDISDNNLTG 441
Cdd:cd21340   75 LGGNRIS---------------------VVEG-----LENLTNLE-----------ELHIENQRLPPGEKLTFDPRSLAA 117
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 442 kISdrrwdmPSLQMLSLARNrffgnlpqsfgasklenldlsenqfsgavpssfgNLSELmqlklsenmlsgdipEELSSC 521
Cdd:cd21340  118 -LS------NSLRVLNISGN----------------------------------NIDSL---------------EPLAPL 141
                        250       260       270
                 ....*....|....*....|....*....|....*..
gi 731385391 522 KKLVSLNLSHNQLSGH--IPASFSDMPVLGQLDLSQN 556
Cdd:cd21340  142 RNLEQLDASNNQISDLeeLLDLLSSWPSLRELDLTGN 178
LRR_8 pfam13855
Leucine rich repeat;
69-129 4.61e-04

Leucine rich repeat;


Pssm-ID: 404697 [Multi-domain]  Cd Length: 61  Bit Score: 39.04  E-value: 4.61e-04
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|..
gi 731385391   69 SHVSSIDLSGKNISGeISP-VFFGLPYIETVNLSNNALSGGIPGNISLCYSLRYLNLSNNNL 129
Cdd:pfam13855   1 PNLRSLDLSNNRLTS-LDDgAFKGLSNLKVLDLSNNLLTTLSPGAFSGLPSLRYLDLSGNRL 61
PTZ00283 PTZ00283
serine/threonine protein kinase; Provisional
844-947 4.77e-04

serine/threonine protein kinase; Provisional


Pssm-ID: 240344 [Multi-domain]  Cd Length: 496  Bit Score: 43.70  E-value: 4.77e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 844 YFAPETRETKDTTEKSDIYGFGLILIELMTGKSPTDAEFG---VHGSIVewGRYcysdchldmwiDPIiraqVSSNQNQM 920
Cdd:PTZ00283 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMeevMHKTLA--GRY-----------DPL----PPSISPEM 273
                         90       100
                 ....*....|....*....|....*..
gi 731385391 921 VEIMNLALhctATDPTARPCASDVLKT 947
Cdd:PTZ00283 274 QEIVTALL---SSDPKRRPSSSKLLNM 297
PLN00009 PLN00009
cyclin-dependent kinase A; Provisional
695-881 5.58e-04

cyclin-dependent kinase A; Provisional


Pssm-ID: 177649 [Multi-domain]  Cd Length: 294  Bit Score: 42.88  E-value: 5.58e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTKNGEMQFVVKEI---NDSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIE----- 766
Cdd:PLN00009  10 IGEGTYGVVYKARDRVTNETIALKKIrleQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDldlkk 89
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 767 --------GKNLsEVLRSLSWERRQKIAIGISKalRFLHcncspsmvvGNMSPQKIIIDGKDEPhLRLSP-------PLM 831
Cdd:PLN00009  90 hmdsspdfAKNP-RLIKTYLYQILRGIAYCHSH--RVLH---------RDLKPQNLLIDRRTNA-LKLADfglarafGIP 156
                        170       180       190       200       210
                 ....*....|....*....|....*....|....*....|....*....|...
gi 731385391 832 VCTDFKCIISSAYFAPET-RETKDTTEKSDIYGFGLILIELMTGKS--PTDAE 881
Cdd:PLN00009 157 VRTFTHEVVTLWYRAPEIlLGSRHYSTPVDIWSVGCIFAEMVNQKPlfPGDSE 209
PTKc_Fer cd05085
Catalytic domain of the Protein Tyrosine Kinase, Fer; Protein Tyrosine Kinase (PTK) family; ...
694-870 5.79e-04

Catalytic domain of the Protein Tyrosine Kinase, Fer; Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells.


Pssm-ID: 270668 [Multi-domain]  Cd Length: 251  Bit Score: 42.69  E-value: 5.79e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 694 VISRGRKGISYKGKTKNgEMQFVVKEINDSnsIPSSFWTEFAQFGKL----RHSNVVKLIGLCRSQKCGYLISEYIEGKN 769
Cdd:cd05085    3 LLGKGNFGEVYKGTLKD-KTPVAVKTCKED--LPQELKIKFLSEARIlkqyDHPNIVKLIGVCTQRQPIYIVMELVPGGD 79
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 770 LSEVLR----SLSWERRQKIAIGISKALRFLHC-NCspsmVVGNMSPQKIIIDgkDEPHLRLSPPLMVCTDFKCIISSA- 843
Cdd:cd05085   80 FLSFLRkkkdELKTKQLVKFSLDAAAGMAYLESkNC----IHRDLAARNCLVG--ENNALKISDFGMSRQEDDGVYSSSg 153
                        170       180       190
                 ....*....|....*....|....*....|....
gi 731385391 844 -------YFAPETRETKDTTEKSDIYGFGLILIE 870
Cdd:cd05085  154 lkqipikWTAPEALNYGRYSSESDVWSFGILLWE 187
RNA1 COG5238
Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Translation, ...
183-440 6.01e-04

Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Translation, ribosomal structure and biogenesis];


Pssm-ID: 444072 [Multi-domain]  Cd Length: 434  Bit Score: 43.24  E-value: 6.01e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 183 IANITSLEFLTLASNQLVGEIPRELGRM-----------KSLKWIYLGYNNLSGGIPKEIGEL----TSLNHLDLVYNNL 247
Cdd:COG5238  141 INLIQVLKDPLGGNAVHLLGLAARLGLLaaismakalqnNSVETVYLGCNQIGDEGIEELAEAltqnTTVTTLWLKRNPI 220
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 248 TGEIPSSLGNLsdlhflflyqnkLSGsippsifdLKKLISLDLSDNSLSGE----IPELVIQLQNLEILHLFANDFTGKI 323
Cdd:COG5238  221 GDEGAEILAEA------------LKG--------NKSLTTLDLSNNQIGDEgviaLAEALKNNTTVETLYLSGNQIGAEG 280
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 324 PRALAslprlqilqlwsnklsgeipKNLGKQNNLTVLDLSTNNLSGE----IPESLCNSGRLFKLILFSNSLEGE----V 395
Cdd:COG5238  281 AIALA--------------------KALQGNTTLTSLDLSVNRIGDEgaiaLAEGLQGNKTLHTLNLAYNGIGAQgaiaL 340
                        250       260       270       280
                 ....*....|....*....|....*....|....*....|....*....
gi 731385391 396 PKSLSDCRSLRRVRLQSNHFSGELSSEFMKL----PLVYFLDISDNNLT 440
Cdd:COG5238  341 AKALQENTTLHSLDLSDNQIGDEGAIALAKYlegnTTLRELNLGKNNIG 389
STKc_HAL4_like cd13994
Catalytic domain of Fungal Halotolerance protein 4-like Serine/Threonine kinases; STKs ...
707-877 6.08e-04

Catalytic domain of Fungal Halotolerance protein 4-like Serine/Threonine kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This subfamily is composed of HAL4, Saccharomyces cerevisiae Ptk2/Stk2, and similar fungal proteins. Proteins in this subfamily are involved in regulating ion transporters. In budding and fission yeast, HAL4 promotes potassium ion uptake, which increases cellular resistance to other cations such as sodium, lithium, and calcium ions. HAL4 stabilizes the major high-affinity K+ transporter Trk1 at the plasma membrane under low K+ conditions, which prevents endocytosis and vacuolar degradation. Budding yeast Ptk2 phosphorylates and regulates the plasma membrane H+ ATPase, Pma1. The HAL4-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270896 [Multi-domain]  Cd Length: 265  Bit Score: 42.68  E-value: 6.08e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 707 KTKNGEMQFVVKEIN--DSNSIP----SSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGY-LISEYIEGKNLSEVL---RS 776
Cdd:cd13994   15 KNPRSGVLYAVKEYRrrDDESKRkdyvKRLTSEYIISSKLHHPNIVKVLDLCQDLHGKWcLVMEYCPGGDLFTLIekaDS 94
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 777 LSWERRQKIAIGISKALRFLHcncspSMVVG--NMSPQKIIIDgkDEPHLRLspplmvcTDF------------------ 836
Cdd:cd13994   95 LSLEEKDCFFKQILRGVAYLH-----SHGIAhrDLKPENILLD--EDGVLKL-------TDFgtaevfgmpaekespmsa 160
                        170       180       190       200
                 ....*....|....*....|....*....|....*....|..
gi 731385391 837 KCIISSAYFAPETRETKDTTEKS-DIYGFGLILIELMTGKSP 877
Cdd:cd13994  161 GLCGSEPYMAPEVFTSGSYDGRAvDVWSCGIVLFALFTGRFP 202
PK_NRBP1 cd14034
Pseudokinase domain of Nuclear Receptor Binding Protein 1; The pseudokinase domain shows ...
734-871 7.04e-04

Pseudokinase domain of Nuclear Receptor Binding Protein 1; The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity and/or ATP binding. NRBP1, also called MLF1-adaptor molecule (MADM), was originally named based on the presence of nuclear binding and localization motifs prior to functional analyses. It is expressed ubiquitously and is found to localize in the cytoplasm, not the nucleus. NRBP1 is an adaptor protein that interacts with myeloid leukemia factor 1 (MLF1), an oncogene that enhances myeloid development of hematopoietic cells. It also interacts with the small GTPase Rac3. NRBP1 may also be involved in Golgi to ER trafficking and actin dynamics. The NRBP1-like subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270936 [Multi-domain]  Cd Length: 277  Bit Score: 42.81  E-value: 7.04e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 734 FAQFGKLRHSNVVKL----IGLCRSQKCGYLISEYIEGKNLSEVLR-------SLSWERRQKIAIGISKALRFLHcNCSP 802
Cdd:cd14034   61 FDNLIQLEHLNIVKFhkywADVKENRARVIFITEYMSSGSLKQFLKktkknhkTMNEKAWKRWCTQILSALSYLH-SCDP 139
                         90       100       110       120       130       140       150
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 731385391 803 SMVVGNMSPQKIIIDGKDEPHLRLSPPLMVCTDFKCIISSA----YFAPETRETKDTTEKSDIYGFGLILIEL 871
Cdd:cd14034  140 PIIHGNLTCDTIFIQHNGLIKIGSVAPDTINNHVKTCREEQknlhFFAPEYGEVANVTTAVDIYSFGMCALEM 212
APH_ChoK_like cd05120
Aminoglycoside 3'-phosphotransferase and Choline Kinase family; This family is composed of APH, ...
747-821 7.58e-04

Aminoglycoside 3'-phosphotransferase and Choline Kinase family; This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K).


Pssm-ID: 270690 [Multi-domain]  Cd Length: 158  Bit Score: 41.13  E-value: 7.58e-04
                         10        20        30        40        50        60        70
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 731385391 747 KLIGLCRSQKCGYLISEYIEGKNLSEVLRSLSWERRQKIAIGISKALRFLHCNCSPSMVVGNMSPQKIIIDGKDE 821
Cdd:cd05120   56 KVYGFGESDGWEYLLMERIEGETLSEVWPRLSEEEKEKIADQLAEILAALHRIDSSVLTHGDLHPGNILVKPDGK 130
LRR_8 pfam13855
Leucine rich repeat;
118-173 7.62e-04

Leucine rich repeat;


Pssm-ID: 404697 [Multi-domain]  Cd Length: 61  Bit Score: 38.66  E-value: 7.62e-04
                          10        20        30        40        50
                  ....*....|....*....|....*....|....*....|....*....|....*....
gi 731385391  118 SLRYLNLSNNNLTgSMPRGSASG---LEALDLSNNVISGEIPADMGLFSRLKVLDLGGN 173
Cdd:pfam13855   2 NLRSLDLSNNRLT-SLDDGAFKGlsnLKVLDLSNNLLTTLSPGAFSGLPSLRYLDLSGN 59
STKc_EIF2AK3_PERK cd14048
Catalytic domain of the Serine/Threonine kinase, eukaryotic translation Initiation Factor ...
694-944 8.57e-04

Catalytic domain of the Serine/Threonine kinase, eukaryotic translation Initiation Factor 2-Alpha Kinase 3 or PKR-like Endoplasmic Reticulum Kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. PERK (or EIF2AK3) is a type-I ER transmembrane protein containing a luminal domain bound with the chaperone BiP under unstressed conditions and a cytoplasmic catalytic kinase domain. In response to the accumulation of misfolded or unfolded proteins in the ER, PERK is activated through the release of BiP, allowing it to dimerize and autophosphorylate. It functions as the central regulator of translational control during the Unfolded Protein Response (UPR) pathway. In addition to the eIF-2 alpha subunit, PERK also phosphorylates Nrf2, a leucine zipper transcription factor which regulates cellular redox status and promotes cell survival during the UPR. EIF2AKs phosphorylate the alpha subunit of eIF-2, resulting in the downregulation of protein synthesis. The PERK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270950 [Multi-domain]  Cd Length: 281  Bit Score: 42.55  E-value: 8.57e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 694 VISRGRKGISYKGKTKNGEMQFVVKEINDSNSIPS--SFWTEFAQFGKLRHSNVVKLI---------GLCRSQKCGYLis 762
Cdd:cd14048   13 CLGRGGFGVVFEAKNKVDDCNYAVKRIRLPNNELAreKVLREVRALAKLDHPGIVRYFnawlerppeGWQEKMDEVYL-- 90
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 763 eYIE-----GKNLSEVL-RSLSWERRQ-----KIAIGISKALRFLHC------NCSPSMVVGNMSPQKIIID-------G 818
Cdd:cd14048   91 -YIQmqlcrKENLKDWMnRRCTMESRElfvclNIFKQIASAVEYLHSkglihrDLKPSNVFFSLDDVVKVGDfglvtamD 169
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 819 KDEPHLR-LSPPLMVCTDFKCIISSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSpTDAEFGVHGSIVEWGRYcys 897
Cdd:cd14048  170 QGEPEQTvLTPMPAYAKHTGQVGTRLYMSPEQIHGNQYSEKVDIFALGLILFELIYSFS-TQMERIRTLTDVRKLKF--- 245
                        250       260       270       280
                 ....*....|....*....|....*....|....*....|....*..
gi 731385391 898 dchldmwidPIIRAQVSSNQNQMVEIMnlalhcTATDPTARPCASDV 944
Cdd:cd14048  246 ---------PALFTNKYPEERDMVQQM------LSPSPSERPEAHEV 277
STKc_BMPR2_AMHR2 cd14054
Catalytic domain of the Serine/Threonine Kinases, Bone Morphogenetic Protein and ...
693-797 9.02e-04

Catalytic domain of the Serine/Threonine Kinases, Bone Morphogenetic Protein and Anti-Muellerian Hormone Type II Receptors; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. BMPR2 and AMHR2 belong to a group of receptors for the TGFbeta family of secreted signaling molecules that includes TGFbeta, BMPs, activins, growth and differentiation factors (GDFs), and AMH, among others. These receptors contain an extracellular domain that binds ligands, a single transmembrane region, and a cytoplasmic catalytic kinase domain. Type II receptors are high-affinity receptors which bind ligands, autophosphorylate, as well as trans-phosphorylate and activate low-affinity type I receptors. BMPR2 and AMHR2 act primarily as a receptor for BMPs and AMH, respectively. BMPs induce bone and cartilage formation, as well as regulate tooth, kidney, skin, hair, haematopoietic, and neuronal development. Mutations in BMPR2A is associated with familial pulmonary arterial hypertension. AMH is mainly responsible for the regression of Mullerian ducts during male sex differentiation. It is expressed exclusively by somatic cells of the gonads. Mutations in either AMH or AMHR2 cause persistent Mullerian duct syndrome (PMDS), a rare form of male pseudohermaphroditism characterized by the presence of Mullerian derivatives (ovary and tubes) in otherwise normally masculine males. The BMPR2/AMHR2 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270956 [Multi-domain]  Cd Length: 300  Bit Score: 42.35  E-value: 9.02e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 693 NVISRGRKGISYKGKTKNGEMqfVVKEINDSNSipSSFWTEFAQFG--KLRHSNVVKLIGLCRSQKC----GYLI-SEYI 765
Cdd:cd14054    1 QLIGQGRYGTVWKGSLDERPV--AVKVFPARHR--QNFQNEKDIYElpLMEHSNILRFIGADERPTAdgrmEYLLvLEYA 76
                         90       100       110
                 ....*....|....*....|....*....|....
gi 731385391 766 EGKNLSEVLR--SLSWERRQKIAIGISKALRFLH 797
Cdd:cd14054   77 PKGSLCSYLRenTLDWMSSCRMALSLTRGLAYLH 110
LRR_8 pfam13855
Leucine rich repeat;
93-151 1.20e-03

Leucine rich repeat;


Pssm-ID: 404697 [Multi-domain]  Cd Length: 61  Bit Score: 37.89  E-value: 1.20e-03
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 731385391   93 PYIETVNLSNNALSGGIPGNISLCYSLRYLNLSNNNLTGSMPRGSA--SGLEALDLSNNVI 151
Cdd:pfam13855   1 PNLRSLDLSNNRLTSLDDGAFKGLSNLKVLDLSNNLLTTLSPGAFSglPSLRYLDLSGNRL 61
LRR_8 pfam13855
Leucine rich repeat;
163-223 1.30e-03

Leucine rich repeat;


Pssm-ID: 404697 [Multi-domain]  Cd Length: 61  Bit Score: 37.89  E-value: 1.30e-03
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 731385391  163 SRLKVLDLGGNFLVGKIPNSIANITSLEFLTLASNQLVGEIPRELGRMKSLKWIYLGYNNL 223
Cdd:pfam13855   1 PNLRSLDLSNNRLTSLDDGAFKGLSNLKVLDLSNNLLTTLSPGAFSGLPSLRYLDLSGNRL 61
PKc_Byr1_like cd06620
Catalytic domain of fungal Byr1-like dual-specificity Mitogen-activated protein Kinase Kinases; ...
763-881 1.34e-03

Catalytic domain of fungal Byr1-like dual-specificity Mitogen-activated protein Kinase Kinases; PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine (ST) or tyrosine residues on protein substrates. Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKK kinase Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The Byr-1 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270792 [Multi-domain]  Cd Length: 286  Bit Score: 41.66  E-value: 1.34e-03
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 763 EYIEGKNLSEVLRSLSW---ERRQKIAIGISKALRFL-------HCNCSPSMVVGNMSPQKIIIDgkdephLRLSPPLM- 831
Cdd:cd06620   84 EYMDCGSLDKILKKKGPfpeEVLGKIAVAVLEGLTYLynvhriiHRDIKPSNILVNSKGQIKLCD------FGVSGELIn 157
                         90       100       110       120       130
                 ....*....|....*....|....*....|....*....|....*....|.
gi 731385391 832 -VCTDFkcIISSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSPTDAE 881
Cdd:cd06620  158 sIADTF--VGTSTYMSPERIQGGKYSVKSDVWSLGLSIIELALGEFPFAGS 206
PTKc_Trk cd05049
Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases; PTKs catalyze ...
704-877 1.41e-03

Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases; PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. They are receptor PTKs (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. The Trk subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270643 [Multi-domain]  Cd Length: 280  Bit Score: 41.68  E-value: 1.41e-03
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 704 YKGKTKNGEMQFVVKEIND--SNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVLRS----- 776
Cdd:cd05049   27 YNLEPEQDKMLVAVKTLKDasSPDARKDFEREAELLTNLQHENIVKFYGVCTEGDPLLMVFEYMEHGDLNKFLRShgpda 106
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 777 ------------LSWERRQKIAIGISKALRFLHC-----------NCspsmVVGnmspQKIIIDGKDEPHLRlsppLMVC 833
Cdd:cd05049  107 aflasedsapgeLTLSQLLHIAVQIASGMVYLASqhfvhrdlatrNC----LVG----TNLVVKIGDFGMSR----DIYS 174
                        170       180       190       200       210
                 ....*....|....*....|....*....|....*....|....*....|
gi 731385391 834 TDFKCIISSA-----YFAPETRETKDTTEKSDIYGFGLILIELMT-GKSP 877
Cdd:cd05049  175 TDYYRVGGHTmlpirWMPPESILYRKFTTESDVWSFGVVLWEIFTyGKQP 224
STKc_Byr2_like cd06628
Catalytic domain of the Serine/Threonine Kinases, fungal Byr2-like Mitogen-Activated Protein ...
841-946 1.46e-03

Catalytic domain of the Serine/Threonine Kinases, fungal Byr2-like Mitogen-Activated Protein Kinase Kinase Kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases, which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. The Byr2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270798 [Multi-domain]  Cd Length: 267  Bit Score: 41.75  E-value: 1.46e-03
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 841 SSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSPTdAEFGVHGSIVEWGRYcysdchldmwIDPIIRAQVSSNQNQM 920
Cdd:cd06628  175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGTHPF-PDCTQMQAIFKIGEN----------ASPTIPSNISSEARDF 243
                         90       100
                 ....*....|....*....|....*.
gi 731385391 921 VEimnlalHCTATDPTARPCASDVLK 946
Cdd:cd06628  244 LE------KTFEIDHNKRPTADELLK 263
STKc_IKK_beta cd14038
Catalytic domain of the Serine/Threonine kinase, Inhibitor of Nuclear Factor-KappaB Kinase ...
760-877 1.76e-03

Catalytic domain of the Serine/Threonine kinase, Inhibitor of Nuclear Factor-KappaB Kinase (IKK) beta; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. IKKbeta is involved in the classical pathway of regulating Nuclear Factor-KappaB (NF-kB) proteins, a family of transcription factors which are critical in many cellular functions including inflammatory responses, immune development, cell survival, and cell proliferation, among others. The classical pathway regulates the majority of genes activated by NF-kB including those encoding cytokines, chemokines, leukocyte adhesion molecules, and anti-apoptotic factors. It involves NEMO (NF-kB Essential MOdulator)- and IKKbeta-dependent phosphorylation and degradation of the Inhibitor of NF-kB (IkB), which liberates NF-kB dimers (typified by the p50-p65 heterodimer) from an inactive IkB/dimeric NF-kB complex, enabling them to migrate to the nucleus where they regulate gene transcription. The IKKbeta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270940 [Multi-domain]  Cd Length: 290  Bit Score: 41.49  E-value: 1.76e-03
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 760 LISEYIEGKNLSEVLRSLS---WERRQKIAI---GISKALRFLHCN------CSPSMVVGNMSPQKIIIDGKDEPHLRLS 827
Cdd:cd14038   75 LAMEYCQGGDLRKYLNQFEnccGLREGAILTllsDISSALRYLHENriihrdLKPENIVLQQGEQRLIHKIIDLGYAKEL 154
                         90       100       110       120       130
                 ....*....|....*....|....*....|....*....|....*....|
gi 731385391 828 PPLMVCTDFkcIISSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSP 877
Cdd:cd14038  155 DQGSLCTSF--VGTLQYLAPELLEQQKYTVTVDYWSFGTLAFECITGFRP 202
STKc_Titin cd14104
Catalytic domain of the Giant Serine/Threonine Kinase Titin; STKs catalyze the transfer of the ...
695-881 1.92e-03

Catalytic domain of the Giant Serine/Threonine Kinase Titin; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. Titin, also called connectin, is a muscle-specific elastic protein and is the largest known protein to date. It contains multiple immunoglobulin (Ig)-like and fibronectin type III (FN3) domains, and a single kinase domain near the C-terminus. It spans half of the sarcomere, the repeating contractile unit of striated muscle, and performs mechanical and catalytic functions. Titin contributes to the passive force generated when muscle is stretched during relaxation. Its kinase domain phosphorylates and regulates the muscle protein telethonin, which is required for sarcomere formation in differentiating myocytes. In addition, titin binds many sarcomere proteins and acts as a molecular scaffold for filament formation during myofibrillogenesis. The Titin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271006 [Multi-domain]  Cd Length: 277  Bit Score: 41.38  E-value: 1.92e-03
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 695 ISRGRKGISYKGKTKNGEMQFVVKEINDSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVL 774
Cdd:cd14104    8 LGRGQFGIVHRCVETSSKKTYMAKFVKVKGADQVLVKKEISILNIARHRNILRLHESFESHEELVMIFEFISGVDIFERI 87
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 775 RSLSWERRQKIAIG----ISKALRFLHcncSPSMVVGNMSPQKIIIDGKDEPHLR---------LSPPLMVCTDFkciIS 841
Cdd:cd14104   88 TTARFELNEREIVSyvrqVCEALEFLH---SKNIGHFDIRPENIIYCTRRGSYIKiiefgqsrqLKPGDKFRLQY---TS 161
                        170       180       190       200
                 ....*....|....*....|....*....|....*....|
gi 731385391 842 SAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSPTDAE 881
Cdd:cd14104  162 AEFYAPEVHQHESVSTATDMWSLGCLVYVLLSGINPFEAE 201
PKc_Pek1_like cd06621
Catalytic domain of fungal Pek1-like dual-specificity Mitogen-Activated Protein Kinase Kinases; ...
690-881 2.23e-03

Catalytic domain of fungal Pek1-like dual-specificity Mitogen-Activated Protein Kinase Kinases; PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine (ST) or tyrosine residues on protein substrates. Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates Pmk1/Spm1 and is regulated by the MAPKK kinase Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKK kinase Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270793 [Multi-domain]  Cd Length: 287  Bit Score: 41.25  E-value: 2.23e-03
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 690 TENNVISRGRKGISYKGKTKNGEMQFVVKEIN-DSN-SIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCG--YLISEYI 765
Cdd:cd06621    4 VELSSLGEGAGGSVTKCRLRNTKTIFALKTITtDPNpDVQKQILRELEINKSCASPYIVKYYGAFLDEQDSsiGIAMEYC 83
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 766 EGKNLSEVLRSLsweRRQ----------KIAIGISKALRFLHcncSPSMVVGNMSPQKIIIDGKDEPHL---RLSPPLMV 832
Cdd:cd06621   84 EGGSLDSIYKKV---KKKggrigekvlgKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLcdfGVSGELVN 157
                        170       180       190       200
                 ....*....|....*....|....*....|....*....|....*....
gi 731385391 833 CTDFKCIISSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSPTDAE 881
Cdd:cd06621  158 SLAGTFTGTSYYMAPERIQGGPYSITSDVWSLGLTLLEVAQNRFPFPPE 206
STKc_Chk2 cd14084
Catalytic domain of the Serine/Threonine kinase, Cell cycle Checkpoint Kinase 2; STKs catalyze ...
714-947 2.35e-03

Catalytic domain of the Serine/Threonine kinase, Cell cycle Checkpoint Kinase 2; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. Checkpoint Kinase 2 (Chk2) plays an important role in cellular responses to DNA double-strand breaks and related lesions. It is phosphorylated and activated by ATM kinase, resulting in its dissociation from sites of damage to phosphorylate downstream targets such as BRCA1, p53, cell cycle transcription factor E2F1, the promyelocytic leukemia protein (PML) involved in apoptosis, and CDC25 phosphatases, among others. Mutations in Chk2 is linked to a variety of cancers including familial breast cancer, myelodysplastic syndromes, prostate cancer, lung cancer, and osteosarcomas. Chk2 contains an N-terminal SQ/TQ cluster domain (SCD), a central forkhead-associated (FHA) domain, and a C-terminal catalytic kinase domain. The Chk2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270986 [Multi-domain]  Cd Length: 275  Bit Score: 40.84  E-value: 2.35e-03
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 714 QFVVKEINDS---------NSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNL-SEVLRSLSW-ERR 782
Cdd:cd14084   33 KVAIKIINKRkftigsrreINKPRNIETEIEILKKLSHPCIIKIEDFFDAEDDYYIVLELMEGGELfDRVVSNKRLkEAI 112
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 783 QK-IAIGISKALRFLHCNcspSMVVGNMSPQKIIIDGKDEphlrlsPPLMVCTDF---KCIISSA----------YFAPE 848
Cdd:cd14084  113 CKlYFYQMLLAVKYLHSN---GIIHRDLKPENVLLSSQEE------ECLIKITDFglsKILGETSlmktlcgtptYLAPE 183
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 849 TRETKDT---TEKSDIYGFGLILIELMTGKSPTDAEFG---VHGSIVEwGRYCYSDCHldmWidpiirAQVSSNQNQMVE 922
Cdd:cd14084  184 VLRSFGTegyTRAVDCWSLGVILFICLSGYPPFSEEYTqmsLKEQILS-GKYTFIPKA---W------KNVSEEAKDLVK 253
                        250       260
                 ....*....|....*....|....*
gi 731385391 923 IMnlalhcTATDPTARPCASDVLKT 947
Cdd:cd14084  254 KM------LVVDPSRRPSIEEALEH 272
STKc_GSK3 cd14137
The catalytic domain of the Serine/Threonine Kinase, Glycogen Synthase Kinase 3; STKs catalyze ...
690-875 2.45e-03

The catalytic domain of the Serine/Threonine Kinase, Glycogen Synthase Kinase 3; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. GSK3 is a mutifunctional kinase involved in many cellular processes including cell division, proliferation, differentiation, adhesion, and apoptosis. In plants, GSK3 plays a role in the response to osmotic stress. In Caenorhabditis elegans, it plays a role in regulating normal oocyte-to-embryo transition and response to oxidative stress. In Chlamydomonas reinhardtii, GSK3 regulates flagellar length and assembly. In mammals, there are two isoforms, GSK3alpha and GSK3beta, which show both distinct and redundant functions. The two isoforms differ mainly in their N-termini. They are both involved in axon formation and in Wnt signaling.They play distinct roles in cardiogenesis, with GSKalpha being essential in cardiomyocyte survival, and GSKbeta regulating heart positioning and left-right symmetry. GSK3beta was first identified as a regulator of glycogen synthesis, but has since been determined to play other roles. It regulates the degradation of beta-catenin and IkB. Beta-catenin is the main effector of Wnt, which is involved in normal haematopoiesis and stem cell function. IkB is a central inhibitor of NF-kB, which is critical in maintaining leukemic cell growth. GSK3beta is enriched in the brain and is involved in regulating neuronal signaling pathways. It is implicated in the pathogenesis of many diseases including Type II diabetes, obesity, mood disorders, Alzheimer's disease, osteoporosis, and some types of cancer, among others. The GSK3 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271039 [Multi-domain]  Cd Length: 293  Bit Score: 40.95  E-value: 2.45e-03
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 690 TENNVISRGRKGISYKGKTKNGEMQFVVKEINDSNSIPSSfwtEFAQFGKLRHSNVVKLI------GLCRSQKCGYLISE 763
Cdd:cd14137    7 TIEKVIGSGSFGVVYQAKLLETGEVVAIKKVLQDKRYKNR---ELQIMRRLKHPNIVKLKyffyssGEKKDEVYLNLVME 83
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 764 YIEgKNLSEVLRSLsWERRQKIAIG--------ISKALRFLHcncSPSMVVGNMSPQKIIIDGKDEpHLRLSpplmvctD 835
Cdd:cd14137   84 YMP-ETLYRVIRHY-SKNKQTIPIIyvklysyqLFRGLAYLH---SLGICHRDIKPQNLLVDPETG-VLKLC-------D 150
                        170       180       190       200       210
                 ....*....|....*....|....*....|....*....|....*....|....
gi 731385391 836 F---KCI---------ISSAYF-APE-TRETKDTTEKSDIYGFGLILIELMTGK 875
Cdd:cd14137  151 FgsaKRLvpgepnvsyICSRYYrAPElIFGATDYTTAIDIWSAGCVLAELLLGQ 204
STKc_aPKC_iota cd05618
Catalytic domain of the Serine/Threonine Kinase, Atypical Protein Kinase C iota; STKs catalyze ...
713-879 3.04e-03

Catalytic domain of the Serine/Threonine Kinase, Atypical Protein Kinase C iota; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270769 [Multi-domain]  Cd Length: 364  Bit Score: 41.17  E-value: 3.04e-03
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 713 MQFVVKE-INDSNSIPssfWTEFAQFGKLRHSNVVKLIGL--C-RSQKCGYLISEYIEGKNLS---EVLRSLSWERRQKI 785
Cdd:cd05618   50 MKVVKKElVNDDEDID---WVQTEKHVFEQASNHPFLVGLhsCfQTESRLFFVIEYVNGGDLMfhmQRQRKLPEEHARFY 126
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 786 AIGISKALRFLHcncSPSMVVGNMSPQKIIIDgkDEPHLRLSPPLMV--------CTDFKCIISSaYFAPETRETKDTTE 857
Cdd:cd05618  127 SAEISLALNYLH---ERGIIYRDLKLDNVLLD--SEGHIKLTDYGMCkeglrpgdTTSTFCGTPN-YIAPEILRGEDYGF 200
                        170       180
                 ....*....|....*....|..
gi 731385391 858 KSDIYGFGLILIELMTGKSPTD 879
Cdd:cd05618  201 SVDWWALGVLMFEMMAGRSPFD 222
PTKc_Btk_Bmx cd05113
Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow ...
698-879 4.08e-03

Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome; PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec-like subfamily of proteins, which are cytoplasmic (or nonreceptor) PTKs with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members except Rlk also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor, leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. The Btk/Bmx subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 173657 [Multi-domain]  Cd Length: 256  Bit Score: 40.25  E-value: 4.08e-03
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 698 GRKGISYKGKTKnGEMQFVVKEINDSNSIPSSFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVLRS- 776
Cdd:cd05113   15 GQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREm 93
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 777 ---LSWERRQKIAIGISKALRFLHcncSPSMVVGNMSPQKIIIDgkdephlrlSPPLMVCTDF---KCIISSAYF----- 845
Cdd:cd05113   94 rkrFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVN---------DQGVVKVSDFglsRYVLDDEYTssvgs 161
                        170       180       190       200
                 ....*....|....*....|....*....|....*....|..
gi 731385391 846 -------APETRETKDTTEKSDIYGFGLILIELMT-GKSPTD 879
Cdd:cd05113  162 kfpvrwsPPEVLMYSKFSSKSDVWAFGVLMWEVYSlGKMPYE 203
PTKc_ALK_LTK cd05036
Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte ...
712-775 5.18e-03

Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase; PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor PTKs (RTKs) whose ligands are not yet well-defined. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. The ALK/LTK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270632 [Multi-domain]  Cd Length: 277  Bit Score: 40.06  E-value: 5.18e-03
                         10        20        30        40        50        60
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 731385391 712 EMQFVVKEINDSNSIPS--SFWTEFAQFGKLRHSNVVKLIGLCRSQKCGYLISEYIEGKNLSEVLR 775
Cdd:cd05036   36 PLQVAVKTLPELCSEQDemDFLMEALIMSKFNHPNIVRCIGVCFQRLPRFILLELMAGGDLKSFLR 101
STKc_TAO2 cd06634
Catalytic domain of the Serine/Threonine Kinase, Thousand-and-One Amino acids 2; STKs catalyze ...
700-877 5.24e-03

Catalytic domain of the Serine/Threonine Kinase, Thousand-and-One Amino acids 2; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 possesses mitogen-activated protein kinase (MAPK) kinase kinase activity and activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating their respective MAP/ERK kinases, MEK3/MEK6 and MKK4/MKK7. It contains a long C-terminal extension with autoinhibitory segments, and is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor, interleukin 1, and Toll-like receptor. The TAO2 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270804 [Multi-domain]  Cd Length: 308  Bit Score: 40.01  E-value: 5.24e-03
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 700 KGISYKGKTKNGEMQFVVKEIndsnsipssfwtEFAQfgKLRHSNVVKLIGLCRSQKCGYLISEYIEG--KNLSEVLRSL 777
Cdd:cd06634   46 KKMSYSGKQSNEKWQDIIKEV------------KFLQ--KLRHPNTIEYRGCYLREHTAWLVMEYCLGsaSDLLEVHKKP 111
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 778 SWERR-QKIAIGISKALRFLHcncSPSMVVGNMSPQKIIIDgkdephlrlSPPLMVCTDF--KCIISSA--------YFA 846
Cdd:cd06634  112 LQEVEiAAITHGALQGLAYLH---SHNMIHRDVKAGNILLT---------EPGLVKLGDFgsASIMAPAnsfvgtpyWMA 179
                        170       180       190
                 ....*....|....*....|....*....|....
gi 731385391 847 PETRETKDTTE---KSDIYGFGLILIELMTGKSP 877
Cdd:cd06634  180 PEVILAMDEGQydgKVDVWSLGITCIELAERKPP 213
PKc_MAPKK cd06605
Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase ...
693-877 5.54e-03

Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase; PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine (ST) or tyrosine residues on protein substrates. MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAPK, which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPKK kinase (MAPKKK or MKKK or MAP3K). There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270782 [Multi-domain]  Cd Length: 265  Bit Score: 39.64  E-value: 5.54e-03
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 693 NVISRGRKGISYKGKTKNGEMQFVVKEINdSNSIPSSFWTEFAQFGKLRHSN---VVKLIGLCRSQKCGYLISEYIEGKN 769
Cdd:cd06605    7 GELGEGNGGVVSKVRHRPSGQIMAVKVIR-LEIDEALQKQILRELDVLHKCNspyIVGFYGAFYSEGDISICMEYMDGGS 85
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 770 LSEVLRSLSW---ERRQKIAIGISKALRFLHCNCSpsMVVGNMSPQKIIIDGKDEPHL---RLSPPL---MVCTDFKCii 840
Cdd:cd06605   86 LDKILKEVGRipeRILGKIAVAVVKGLIYLHEKHK--IIHRDVKPSNILVNSRGQVKLcdfGVSGQLvdsLAKTFVGT-- 161
                        170       180       190
                 ....*....|....*....|....*....|....*..
gi 731385391 841 sSAYFAPETRETKDTTEKSDIYGFGLILIELMTGKSP 877
Cdd:cd06605  162 -RSYMAPERISGGKYTVKSDIWSLGLSLVELATGRFP 197
RNA1 COG5238
Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Translation, ...
352-583 5.86e-03

Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Translation, ribosomal structure and biogenesis];


Pssm-ID: 444072 [Multi-domain]  Cd Length: 434  Bit Score: 40.16  E-value: 5.86e-03
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 352 GKQNNLTVLDLSTNNLSGEIPESLCnsgrlfklilfsnslegevpKSLSDCRSLRRVRLQSNHFsGELSSEFM-----KL 426
Cdd:COG5238  177 LQNNSVETVYLGCNQIGDEGIEELA--------------------EALTQNTTVTTLWLKRNPI-GDEGAEILaealkGN 235
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 427 PLVYFLDISDNnltgKISDrrwdmPSLQML--SLARNRffgnlpqsfgasKLENLDLSENQFSG----AVPSSFGNLSEL 500
Cdd:COG5238  236 KSLTTLDLSNN----QIGD-----EGVIALaeALKNNT------------TVETLYLSGNQIGAegaiALAKALQGNTTL 294
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 501 MQLKLSENMLSGD----IPEELSSCKKLVSLNLSHNQLSGH----IPASFSDMPVLGQLDLSQNQLSGK----IPPNLGR 568
Cdd:COG5238  295 TSLDLSVNRIGDEgaiaLAEGLQGNKTLHTLNLAYNGIGAQgaiaLAKALQENTTLHSLDLSDNQIGDEgaiaLAKYLEG 374
                        250
                 ....*....|....*
gi 731385391 569 VESLVQVNLSNNHLH 583
Cdd:COG5238  375 NTTLRELNLGKNNIG 389
LRR_RI cd00116
Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 ...
327-606 6.47e-03

Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).


Pssm-ID: 238064 [Multi-domain]  Cd Length: 319  Bit Score: 39.65  E-value: 6.47e-03
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 327 LASLPRLQILQLWSNKLSGE----IPKNLGKQNNLTVLDLSTNNLsGEIPESLcnsgrlfklilfsnsleGEVPKSLSDC 402
Cdd:cd00116   19 LPKLLCLQVLRLEGNTLGEEaakaLASALRPQPSLKELCLSLNET-GRIPRGL-----------------QSLLQGLTKG 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 403 RSLRRVRLQSNHFSGELSSEFMKLPLVYFL---DISDNNLT---GKISDRrwdmpSLQMLSLArnrffgnlpqsfgaskL 476
Cdd:cd00116   81 CGLQELDLSDNALGPDGCGVLESLLRSSSLqelKLNNNGLGdrgLRLLAK-----GLKDLPPA----------------L 139
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 731385391 477 ENLDLSENQFSGAvpssfgnlselmqlklsenmLSGDIPEELSSCKKLVSLNLSHNQLSGH-IPASFSDMPV---LGQLD 552
Cdd:cd00116  140 EKLVLGRNRLEGA--------------------SCEALAKALRANRDLKELNLANNGIGDAgIRALAEGLKAncnLEVLD 199
                        250       260       270       280       290       300
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 731385391 553 LSQNQL----SGKIPPNLGRVESLVQVNLSNN--------HLHGSLPSTGAFLAinSSSVSGNNLC 606
Cdd:cd00116  200 LNNNGLtdegASALAETLASLKSLEVLNLGDNnltdagaaALASALLSPNISLL--TLSLSCNDIT 263
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH